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CHAPTER 1 
INTRODUCTION 
 
 Cancer is a hyperproliferative disorder which involves proliferation, 
apoptosis dysregulation, invasion, angiogenesis and metastasis
1
 and  also  gene  
mutation. Cancer is induced by genetic and epigenetic changes that disrupt pathways 
controlling cell signaling, cell proliferation, apoptosis & differentiation.
2
 The 
uncontrolled proliferation of cells within the tissues produces cell masses known as 
tumors.
3
 Tumors may be benign or malignant. Malignant tumors are aggressive in 
nature that shows indefinite growth without phenotypic changes in the body. Like 
other biological process, cell division is under genetic control and some genes 
regulate the process of cell division in response to intra-cellular, intercellular, and 
environmental signals. Mutation in these genes could destruct the function of 
regulatory genes leading to abnormal cell division.
4
  
 The various stages of cancer include initiation, promotion and 
progression. Cancer initiation might occur due to misreading of the genetic code and 
loss of normal control of gene expression.
4
 If a chemical signal or event induce the 
expansion of the initiated cell into a clone of cancer cells, promotion occurs. 
Progression is the terminal stage of cancer where the clonal group of cells expands 
into multiple tumours.
5
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1.1 Genes and Cancer 
 The evolution of a normal cell into cancer is a multistage process, which 
consists of mutation in the genes involved in control of the reproduction and 
differentiation of a cell. These genes are broadly divided into three categories 
namely proto-oncogene, tumor suppressor genes and repair genes. Chromosomal 
aberrations also lead to cancer. 
1.1.1 Proto-oncogenes 
 The term oncogene was first coined by Heubner and Torado
6
 and altered 
form of a normal gene (oncogene) is called proto-oncogene. Proto-oncogene may be 
converted into potentially tumorogenic oncogenes by a variety of mechanisms
7
 such 
as transduction of cellular sequence by retroviruses, insertional mutagenesis by 
integration of viral sequence, amplification of oncogenes and chromosome 
translocation. These changes activate proto-oncogenes resulting in an unregulated 
expression of the normal product or alterations in the regulatory domains of the 
proteins.
 
1.1.2 Tumor suppressor genes 
 It is a very diverse group of genes and the product of these genes 
negatively regulate the growth of cancer cells. These genes encode the function of 
proteins at a variety of levels in signal transduction and cell cycle. Several 
mechanisms involved in these processes are genetic alterations such as deletions or 
point-mutations leading to direct loss of function in the encoded protein.
8
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1.1.3 Repair genes 
 The presence of a mutation in a gene and the gene responsible for 
mismatch repair in bacteria is found in HNPCC.
9
 It is suggested that repair genes act 
in  a  similar  way  to  tumor  suppressors,  where  loss  of  both  alleles  of  any  of  these  
genes may result in rapid mutation accumulation that increased risk of cancer. 
1.2 Cancer and cell growth regulatory pathways 
 The growth factors are polypeptide molecules that regulate cell growth 
and function by binding with specific receptor, stimulating receptor mediated 
activation of intracellular signal transduction pathways.
1 
Growth factors and 
mitogens activate growth stimulatory pathways. These growth stimulatory molecules 
enabling the cells divide continuously overcoming cell cycle checkpoints.
10
 
Uncontrolled activation of tyrosine kinase-Ras-mitogen activated protein kinase 
pathway leads to cancer.
11
 The key elements of these pathways are proto-oncogene 
products.  Many converging lines of evidence strongly suggest that growth factors 
play a central role in malignancy.  
1.2.1 Cell cycle checks points 
 The fundamental task of cell cycle is to ensure that DNA is faithfully 
replicated once during S-phase and that identical chromosome copies are equally 
distributed to two daughter cells during M-phase.
12
 Oncogenic processes exert their 
greatest effect by targeting particular regulators of post synthetic phase (G1) 
progression.
13
 Cancer cells abandon these controls and tend to remain within cell 
cycle that facilitate maturation and terminal differentiation. 
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1.3 Etiology of Cancer 
 A carcinogen is any substance or agent that induces the formation of 
cancer. The evolution of a normal cell into a cancer cell is a complex multistage 
process where external and internal factors are involved like chemical, physical 
and/or biological insults to cells.
14
 The common pattern to these insults involve 
genetic changes evidenced by possible type of mutation, described transitions, 
transversions, and deletions of various sizes, chromosomal rearrangements, gene 
amplification and point mutations.
14
 
1.3.1 Physical insults (Radiation) 
1.3.1.1 Ultraviolet radiation 
 Ultraviolet radiation is a potent DNA damaging and known inducers of 
skin cancer in experimental animals. Evidence indicates that most non-melanoma 
human cancers result from repeated exposure to sunlight, which induces DNA 
damage. 
 
1.3.1.2 Ionizing radiation 
 The ?-particles and neutrons are the most important potent carcinogenic 
ionizing radiation. The initiation of radiation carcinogenesis involves interaction of 
free radicals with the generic material of the cell. The lethal effect of ionizing 
radiation on mammalian cells is due to strand break and other chromosomal 
aberrations induced by the radiation.
15 
1.3.2 Biological insults (Viral carcinogenesis) 
 One of the first major oncogenic virus identified which induced 
leukaemia in chickens There is strong epidemiological evidence for certain DNA 
viruses which cause human cancers.
16
 Epstain-Barr Virus, Human papilloma virus 
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and Hepatitis B virus cause Burkits lymphoma, cervical cancer and liver cancer 
respectively. This viral genome contains viral oncogene which expresses in cells that 
loses the control on cell replication. 
1.3.3 Chemical insults (Chemical carcinogenesis) 
 Chemicals which cause cancer include aromatic amines, benzene and 
tobacco smoke that produces bladder cancer, leukemia and lung cancer respectively. 
Chemical carcinogens are broadly divided into two classes, organic and inorganic. 
1.3.3.1 Organic carcinogens 
 Based on their donor groups in DNA adduct formation, organic 
carcinogens fall into three categories (i) alkylating, (ii) arylalkylating and (iii) 
arylhydroxyamines. 
1.3.3.2 Alkylating agents 
 Chemicals such as N-nitroso dimethyl amine, N-methyl-N-nitrosourea 
can transfer alkyl groups or a methyl or ethyl group to nucleotides to form DNA 
adducts. N-nitroso compounds, especially nitrosoamines are perhaps the most 
hazardous of the various carcinogens. Aflatoxin B1 is a naturally occurring 
alkylating carcinogen produced by Aspergillus flavus, a common food-
contaminating mold 
1.3.3.3 Arylkylating agents 
 Polycyclic aromatic hydrocarbons (PAH), the principal group of 
aralkylating agents is abundantly present as environment pollutants. The compounds 
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such as benzo [a] pyrene (BP), 7, 12-dimethyl benz (a) antharcene (DMBA) are 
potent chemical carcinogens. 
1.3.3.4 Arylhydroxylamines 
 N-acetoxy-N-acetylaminoflourene (AAF), dimethylamino-azobenzene, 2-
napthyl amine, benzidene etc. are some examples for arylhydroxylamine 
carcinogens. These chemicals transfer aromatic amines to nucleotides to form 
adducts. N-hydroxyl metabolites of 2-naphthyl amine react with DNA in the bladder 
epithelia cause bladder cancer.  
1.3.3.5 Inorganic compounds 
 Certain inorganic metals like arsenic, nickel, chromium, asbestos and 
minerals will elevate risk of cancer in humans. The causation of lung cancer and 
mesothelioma is evident from the asbestos miners.
17
 
 
1.4 Pathogenesis of cancer 
 The commonly accepted basis of the pathogenesis of cancer is the damage 
to the genetic apparatus of cells (mutation, disturbance of gene expression, 
activation of tumor promoter gene, inactivation of tumor suppressor genes, etc.
18, 19 
Defects in the p53 tumour suppressor gene have been linked to more than 50% of 
human cancers.
20
 Recently, Avery-Kieida et al reported  that  some  target  genes  of  
p53 are involved in apoptosis and cell cycle regulation, aberrantly expressed in 
melanoma cells. The mechanism of apoptosis is complex which involves many 
pathways. Defects can occur at any point along these pathways, leading to malignant 
transformation of the affected cells, Morphological hallmarks of apoptosis in the 
nucleus are chromatin condensation and nuclear fragmentation, accompanied by 
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reduction in cellular volume. Broadly, three main types of biochemical changes can 
be observed in apoptosis. They are activation of caspases, DNA and protein 
breakdown and membrane changes and recognition by phagocytic cells.  
             Activated caspases cleave many vital cellular proteins and break up the 
nuclear scaffold and cytoskeleton. Generally, the other mechanisms involved are 
disrupted balance of pro-apoptotic and anti-apoptotic proteins, impaired death 
receptor signalling. This explains the importance in pathogenesis of cancer. 
Fig. 1:  Pathophysiology of cancer 
 
1.5 Epidemiology 
 Cancer is a major public health problem worldwide. Cancer is second 
leading cause of death next to cardiovascular disease in the United States of America
 
and in the UK it is the leading cause of death. The most commonly occurring cancer 
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in men is prostate cancer (about 25% of new cases) while in women it is breast 
cancer (also about 25%). Cancer can occur in children and adolescents with 
leukemia being the most common.
21
 The lifestyle and environmental factors known 
to affect cancer risk include the use of exogenous hormones, exposure to  radiation 
and certain occupational and chemical exposures.
22 
Statistics from the SEER 
program of the US NCI demonstrate that childhood cancers increased 19% between 
1975 and 1990, mainly due to an increased incidence in acute leukemia.  
1.6 Role of free radicals in cancer progression 
 Free radicals can be defined as molecules or molecular fragments 
containing one or more unpaired electrons in atomic or molecular orbitals.
23 
The 
initial attack of free radicals initiate a chain reaction targeting organ damage. This 
unstable radical is highly reactive and causes formation of reactive oxygen species. 
Beneficial biological functions such as apoptosis, necrosis, and phagocytosis are 
mediated by reactive oxygen species. These reactive metabolites are selectively 
neutralized by body's defensive mechanism such as enzymatic and non-enzymatic 
antioxidants. At low to moderate concentrations they function in physiological cell 
processes, but at high concentrations, they produce adverse modifications to cell 
components such as lipids, proteins and DNA.
24-26
  
1.7 Treatment of cancer 
 There are three established strategies used to kill cancer cells in the 
patient's body.    They are physical - removal of tumor mass (resection) which is the 
foundation of surgery and radiotherapy (or) chemotherapy. The radiotherapy and the 
chemotherapy include the exposure to toxic ionizing radiation or cytotoxic 
chemicals respectively to destroy cancer cells. 
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1.7.1 Surgery 
 Surgical procedures are used to remove malignant tissues and it remains 
one of the  important  modalities  of  treatment  for  malignant  tumors.  It  has  a  role  in  
cure, prevention, diagnosis, staging and papulation.  
1.7.2 Radiation therapy 
 Radiation is most toxic to proliferating cells and higher doses are required 
to kill cells that are capable of proliferating but are not actively dividing (quiscent 
cells) at the time of exposure. X-rays sterilize rams by killing the proliferating germ 
cells in testes that maintain spermatogenesis.
27
 In modern oncogenic practice, 
radiotherapy is frequently combined with surgery and chemotherapy to provide the 
most effective tumor control with the least damage to normal tissues.  
1.7.3 Chemotherapy 
 The purpose of treating cancer with chemotherapeutic agent is to prevent 
cancer cells from multiplying, invading, metastasizing and ultimately killing them. 
There are two classes of chemotherapeutic agents namely, Phase specific drugs and 
cell cycle non-specific drugs. Phase specific drugs are agents which are active 
against cells in a specific phase of the cell cycle. Cell cycle non-specific agents are 
not schedule dependent, e.g. alkylating agents such as busulphan, chlorambusil, 
cyclophosphamide and nitrosourea. The chemotherapeutic agents can be classified 
in two groups based on their source/origin namely, non-plant derived anticancer 
agents and plant derived anticancer agents. 
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1.7.3.1  Non-plant derived anticancer agents 
 The non plant derived anticancer agents can be classified into alkylating 
agents and antimetabolites. Nitrogen mustard, chlorambucil, cylophosphamide, 
busulphan are the examples of alkylating agents used against lymphomas, many 
solid tumors, chronic leukemia, multiple myeloma etc.
28
  Antimetabolites are 
structural analogues of normal metabolites. There are four major classes of 
antimetabolites namely purines, pyramidines, folic acid and glutamine 
antimetabolites. Methotrexate (MTX) is used against acute leukemia, carcinomas of 
head and neck, breast and testis. Cytosine arabinoside (Ara-c) and 5-flourouracil (5-
FU) are the most important pyramidine analogue. 5-FU is used for the treatment of 
breast and gastrointestinal cancers. Mercaptopurine (6-MP) and thioguanine (6-TG) 
are purine analogues used for granulocytic leukemia.   
 Antibiotics is another class of drugs used for the treatment of cancer and 
are synthesized by bacterial or fungal species. They interfere with cellular 
metabolism by binding to nucleic acid by scission of DNA or by functioning as 
antimetabolites e.g. azotomycin. adriamycin, actinomycin, actinomycin-D and 
bleomycin are most important drugs coming under this class. Adriamycin is 
effective against lymphomas, leukemias, sarcomas and carcinomas. 
 Enzyme such as asparaginase isolated from pig serum was first identified 
as anti-lymphoma agent. Further experiments revealed that some tumor cells need L-
aspargine to maintain its growth. When the circulating levels of asparagines are 
depleted by asparginase, the tumor cells are unable to grow or survive. Currently L-
asparaginase is used in the treatment of acute lymphoblastic leukemia either in 
relapse or at initial diagnosis.  
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1.7.3.2 Plant Derived Anticancer Agents 
 Plants have formed a basis for traditional medicine systems that have been 
used for thousands of years in countries with ancient civilizations such as China, 
29
 
India and Thailand.
30
 In recent year’s extensive research for antitumor agents from 
plants have been undertaken. One of the most intensive projects carried out by 
National  Cancer  Institute  (NCI)  in  United  States  is  to  screen  anticancer  principle  
from the plants. From these screening projects vinblastin, vincristin, 
podophylltoxins, taxol and recently camptothecins were selected and used for 
clinical treatment of cancer. 
1.8 Hepatotoxicity  
 The liver plays an astonishing array of vital functions in the maintenance, 
performance and regulating homeostasis of the body and is considered as the central 
chemical laboratory responsible for the metabolism and disposition of exogenous 
toxins and therapeutic agents responsible for metabolic derangement. It also helps in 
the biochemical regulation of fats, carbohydrates, amino acids, proteins, blood 
coagulation and immuno-modulation. The liver performs all the process of secretion, 
regulation and storage via the use of specific genes for operation that are located in 
the  chromosomes  of  the  hepatocytes.  It  is  the  principal  site  of  synthesis  of  all  
circulating proteins and all factors involved in coagulation. Any damage to liver is 
reflected by a change in the following biochemical parameters of the blood. Serum 
bilirubin is  a  metabolic  product  of  heme  and  one  of  the  markers  of  the  liver  
function. The bilirubin rises in diseased conditions of the liver. Serum hepatocyte 
enzymes like aspartate transaminase (AST) and alanine transaminase (ALT), 
alkaline phosphatase (ALP) are markers of hepatocellular injury. When the liver cell 
is injured or dies, these proteins may leak through the liver cell membrane into the 
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circulation and may increase in level sometimes. ALT levels are very high in 
patients of viral hepatitis and hepatic necrosis.  
 A vast majority of pharmaceuticals, chemical agents and industrial toxins 
are capable of causing liver damage. Hepatotoxins are of two major groups, namely 
direct and indirect hepatotoxins. The former hepatotoxins damage the membrane of 
hepatocytes directly resulting interference in cell metabolism and the later 
hepatotoxins cause hepatic injury as a result of selective interference with metabolic 
pathways or selective binding to or alteration of a specific component.  
1.8.1 Role of free radicals in hepatic disorders  
 Free radicals are reactive molecules playing an important role in normal 
physiological processes and in diseased states such as cancer, liver injury, aging, 
arthritis, Parkinson syndrome. Superoxide anion O2
·
 is generated by direct auto 
oxidation of oxygen during mitochondrial electron transport chain. Hydroxyl radical 
(OH
-
) is formed by 2 ways (i) By radiolysis of H2O and (ii) by reaction of H2O2 with 
Ferrous (Fe
++
) ions in a reaction termed as Fenton reaction. The hydroxyl radical is 
the most reactive species and produces membrane damage by lipid peroxidation. 
Free radicals derived from oxygen also cause cell injury by oxidation of protein 
macromolecules of the cell and results in degradation of cytosolic neutral proteases 
and cell destruction. They also break in single strands of nuclear and mitochondrial 
DNA .This results in cell injury and may also cause malignant transformation of 
cells. Reactive oxygen species interact with cytoskeletal elements and interfere with 
mitochondrial phosphorylation and cause ATP depletion. These free radicals attack 
unsaturated fatty acids of biomembranes, results in lipid peroxidation followed by 
destruction of proteins and DNA.
31
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Antioxidants are substances that neutralize activity of free radicals.
32
 Nature has 
endowed each cell with adequate protective mechanisms against any harmful effects 
of free radicals such as superoxide dismutase (SOD), glutathione peroxidase, 
glutathione reductase, thioredoxin and thiols. ?-Tocopherol (vitamin E) is an 
essential nutrient which functions as a chain-breaking antioxidant and it prevents the 
propagation of free radical reactions in all cell membranes in the human body. 
Ascorbic acid (vitamin C) is also part of the normal protecting mechanism. The non-
enzymatic antioxidants include carotenoids, flavonoids and related polyphenols, ?-
lipoic acid, glutathione etc. 
1.8.2 Induction of Hepatotoxicity 
 Heepatoprotective effect are generally studied by inducing hepatotoxicity 
by administration of  hepatotoxicants like carbon tetrachloride, D-galactosamine, 
thioacetamide, ethanol, aflatoxin B1, alpha amanitine, phalloidin, cadmium, 
paracetamol, hydrazine, halothane, isoniazid etc which causes damage of rat liver, 
resulting in biochemical and histopathological changes and then studying the effect 
of the agent.  
1.8.2.1 D-Galactosamine induced liver injury 
 D-galactosamine induced liver damage is a well-established model that 
induces a diffuse type of liver injury closely resembling human viral hepatitis.
33 
Galactosamine is a hexosamine derived from galactose and is a constituent of 
glycoprotein hormones such as follicle stimulating hormone (FSH) and leteinizing 
hormone (LH).  
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 The metabolites of D-galactosamine (GaIN), uridiophosphogalactos 
amine may deplete several uracil nucleotides such as UDP-lactose, UDP-glucose 
and UTP, causing reduction of mRNA and glycoprotein synthesis (i.e. reduction of 
ATP and glycogen synthesis) which leads to cellular membranes alteration.
34 
inducing transcriptional arrest and causing an increase in sensitization to cytokines 
such as TNF-? and an increase in oxidative stress and GSH depletion, which lead to 
mitochondrial dysfunction and cell death.
35
  This mechanism of toxicity brings about 
an increase in cell membrane permeability leading to enzyme leakage and eventually 
cell death. This phenomenon may lead to cellular damage and cellular inflammation 
resulting in histological and biochemical picture closely resembling viral hepatitis. 
 The diagnosis and treatment of most cancers remains elusive despite 
advances in understanding the molecular basis and therefore the identification of 
new and efficient anticancer drugs especially herbal drugs for various types of 
cancer has always been a focal point in cancer research.
36,37 
 Plants  are  potential  
sources of phytoconstituents that have anti cancer properties which needs to be 
explored.  
1.8 Herbal Medicine     
 Herbal medicines are indispensable to nearly 80% of the population of 
developing nations as indicated in the survey conducted by World Health 
Organization. According to study conducted in USA in the year 1993, more than 
50% of the prescriptions prescribed contained atleast one active compound of 
biological origin and a study in 1997 showed that nearly 40% of the best-selling 
pharmaceutical drugs were or natural origin or derived from natural products.                
India is a vast storehouse of medicinal plants that are being used in Indian systems 
of Medicine.
38
 Alhough more than 20,000 medicinal plants have been recorded, only 
7,000-7,500 of them are being used by traditional communities for cure of different 
diseases
39
 but there are large numbers of plants which are still to be explored.  
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 The scientific literature is rich in epidemiological studies that support 
significant differences in the occurrence of cancers between oriental and occidental 
populations.
40,41 
Reduced incidence of cancer is seen in populations which consume 
high level of natural herbal products for example, High consumption of soybean 
which is dietary source of saponins by populations in Asian countries have shown 
lower incidence of colon cancer.
42
 The phytoconstituents present in herbs like Vinca, 
Aloe, Taxus, onion, ginger, liquorice etc. promote production of cytokines which 
enhances the activity of immune cells of body. The toxic side effects of radiotherapy 
and chemotherapy are reduced by these herbs, which fight cancer more effectively.
43
  
              Phytoconstituents and their semi synthetic derivatives namely vinblastine, 
vincristine, camptothecin, topotecan and irinotecan, etoposide derived from 
epipodophyllotoxin and paclitaxel (taxol) etc. continue to play an important role 
treatment of cancer
44
 and more than 60% of agents used currently for treating 
cancers are derived from natural sources.
45
 Consumption of fruits, vegetables and 
edible plants reduce the risk of cancer and therefore considered as a method for 
preventing cancer.
46,47
 Hence increasing interest in screening of plants for potential 
anticancer activity has been seen lately and an attempt in the present investigation is 
made to select appropriate plants and evaluate them for anticancer activity.  
             In the present investigation, the medicinal herb Boerhaavia diffusa Linn 
belonging to the family Nyctaginaceae, widely distributed throughout India, is being 
used extensively in Ayurvedic system of medicine for treating various ailments but 
not as an anti cancer agent though there is ethnobotanical claim for its 
chemotherapeutic potential.  The review of literature revealed very little information 
on evaluation of anticancer activity and hence chosen for the present study to 
scientifically validate the ethno botanical claim.  
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CHAPTER 2 
REVIEW OF LITERATURE 
 
 Plants are indispensable in treating diverse forms of disease including 
cancer and it can be used as an alternative to limit the emergence and spread of 
cancer. The chapter on review of literature deals with reports from primary and 
secondary sources about medicinal plants known to exhibit anticancer activity and 
also about ehtnopharmacological, phytochemical and pharmacological studies on the 
plant Boerhaavia diffusa belonging to the family Nyctanginaceae 
 The plants known to exhibit anti cancer properties include vinca alkaloids 
from Cantharanthus roseus used for treatment of lymphomas, leukemias, breast 
cancer, testicular cancer, lung cancers, and Kaposi’s sarcoma.
48
 podophyllotoxins 
from Podophyllum peltatum Linn., and  P. emodii Wallich for treatment of skin 
cancers and warts.
48  
 Curcuma longa L., a member of the ginger family have been studied for 
colon cancer, breast cancer, lung metastases, and brain tumor. In vitro and in vivo 
studies show that genistein isolated from Genista tinctoria has been found to be 
useful in treating leukemia.
1 
Paclitaxel isolated from Taxus bravifolia Nutt.  is  used 
in the treatment of wide variety of cancers including breast, ovarian and non-small-
cell lung cancer, and has also shown efficacy against Kaposi sarcoma.
48  
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Withania somnifera is highly appreciated in Ayurveda for cancer patients and also 
used as a folklore remedy for combating the cancer like conditions and also prolong 
life.
49 
Specific acetogenins from Annona muricata have been reportedly identified to 
be toxic for various cancer cell lines like lung solid human-breast cancer, tumor 
carcinoma, pancreatic carcinoma, prostatic adenocarcinoma, colonic 
adenocarcinoma, human lymphoma, liver cancer, and multiple-drug resistant 
human-breast adenocarcinoma.
50 
 The cytotoxic activity of Centaurea ainetensis extracts has been studied 
in human colon carcinoma cells and isolated salograviolide A also exhibited potent 
cytotoxic action against epidermal squamous cell carcinogenesis.
 51, 52 
 In vivo and in vitro studies revealed the antitumor properties of gossypol 
isolated from various species of Gossypium, on many cytosolic and mitochondrial 
enzyme systems that is fundamental for tumor cell growth, including melanoma, 
endometrial, colon, lung, prostate, breast, brain, and adrenocortical cancer.
53-55 
 Oroxylum indicum has anti-tumour effect on human cancer cell lines and 
inhibited the 50% proliferation of HL-60 cell lines at a concentration of 25-30µM
56
 
while the methanol extract of Cissampelos pariera and various C. hirsutus extracts 
showed in vitro antitumor activity against  MCF-7 cancer cell line and in vivo 
antitumor activity in DAL tumor-bearing mice.
57,58
 Cleistanthin B isolated from  
leaves of Cleistanthus collinus also showed significant antitumor activity against 
EAC and DAL cell line induced malignant ascites tumor animals at 50 mg/kg.
59 
Review on Boerhaavia diffusa 
 Nyctaginaceae known as the four o'clock family comprises of 33 genera 
and 290 species of flowering plants widely distributed in tropical and subtropical 
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regions and a few in the temperate region. The genus Boerhaavia belonging to the 
family Nyctaginaceae is named after the famous Dutch physician Hermann 
Boerhaave of the 18
th
 century who discovered the same. The genus has 40 species 
distributed in the tropical, subtropical, and temperate regions of the world and 6 
species in India. The species found in India include B. diffusa, B. chinensis, B. 
erecta, B. repens, B. rependa, and B. rubicund. Boerhaavia diffusa is indigenous to 
India and is found in warmer parts of the country. Several articles are available on 
the plant as it is being extensively used in Indian systems of Medicine especially 
Ayurveda. A few of the pharmacological phytochemical and pharmacognostical 
studies are described in this chapter.  
Pharmacological studies 
 The aqueous and acetone extracts of the roots of Boerhaavia diffusa Linn 
showed significant anti inflammatory activity against carageenan induced oedema 
and formaldehyde induced arthritis in albino rats
60
 while 50% ethanolic extract 
exhibited protective effect against hepatoxicity produced by country made liquor
61 
carbon tetrachloride and also rifampicin isonazid.
62 
 The ethanolic extract of roots of Boerhaavia diffusa Linn exhibited anti-
diabetic and anti-hyperlipideamic effect against streptozocin induced experimental 
rats by restoring the increased blood glucose and lipids;
63
 anti histaminic effect and 
bronchodilating activity against histamine on isolated goat tracheal chain preparation 
and histamine induced broncho constriction in Guinea pig
64
 and the methanolic 
extract of the roots and its different fraction including liriodendrin rich fraction in 
pentylenetetrazol induced seizures exhibited a dose dependent protection against 
PTZ induced convulsion.
65
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 The aqueous extract of Boerhaavia diffusa Linn roots exhibited 
nephroprotective against acetaminophen induced nephrotoxicity by restoring to near 
normal the depleted values of blood urea nitrogen (BUN), serum creatinine, protein 
thiol, and anti oxidant enzymes
66
 and anti-urolithiatic activity by reducing the hyper 
oxaluria and crystal depositions in a dose dependent manner
20 
while the hydro-
alcoholic extract of roots improved the symptoms of prostatic hyperplasia when 
tested in experimental Benign prostatic hyperplasia in rats 
67
 
 The chloroform and ethanolic root extract of Boerhaavia diffusa Linn 
showed antioxidant activity in DPPH radical scavenging assay, anti-proteolytic 
activity, polyphenol oxidase and hydroperoxide inhibition and ferric reducing power 
by Shisode. The ethanolic extracts had better antioxidant activity than standard 
quercetin, salicylic acid, L-cysteine and ascorbic acid and the phytochemical 
screening revealed the presence of carbohydrate saponins, proteins, flavonoids, 
steroids, fats & alkaloid
68
 while the ethyl acetate extract of roots exhibited anti 
fungal activity.  
 The chloroform, ethanol and ethyl acetate fraction of roots of Boerhaavia 
diffusa Linn exhibited in vitro antioxidant activities in nitric oxide & DPPH radial 
scavenging activity suppororting the use of plant in traditional medicine
 69
 while the 
petroleum ether extract, methanolic extract and isolated compound of Boerhaavia 
diffusa Linn showed hepatoprotective properties against carbon tetra chloride 
induced hepatic damage in rats.
70 
 Some rotenoids (i.e. boeravinones) isolated from the roots of Boerhaavia 
diffusa showed antioxidant and genoprotective activity when tested using both 
chemical (Electron Spin Resonance spectroscopy, ESR) and Caco-2 cells-based 
(TBARS and ROS) assays. DNA damage was evaluated by Comet assay, while 
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pERK1/2 and phospho-NF-kB p65 levels were estimated by Western Blot. Among 
rotenoids tested, boeravinone G was the most potent lead compound.
71 
 The aqueous extract of Boerhaavia diffusa Linn roots and leaves showed 
hypoglycemic effect against alloxan induced diabetes in rats
72
 due  to  presence  of  
glycosides, flavonoids, tannins and saponins.  
 The alkaloidal fraction from the roots inhibited SRBC induced delayed 
hypersensitivity reactions in mice. However the inhibition only post-immunization 
drug treatment and not pre immunization drug treatment. Therefore the fraction 
exhibited only an in vivo immunostimulatory effect.
73 
 The immune-modulatory activities of punarnavine, an alkaloid from 
Boerhaavia diffusa Linn using Balb/C mice was studied by Kanjoormana Aryan 
Manu, et al.,  (2009).  It  was  found  to  enhance  proliferation  of  splenocytes  and  
hymocytes and also significantly reduced the LPS induced elevated levels of pro 
inflammatory cytokines such as TNF-?, IL-1? and IL-6 in mice.74 
 The ethanolic extract of the roots at a dose of 250mg/kg b.w. p.o. daily to 
pregnant female rats during the entire period of gestation did not show any 
teratogenic effect as litter size and survival rate of fetuses were the same and no fetal 
abnormality was observed 
75  
 The  alcoholic  extract  of  the  roots  of  Boerhaavia diffusa Linn had 
significant in vitro antibacterial effect against Staphylococcus aureus while aqueous 
extract was active against Escherichia coli and inactive against Staphylococcus 
aureus 
76 
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 A comparative study of hydroalcoholic extract (80%) of Boerhaavia 
diffusa Linn (HAEBD) & a polyherbal formulation PHF-09 containing Boerhaavia 
diffusa Linn for their anti-stress activity using cold restrain stress model concluded 
that the imbalance in the level of biochemical parameter like glucose, triglycerides, 
cholesterol, SGOT, SGPT in the conditions of stress were brought back to near 
normalized values following the administration of HAEBD & PHF-09.
77
  
 The bioactivities of crude n-hexane, ethyl acetate and methanolic extract 
of aerial parts of the Boerhaavia diffusa Linn and its phytochemical analysis were 
investigated and the methanolic extract showed higher antioxidant, thrombolytic 
activity and less cytotoxicity than those of n-hexane and ethylacetate extract of 
Boerhaavia diffusa Linn. All the extracts showed significant activity against 
Candida albicans, at a concentration of 100µg/disc.
78 
 The alcoholic extract of stem and leaves of Boerhaavia diffusa Linn 
showed analgesic and antipyretic activity, while the alcoholic and aqueous extract of 
leaves of Boerhaavia diffusa Linn showed hepatoprotective activity against on CCl4 
induced hepatotoxicity in rat.
79
  
 The alcoholic and aqueous extract of whole plant of Boerhaavia diffusa 
Linn anti cirrhotic activity against dimethyl nitrosoamine (DMN) induced liver 
cirrhosis in rat model. The depleted biochemical and hematological parameters in 
DMN induced liver cirrhosis were corrected by the administration of Boerhaavia 
diffusa Linn extracts
80
 and mitochondrial dysfunction in Angiotensin II induced 
hypertrophy in H9c2 Cardiomyoblast Cells 
81 
 The  whole  plant  extract  of  Boerhaavia diffusa Linn exhibited protective 
effect against cisplatin induced nephrotoxicity in rats 
82
 and the methanolic extract 
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of the leaves showed renal antioxidant and lipid peroxidative efficacy against D- 
galactosamine induced toxicity in kidney of male albino Wistar rats suggesting the 
potential therapeutic value in the treatment of kidney diseases
83 
 The neuroprotective effect of hydro alcoholic extract of aerial parts of 
Boerhaavia diffusa (HAEBD) against MPTP induced neurotoxicity in male Wistar 
rats was evaluated by observing the motor activity and behavioral changes using 
actophotometer and elevated pluz maze and estimating the antioxidant enzyme level 
which increased after treatment with HAEBD which rendered significant 
neuroprotection.
84
 
 The  anti-diabetic  activity  of  chloroform  extract  of  Boerhaavia diffusa 
Linn leaves on chronic administration in streptozotocin-induced non-insulin-
dependent diabetes mellitus (NIDDM) model diabetic rats was evaluated and the 
study concluded that it chloroform extract possessed significant anti-diabetic activity 
which supported the traditional usage by Ayurvedic physicians for the control of 
diabetes
85
while the nephroprotective effect of hydroalcoholic extract of aerial plant 
of Boerhaavia diffusa Linn (HAEBD) in cisplatin induced acute renal failure in rats 
was investigated and the results revealed that HAEBD treatment significantly 
reduced blood urea and serum creatinine and elevated the antioxidant enzyme levels 
which indicated that that the extract was endowed with nephroprotective effect.
86 
 The aqueous and ethanolic extracts of Boerhaavia diffusa Linn leaves 
exhibited antioxidant potential when tested in DPPH radical scavenging method, 
nitric oxide scavenging method and reducing ability method.  
 The methanol extract of the leaves of Boerhaavia diffusa Linn had 
significant in vitro antibacterial effect against Staphylococcus aureus, Bacillus 
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megaterium and Bacillus cereus at 50µL concentration.The chemopreventive 
property of Boerhaavia diffusa was evaluated on DMBA induced skin 
papillomagensis in male Swiss albino mice. The extract inhibited tumorigenesis by 
preventing the formation of active carcinogens from their precursos or by 
augmenting detoxification process through free radical scavenging mechanism.
87
  
Phytochemical studies 
 The compounds isolated from the roots of include hentriacotane, ?-
sitosterol, ursolic acid, punarnavine
88
 boerhavone (5,7-dihydroxy-6-8-dimethoxy 
flavones) , boerhavisterol, boerhadiffusene, diffusarotenoid,  and boerhavilanastenyl 
benzoate and boerhavinone A , boeravinone A-F, punarnavoside  eupalitin 3-O-?-D-
galactopyanoside, borhavine,
89
 boerhavinone G and H,
90
 kaempferol-3-O-
robinobioside, quercetin and caffeoyltartaric acid,
91
 two quinolizidine alkaloids 
identified as punarnavine I and II, 
92
  borhavine, two known lignin namly 
liriodendrin an dsyringaresinol mono-?-D-glycoside. 
 The compounds isolated from the leaves include eupatilin-7-O-2,6-di-
rhamnosyl galactoside exhibited antioxidant activity against DPPH free radicals  
 Quantitative determination of boerhavinone B in hydro-alcoholic, water 
and methanol extracts of Boerhaavia diffusa Linn using simple HPLC (High 
Performance  Liquid  Chromatography)  was  done  and  the  maximum  content  n  was  
observed in hydro-alcoholic extract as compared to water and methanol extracts.
93
  
 A metabolite profiling and biological study of the leaves and roots was 
done and there were substantial differences found between them.  The volatile 
composition was analyzed using HS-SPME-GC-MS and terpenes, 
phenylpropanoids, indole compounds and noisoprenoids were identified. The 
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various organic acids present include ketoglutaric, pyurvic, oxalic, quinic and 
fumaric acids. Several flavonoids and one phenolic acid were also confirmed.
 
Pharmacognostical studies  
 The pharmacognostical examination of morphological and microscopical 
characters and phytochemical investigations of Boerhaavia diffusa Linn, including 
determination of loss on drying, ash values, TLC and extractive values was carried 
and the qualitative chemical examination revealed the presence of various 
phytoconstituents like carbohydrates, saponins, phenolic compounds and mucilages 
in the extracts
94 
in aqueous and hydroalcoholic extracts of the plant Boerhaavia 
diffusa Linn.  
 The pharmacognostical evaluation and qualitative analysis of Boerhaavia 
diffusa Linn leaves was carried out and various parameters like macroscopy, 
microscopy, fluorescence analysis as well as extractive value and quantitative 
phytochemical screening of different extractives were studied. Total flavonoid 
content of Boerhaavia diffusa Linn was estimated by colorimetric method. The 
various histological parts examined and drawn with the help of camera Lucida 
which can be used for future identification of the plant material
95
. 
 The TLC fingerprint profile of methanolic and chloroform extracts of 
whole plant of Boerhaavia diffusa Linn was carried out using a large number of 
solvent systems including different proportions of solvents in toluene : acetone : 
acetic acid solvent system. The best resolution of chloroform extract was observed 
in a solvent system, toluene: acetone: acetic acid (9 : 1 : 0.5) which will be useful for 
the determining the purity of the sample.
96
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CHAPTER 3 
PLANT PROFILE 
 
Scientific Name : Boerhaavia diffusa Linn. Syn. B. repens; B. repens 
 var. diffusa. 
Family     : Nyctaginaceae 
Family Name    : Hog weed, Horse Purslane 
Fig. 2: Habitat of Boerhaavia diffusa Linn . 
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3.1 Taxonomical classification 
Kingdom  : Plantae 
Family : Nyctaginaceae 
Division : Magnoliophyta 
Class : Magnoliopsida 
Order : Caryophyllales 
Genus : Boerhaavia 
Species : diffusa 
3.1.1 Common Names 
 Raktapunarnava, Shothaghni, Kathillaka, Kshudra, Varshabhu, 
Raktapushpa, Varshaketu, Shilatika. 
3.1.2 Vernacular Names
97 
English : Horse Purslene, Hog Weed. 
Hindi : Gadapurna, Lalpunarnava. 
Kannada : Sanadika, Kommeberu, Komma. 
Malayalam : ChuvannaTazhutawa. 
Tamil : Mukurattai (Shihappu). 
Telugu :         Atikamamidi, Erragalijeru. 
Bengali :         Raktapunarnava. 
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Sanskrit:         Kahtilla, Sophaghni, Sothaghni, Varshabhu 
Assamese:     Ranga Punarnabha 
3.1.3 Habitat 
 The plant grows as a common weed. 
3.1.4 Useful parts 
 All the parts of the plant useful especially the roots
98 
3.2 Geographical distribution 
 The genus Boerhaavia has 40 species and is distributed in the tropical, 
subtropical, and temperate regions of the world. Out of the 40 species, 6 species are 
found in India and they are B. diffusa, B. chinensis, B. erecta, B. repens, B. rependa, 
and B. rubicund. Boerhaavia diffusa is indigenous to India and found throughout the 
warmer parts of the country upto an altitude of 2000m in the Himalayan region. It is 
a perennial, spreading hogweed, commonly occurring abundantly in waste places, 
ditches and marshy places during rains
99
. 
3.3  Morphological profile of B. diffusa
100,101
 
           It is a perennial creeping weed, prostrate or ascending herb, upto 1m long 
or more, having diffusely spreading branches. The photographic representation of 
the macroscopic of the plant is depicted in Fig. 3. The plant has a large root system 
and has fusiform roots. The stems are prostrate, decumbent or ascending, 4-10cm 
long, rather slender, divaricately branched. The leaves are opposite or sub-opposite, 
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two of a node unequal, broadly ovate or sub-orbicular, obtuse to rounded or sub-
cordate at the base.  
Fig. 3:  Macroscopic features of Boerhaavia diffusa 
 
Root Leaves Flowers 
 
 The flowers are yellow and white and are in pendunculate, glomerulate 
clusters arranged in slender, long stalked, axillary or terminal corymbs. The furits 
are ovoid or sub-ellipsoid, rounded above, slightly cuneate, below, broadly and 
bluntly 5-ribbed, very glandular throughout.  
3.4 Phytochemicals present in Boerhaavia diffusa Linn. 
 Boerhaavia diffusa contains a large number of phytoconstituents 
belonging to the class of flavonoids,
102 
alkaloids, steroids, triterpenoids, lipids, 
lignins, carbohydrates proteins and glycoproteins.
103 
The herb  comprises  15  amino  
acids, including 6 essential amino acids, while the root contains 14 amino acids. The 
various constituents isolated from roots include retinoids,
104-105 
boeravinones (A-
F),
106-107
 punarnavoside, a phenolic glycoside and C-methyl flavones. Two known 
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lignans viz. liriodendrin
109
 and syringaresinol mono-?-D-glycoside,110 purine 
nucleoside hypoxanthine 9-L-arabinofuranoside,
 111
dihydroisofuroxanthone-
borhavine,
 112
phytosterols,
113-114
 punarnavine,
115 
and and ursolic acid.
116 
The seeds of 
this plant contain fatty acids and allantoin.
117
 Boerhaavin and boerhavic acid
118
 have 
been isolated  from  the green stalk of the plants. 
3.5 Ethnomedicinal uses of Boerhaavia diffusa Linn. 
 The root, leaves, aerial parts or the whole plant of Boerhaavia diffusa 
have been employed for the treatment of numerous disorders. The word 
‘punarnava’ literally means, one which renews the body i.e. bringing back the 
youth. Punarnava enjoys an important place among medicinal herbs in India since 
ancient times and the old Indian books of medicine Charaka Samhita and Sushrita 
Samhita mentions that the Ayurvedic preparations made from punarnava namely, 
Punarnavastaka kvath, Punarnava kshar, and Punarnava taila – were used for the 
treatment  of  various  ailments.  The  whole  plant  of  B. diffusa is documented in 
Pharmacopoeia as a diuretic.
119
 It  is  used  to  treat  seminal  weakness  and  blood  
pressure and also used in the treatment of stomach ache, anemia, cough, and cold, 
and as a diaphoretic, laxative, expectorant, and a potent antidote for snake and rat 
bites, in the treatment of nephrotic syndrome, hepatitis, gall bladder abnormalities, 
and urinary disorders. The root is mainly used to treat gonorrhea, internal 
inflammation of all kinds, dyspepsia, oedema, jaundice, menstrual disorders, 
anaemia, liver, gallbladder and kidney disorders, enlargement of spleen, abdominal 
pain,  abdominal  tumours,  and  cancers.
120 
The juice of Boerhaavia diffusa leaves 
serves as a lotion in ophthalmia. It is also administered orally as a blood purifier and 
to relieve muscular pain 
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3.6 Pharmacological activities of Boerhaavia diffusa Linn. 
 The pharmacological studies have demonstrated that the roots of B. 
diffusa exhibit anti-inflammatory
121 
diuretic,
119
 laxative,
122
 antiurethritis,
123
 
anticonvulsant,
124
 antinematodal,
125 
antifibrinolytic,
126
 antibacterial,
127
 
antihepatotoxic,
128-130
 anthelmintic, antileprotic, antiasthmatic, antiscabbies property 
and  as  an  anti  stress  agent.  The  use  of  B. diffusa roots to treat liver disorders was 
validated when researchers demonstrated antihepatotoxic properties.
130
 
3.7 Ayurvedic preparations which contain Boerhaavia diffusa  
 The plant Boerhaavia diffusa has been used for the treatment of various 
ailments in Ayurveda and the various preparations and their therapeutic uses are 
summarized.  
Name of the Ayurvedic preparation Therapeutic uses 
Asmarighna               Litholyic 
Indralupta nasaka         Mitigates Alopecia aeriata 
Deepana   Enkindles appetite 
Shothaghna Destroys oedema 
Kasahara Alleviates coughs 
Vyasthapana               Promoter of youth and longevity 
Rasayana Rejuvenate 
Hridaya Nourishes the heart 
Stambhana Astringes bleeding 
Chakshushya Benefits the eyes 
Arshoghna Reduces haemorrhoids 
Grahi Absorbs fluids from the intestines and is 
constipative 
Shula prashamana   Alleviates colic 
Mutrala Diuretic 
Mutravaha rasayana Rejuvenative to the urinary system 
Ashmarighna Lithotriptic 
Mutrakricchaghna Alleviates dysuria 
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CHAPTER 4 
AIM AND SCOPE 
 
 Natural plants have been used to prevent and to treat various diseases for 
thousands of years. Among the human diseases cancer is probably the most 
important genetic disease which can be treated with medicinal plants. In recent 
times, focus on plant research has increased all over the world and a large amount of 
evidence has been collected to show immense potential of medicinal plants used in 
various  traditional  systems.  There  are  excellent  sources of bioactive components 
from medicinal plants which make them targets for potential anticancer treatments. 
The increasing costs of conventional treatments (chemotherapy and radiation) and 
the lack of effective drugs to cure solid tumors encouraged people to depend on folk 
medicine which is rooted in medicinal plants use. Scientific and research interest is 
drawing its attention towards naturally-derived compounds as they are considered to 
have less toxic side effects compared to current treatments such as chemotherapy.   
 Plants offer a safer alternative in the prevention and treatment of cancer. 
There is lately a great interest in screening of plants to be used in cancer prevention 
and treatment. Plants are generally rich sources of antioxidants and hence may be 
considered to be potential anticancer drugs. The objective of this study is to identify 
suitable plants and screen the chosen plants for anticancer activity.   
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 Ethnopharmacological studies on such herbs and medicinally important 
plants continue to interest investigators throughout the world. Today, we are 
witnessing a great deal of public interest in the use of herbal remedies. The different 
parts of the plant Boerhaavia diffusa has been used in different systems of traditional 
medicine for the treatment of diseases and ailments of human beings and has invited 
the attention of researchers worldwide for its pharmacological activities.  
 The aim and objective of this study is to perform a thorough literature 
review of this plant to verify whether any scientific data is available on Boerhaavia 
diffusa Linn for anticancer activity and then to evaluate the plant for anticancer 
activity by in vitro and in vivo methods.  It  is  also  aimed  to  isolate  the  phyto  
constituents from the extract and also screen for anti cancer activity.  
 The review of literature yielded no reports on in-vivo anti-proliferative 
and antioxidant status of this plant in DAL and EAC and DMBA induced tumor 
bearing mice. Hence, the present study was planned to evaluate the in-vivo anti-
proliferative, antioxidant and hepatoprotective status of the hydro-alcoholic extract 
of Boerhaavia diffusa Linn in DAL and EAC tumor bearing and DMBA induced 
breast cancer and D-galactosamine induced toxicity in Swiss albino mice.  
PLAN OF WORK 
1. Soxhlet extraction of the powdered aerial parts of Boerhaavia diffusa 
Linn with a mixture of ethanol and distilled water after defatting the 
material with petroleum ether  
2. Phytochemical screening of the hydro-alcoholic extract of aerial parts 
of Boerhaavia diffusa Linn. 
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3. Evaluation of in vitro antioxidant activity of hydroalcoholic extract of 
Boerhaavia diffusa Linn.  
? Total reduction capability of hydroalcoholic extract of 
Boerhaavia diffusa Linn by potassium ferricyanide reduction 
method. 
? Superoxide anion radical scavenging activity of hydro-alcoholic 
extract of Boerhaavia diffusa Linn in nitro blue tetrazolium 
reduction assay. 
? Free radical scavenging activity of hydroalcoholic extract of 
Boerhaaviadiffusa Linn by DPPH Method. 
? Hydrogen peroxide scavenging activity of hydro-alcoholic 
extract of Boerhaavia diffusa Linn.  
4. In-vitro anti-cancer of hydro-alcoholic extract of Boerhaavia diffusa 
Linn.  against  breast  cancer  cell  line  (MCF-7)  and  colon  cancer  cell  
line (HCT-116). 
? Effect of hydro-alcoholic extract of Boerhaavia diffusa Linn on 
cell viability by MTT assay. 
? Effects of hydro-alcoholic extract of Boerhaavia diffusa Linn on 
cell morphology studies. 
? Effect of hydro-alcoholic extract of Boerhaavia diffusa Linn on 
chromatin condensation and apoptosis measurement. 
? Effect of hydro-alcoholic extract of Boerhaavia diffusa Linn on 
cell cycle analysis. 
5. Toxicity studies study of hydro-alcoholic extract of Boerhaavia 
diffusa Linn. 
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? Acute toxicity studies  
? Sub acute toxicity studies 
? Chronic toxicity studies  
6. Evaluation of anticancer activity of hydro-alcoholic extract of 
Boerhaavia diffusa Linn using Dalton’s Ascitic Lymphoma Cells 
? Effect of Boerhaavia diffusa Linn on clinical parameters.  
? Effect of Boerhaavia diffusa Linn on haematological parameters. 
? Effect of Boerhaavia diffusa Linn on serum enzyme levels. 
7. Evaluation of anticancer activity of hydro-alcoholic extract of 
Boerhaavia diffusa Linn using Ehrlich Ascitic Carcinoma Cells 
? Effect of Boerhaavia diffusa Linn on solid tumour volume (STV) 
8. Evaluation of anticancer activity of hydro-alcoholic extract of 
Boerhaavia diffusa Linn against DMBA induced breast carcinoma. 
? Effect of Boerhaavia diffusa Linn on body weight and tumour 
volume.  
? Effect of Boerhaavia diffusa Linn on breast tissue homegenate 
? Histopathological studies of the breast tissue  
9. Evaluation of in-vivo hepatoprotective activity and anti-oxidant of the 
hydro-alcoholic extract of Boerhaavia diffusa Linn.  
? Effect of Boerhaavia diffusa Linn on liver marker enzymes. 
? Assessment  of  the  effect  of  Boerhaavia diffusa Linn by 
histopathology of mouse liver. 
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10. Isolation and Characterization of compounds from hydro-alcoholic 
extract of Boerhaavia diffusa Linn. 
? Isolation of compounds using column chromatographic and thin 
layer chromatographic separation. 
? Characterization of isolated Compounds using various analytical 
techniques. 
? IR studies 
? NMR studies 
? Mass Spectral studies 
10. Statistical analysis by Graphpad instat software Inc. 
11. In vitro anticancer activity of isolated compound of hydro-alcoholic 
extract of Boerhaavia diffusa Linn. 
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CHAPTER 5 
MATERIALS AND METHODS 
 
5.1 COLLECTION AND AUTHENTICATION 
 The aerial parts of Boerhaavia diffusa Linn belonging to the family 
Nyctaginaceae  were  collected  in  the  month  of  September  2013  from  Alagar  Hills,  
Madurai District Tamil Nadu, India. The botanical identification and authentication 
of the plant was carried out by Dr.  D. Stephen, Taxonomic Officer,  Department of 
Botany, American College, Madurai. The aerial parts of Boerhaavia diffusa were 
dried under shade, pulverized by a mechanical grinder and passed through a 40 mesh 
sieve and the powder was extracted sequentially by hot continuous percolation 
method using Soxhlet apparatus
 
using solvents of increasing polarity like petroleum 
ether, chloroform and a mixture of ethanol and distilled water (70:30). The extracts 
were concentrated by using a rotary evaporator and subjected to lyophilization to 
obtain a dry powder. 
5.2 PREPARATION OF HYDROALCOHOLIC EXTRACT OF 
AERIAL PARTS OF   BOERHAAVIA DIFFUSA              
 About 2g of dried fine powder of aerial parts of Boerhaavia diffusa Linn 
was extracted using Soxhlet apparatus by hot continuous percolation method. The 
powdered material was soaked in the extractor and macerated for 30h with 
petroleum ether and refluxed with petroleum ether to de-fat the material. The marc 
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was dried and then extracted with a mixture of alcohol and water (50 : 50) by 
continuous hot percolation method using Soxhlet apparatus for 40h. The hydro-
alcoholic extract was filtered with Whatmann filter paper No. 40 and concentrated 
under vacuum using rotary flask evaporator under reduced pressure. The colour and 
consistency of the extract was observed, then weighed and the yield obtained 
calculated and stored in screw capped vial at 4
0
C. The percentage yield was 
calculated with reference to the crude material taken. 
5.3 PHYTOCHEMICAL ANALYSIS 
 The phyto constituents present are generally responsible for the 
therapeutic  properties  of  the  plant  and  therefore  the  pharmacological  actions  of  
crude drugs are determined by the nature of their constituents. Therefore the hydro 
alcoholic extract of aerial parts of Boerhaavia diffusa Linn was subjected to 
preliminary phytochemical screening for identification of various plant 
constituents.
127
  
Table 1: Phytochemical Analysis of Boerhaavia diffusa Linn. 
128 
S. 
No. 
Phyto-
constitutents 
Description Observation 
expected 
1. Carbohydrates Molisch test:  Addit ion of 
conc.H2SO4  along the sides of the test 
tube to a solution of  extract and 
alcoholic ?-naphthol  
Reddish violet colour 
at the junction of  
two layers 
Benedict’s test: Boiling and cooling 
of Extract  and  Benedict’s reagent 
Red precipitate 
Fehling’s test: Addition of Fehling’s 
A and B to the extract and heating  
Brick red colour 
2. Proteins and 
Amino Acids 
Ninhydrin Test: Heating extract and 
ninhydrin solution 
Blue colour 
Chapter 5             Materials and Methods 
 
38 
S. 
No. 
Phyto-
constitutents 
Description Observation 
expected 
Biuret Test: Adding NaOH and and 
copper sulphate 
Violet Colour 
3 Flavonoids Shinoda Test:  Adding magnesium 
turnings and  conc. HCl to the extract 
Red Colour 
4. Glycosides Legal Test: Adding sodium 
niroprusside to the extract in pyridine 
Pink or red colour 
Borntrager’s Test: Extract and dil. 
HCl boiled, cooled and filtered and 
filtrate extracted with chloroform  
Red colour  
Keller Killiani Test:  Adding conc. 
H2SO4 to the extract  in acetic acid 
containing of ferric chloride 
Reddish brown 
colour turning blue 
5 Saponins Extract shaken with water Foam or lather 
formed 
6 Tannins and 
Phenolic 
compounds 
Adding 5% ferric chloride to extract dark blue or greenish 
black colour 
Adding lead acetate solution to extract white precipitate 
Adding gelatin solution to extract                                      white precipitate
Adding bromine water to extract decolouration  
Adding acetic acid solution to extract red colour 
Adding dil. HNO3 to extract                             transient red colour 
Adding dilute iodine solution to 
extract 
Yellow colour 
7. Phytosterols  
 
Libermann Burchard Test: Adding 
acetic anhydride and conc. H2SO4 to 
the extract in chloroform 
Solution turning red 
and then blue 
Salkowski Test: Adding conc. H2SO4 
to the extract in chloroform 
Cherry red colour in 
chloroform layer and 
green fluorescence in 
acid layer 
8. Triterpenoids Adding tin and thionyl chloride 
solution to the extract  
Pink colour 
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S. 
No. 
Phyto-
constitutents 
Description Observation 
expected 
9. 
 
 
Alkaloids Dragondroff’s test:  Extract and  
Dragondroff reagent 
Reddish orange 
precipitate 
Wagner’s test: Extract  and Wagner 
reagent 
reddish brown 
precipitate 
Mayer’s test: Extract and Mayer’s 
reagent 
Dull white 
precipitate 
Hager’s test: Extract and Hager’s 
reagent 
Yellow precipitate 
10. Fixed Oils Saponification Test: Adding 
alcoholic KOHand phenolphthalein 
and heating  
Partial Neutralization 
or soap formation 
Spot Test: Extract pressed between 
two filter papers 
Oil stains 
11. Gums and 
Mucilage 
Ruthenium red test:  Extract diluted 
with water and adding ruthenium red. 
Pink colour 
 The results obtained for phytochemical screening of HAEBD is presented 
in Table 8. 
5.4  IN VITRO ANTIOXIDANT ASSAYS  
 Free radicals and reactive oxygen species (ROS) such as superoxide (O2
??
, 
OOH
•
), hydroxyl (OH
•
) and peroxyl (ROO
•
) radicals are generated during oxidative 
stress and play an important role in the pathogenesis of various diseases like 
neurodegenerative disorders, cancer, cardiovascular diseases, atherosclerosis, 
cataracts, and inflammation.
129
 The generated free radicals and ROS cause oxidative 
damage of biological macromolecules such as deoxyribonucleic acid (DNA), 
proteins and lipids. Oxidative damage in DNA causes cell injury that leads to several 
diseases including cancer
130
 and  the  rate  of  DNA  damage  in  a  specific  cell  type  
depends on the formation of ROS and the degree of quenching of the anti-oxidant 
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defense system.
131
 The diet derived anti-oxidants are important for maintaining good 
health
132 
as endogenous anti-oxidant defense system cannot prevent the damage 
completely. Thus pharmacologists and biologists are searching for scavengers, 
especially naturally occurring anti-oxidants which can inhibit oxidative damage 
caused by ROS. 
 The antioxidant capability of hydro-alcoholic extract of Boerhaavia 
diffusa Linn   (HAEBD) was carried out using various assay methods such as total 
reduction capability, superoxide anion radical scavenging activity, 2,2-diphenlyl-1-
picrylhydrazyl (DPPH
•
) radical scavenging activity and the scavenging of hydrogen 
peroxide. The  results  of  the  test  extract  were  compared  with  different  reference  
products such as L-ascorbic acid, an antioxidant of natural origin and butylated 
hydroxyl anisole (BHA), the most widely used synthetic antioxidant employed in the 
food industry. 
5.4.1 Estimation of total reduction capability of hydro-alcoholic extract of 
Boerhaavia diffusa by potassium ferricyanide reduction method 
Principle: The reduction capacity of a compound indicates its antioxidant potential 
and higher the reduction capacity, the higher the antioxidant potential.  The total 
reduction capability of HAEBD was estimated using the method described by 
Oyaizu
133 
which involves the measurement of the transformation of Fe
3+ 
to Fe
2+
 by 
the study material i.e. the extract.  
 
Instrument: Shimadzu UV Visible spectrophotometer, Model 160 UVPC  
Reagents: 0.2 M phosphate buffer (pH 6.6), 1% Potassium ferricyanide [K3 Fe(CN) 
6], 10%  trichloroacetic acid 
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Procedure: Various concentrations of HAEBD were prepared in 1ml of distilled 
water and 2.5ml of 0.2M phosphate buffer pH 6.6 was added. To this 2.5ml of 1% 
potassium ferricyanide and 2.5ml of 10% trichloroacetic acid were added and 
incubated at 50
o
C for 20min and centrifuged. The supernatant solution (2.5ml) was 
mixed with equal volume of distilled water and 0.5ml of 0.1% ferric chloride. The 
absorbance of the solution was measured at 700nm using spectrophotometer.  The 
higher absorbance indicated greater reduction power and was compared with the 
absorbance capacity of standard antioxidants like ascorbic acid and BHA. The 
results obtained are presented in Table 9. 
5.4.2 Estimation of superoxide anion radical scavenging activity of hydro-
alcoholic extract of  Boerhaavia diffusa Linn. 
Principle: Superoxide anion is an oxygen-centered radical with selective reactivity 
and is produced by a number of enzyme systems in auto-oxidation reactions and by 
non-enzymatic electron transfers that univalently reduce molecular oxygen. The 
method of Gulcin et.al.,2003
134
was followed and in this method superoxide anions 
are generated in a non-enzymatic phenazine methosulfate-nicotinamide adenine 
dinucleotide  (PMS-NADH)  system  through  the  reaction  of  PMS-  NADH  and  
oxygen. The superoxide anions so generated is assayed by the reduction of nitro blue 
tetrazolium (NBT). 
Instrument: Shimadzu UV Visible spectrophotometer, Model 160 UVPC  
Reagents: Tris-HCl buffer (100mM, pH 7.4), Nitro blue tetrazolium (NBT) 
(300?M) solution, Nicotinamide adenine dinucleotide (NADH) (936?M) solution,  
Phenazine methosulfate (PMS) (120?M) solution 
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Procedure: The superoxide anion was generated in 3ml of Tris-HCl buffer 
(100mM, pH 7.4) containing 0.75ml of NBT (300?M) solution, 0.75ml of NADH 
(936?M) solution and 0.3ml of various concentrations of HAEBD. The reaction 
began  with  the  addition  of  0.75ml  of  PMS (120?M) to  the  mixture.  After  5min  of  
incubation at room temperature, the absorbance at 560nm was measured using a 
spectrophotometer. The percentage of superoxide anion scavenging activity was 
calculated using [(A0-A1)  /  A0 × 100],  where A0 was absorbance of control (blank, 
without extract) and A1 was absorbance of standard or extract. The results obtained 
are presented in Table 10.  
5.4.3 Estimation of free radical scavenging activity of hydro-alcoholic 
extract of  by DPPH method 
Principle: The free radical scavenging activity of HAEBD was estimated using 1, 
1-diphenyl-2- picryl-hydrazil (DPPH) method.  DPPH is used as a free radical to 
evaluate antioxidant activity of natural compounds and the degree of its 
discoloration is attributed to the hydrogen donating ability of test compound.  
Instrument: Shimadzu UV Visible spectrophotometer, Model 160 UVPC  
Reagents: 0.1mM solution of DPPH in ethanol  
Procedure: 1ml  of  the  0.1mM  DPPH  in  ethanol  solution  was  added  to  3ml  of  
various concentrations of the extract and shaken vigorously and kept at room 
temperature for 30min.  The absorbance was measured at 517nm using UV-Visible 
spectrophotometer. Lower absorbance of the reaction mixture indicated higher free 
radical scavenging activity and the percentage of DPPH scavenging effect was 
calculated using [(A0-A1)  /  A0 × 100], where A0 was absorbance of the control and 
A1 the absorbance of standard or extract. The results obtained are presented in Table 11.  
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5.4.4 Estimation of scavenging of hydrogen peroxide by HAEBD 
Principle: The ability of the extract to scavenge hydrogen peroxide was determined 
by the method of  Ruch, et al., 1989.
135 
Instrument: Shimadzu UV Visible spectrophotometer, Model 160 UVPC  
Reagents: Hydrogen peroxide (40mM) in phosphate buffer (pH 7.4)   
Procedure: A solution of hydrogen peroxide (40mM) was prepared in phosphate 
buffer (pH 7.4).  Various concentrations of the extract in distilled water were added 
to hydrogen peroxide solution (0.6ml). After 20 min the absorbance of hydrogen 
peroxide was measured at 230nm against a blank solution consisting of phosphate 
buffer without hydrogen peroxide. The percentage of scavenging activity of 
hydrogen peroxide in sample and standard compounds was calculated using the 
equation [(A0-A1)  /  A0 × 100],  where A0 was absorbance of the control and A1 the 
absorbance of standard or extract. The results obtained are presented in Table 12.  
5.5 EVALUATION OF IN VITRO ANTI CANCER ACTIVITY OF 
HAEBD 
 The search for anti-cancer agents from plant sources started in the 1950s 
with the discovery and development of the vinca alkaloid, vincristine, and the 
isolation of the cytotoxic podophyllotoxins.
136-139
 Among them, the agents that alter 
the cell cycle have been of special interest, since cell cycle regulation is the basic 
mechanism underlying cell fate, i.e., proliferation, differentiation or acquired 
death.
140
 In cancer therapy, one approach to suppress tumor growth is by activating 
the apoptotic machinery in the cell,
141
 i.e. by the activation of an intrinsic cellular 
suicide programme when the cells are no longer needed or when they are seriously 
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damaged.
142
  Hence, the present research is carried out to evaluate the anticancer 
activity of hydro-alcoholic extracts of Boerhaavia diffusa Linn  using breast 
cancer cell line known as Michigan cancer foundation MCF-7 and colon cancer cell 
line HCT-116.  
5.5.1  MTT cell proliferation assay
143
 
 MTT assay is used to measure the mitochondrial activity in viable cells 
based on the activity of mitochondrial dehydrogenase enzyme that reduces the 
yellow tetrazolium MTT into purple formazan crystal. The amount of the purple 
formazan formed indicates the number of metabolically active viable cells. 
Cell lines 
 The cell lines used for the present study with their type, source, culture 
medium and culture conditions are summarized  
Table 2:  Cell lines used for study of in vitro cytotoxicity and culture medium 
Cell line Type Source Culture medium Culture 
condition 
MCF-7 Human 
breast 
cancer cell 
line 
National Centre for 
Cell Sciences, 
Pune 
Dulbucos Modified 
Eagles Medium 
(DMEM) containing 
10% fetal bovine 
serum (FBS) 
Inoculation at 
37ºC, 5% CO2 
with optimum 
humidity 
HCT-116 Human 
colon 
adeno 
carcinoma 
cell line 
Dr.Bert Vogelstein 
(John Hopkins 
University School 
of Medicine, 
Baltimore) 
Mac-Coys medium 
containing 10% fetal 
bovine serum (FBS) 
Inoculation at 
37ºC, 5% CO2 
with optimum 
humidity 
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Preparation of the extract 
 An aliquot quantity of the dried HAEBD powder was weighed and 
dissolved in 10% DMSO to get a stock solution of 200mg/ml of hydro-alcoholic 
extract of Boerhaavia diffusa which  was  stored  at  ?10°C.   The  stock  solution  was  
further diluted to get the concentrations required.  
Preparation of media 
 The media used for cell culture and preparation of the media are 
summarized in Table 3. 
Table 3: Different Media and their preparation used in the study of in vitro 
cytotoxicity activity by MTT assay 
MEDIA PREPARATION 
DMEM  (Dulbucos 
Modified Eagles 
Medium) 
One packet of powdered DMEM with glutamine and sodium 
bicarbonate (Gibco, Cat. No. 31600-075) was dissolved in 1L 
of MQ water with 100µg/ml
 
of streptomycin sulphate (Sigma, 
Cat. No. S0890). The pH of the medium was adjusted between 
7.2-7.4 before the final volume was adjusted to 1L. The 
medium was filter sterilized and stored at 4º C before use. 
Opti-MEM Medium Reduced serum medium, Modification of MEM (Eagles),with 
gluta maxi, with Hepes Buffer, 2400mg/l Na2HCO3 
Liquid Mac. Coys 
Medium 
Mac coys medium with glutamine and hepes (25 milli molar) 
supplemented with streptomycin  100µg/mlof Benzyl 
penicillin 100 units/ml. 
PBS-EDTA solution 
(500 ml) 
Readymade mix was procured from Invitrogen  
Trypsin-EDTA PBS-EDTA solution containing 0.25% trypsin was prepared 
and sterile filtered before use. 
Fetal bovine serum 
(FBS) 
Mycoplasma free FBS (PAA Laboratories GmbH, Cat. No.  
A11-501) was used for cell culture. 
For heat inactivation, thawed FBS was placed in a water bath 
at 56ºC for 30 min. 
Different batches of FBS were tested for their ability to 
support growth of cells before use. 
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Reagents for MTT assay 
 The reagents used for in vitro cytotoxicity studies are presented in Table 4.   
Table 4:  Reagents used for in vitro cytoxicity studies by MTT assay 
Reagent Preparation 
PBS-EDTA solution 
 
 Readymade mix was procured from Invitrogen, Cat. No. 
11668027 
MTT (5mg/ml) 5mg of MTT is prepared in serum free medium 
MTT lysis buffer Isopropanol procured from Invitrogen, Cat. No. I0398 
 
Instrument  
 Enzyme linked immunosorbent assay Reader (ELISA reader)  
Procedure: 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) 
was dissolved in phosphate-buffered saline (5mg/ml) and was used to measure 
cellular proliferation. Cells (1×10
3
)  were  incubated  with  100?L of  culture  medium 
for 24h in 96-well plate. After 24h, HAEBD at various concentrations were added to 
the medium and incubated for 24h. At the end of the incubation, 10?l of MTT 
solution was added and again incubated for 4h. Formazan crystals formed were 
solubilized in acidified isopropanol after aspirating the medium and cells were then 
incubated at 37°C for 16h. In this assay, MTT was cleaved to an orange formazan 
dye by metabolically active cells. The dye was directly quantified using an enzyme-
linked immunosorbent assay reader at 570nm. The active cells were calculated using 
the equation [Cell Survival = (Mean OD drug treated cell/Mean OD control cell) 
× 100]. The percentage cytotoxicity was then calculated and the results obtained are 
presented in Table 13. 
5.5.2  Cell Morphological studies 
 The morphology of the extract treated cells was studied using phase 
contrast microscope and compared with the morphology of the untreated cells.   
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Procedure: The effect of hydro-alcoholic extracts of Boerhaavia diffusa on cell 
morphology of MCF-7 and HCT-116 cells was investigated.  The cells grown in 96 
well plates in DMEM medium were treated with 200µg/ml extract and incubated at 
37ºC for 24h in 5% CO2 incubator. Morphological changes occurring in the cells 
were observed under phase contrast microscope and images were captured using 
CCD camera attached to the TE 2000E microscope. The images obtained are 
presented in Figs. 5 to 8. 
5.5.3  Chromatin condensation and apoptosis  
 One of the prominent changes of apoptosis is condensation of chromatin 
brought about by the activated caspases which can be examined using Hoest 
staining. The method of Alvin Lee Lope Pihie, 2002 
144
 was  adopted  for  
measurement of chromatin condensation and apoptosis. 
Reagents 
                          Table 5: Reagents for chromatin condensation  
Reagent Preparation 
Bis benzamide (Hoest 
33342 - 
10?g/ml Bis benzamide (Hoest 33342) was prepared in 
serum free corresponding culture medium  and added 
directly to the cells 
 
Procedure: The effects of HAEBD on chromatin condensation and apoptosis of 
MCF-7 and HCT-116 cells were examined by Hoest staining. The cells grown on 96 
well plates were stained with 0.5µg/ml of Hoechst 33342 for 10min and viewed 
under UV filter sets using Nikon fluorescent microscope (TE2000E). The images 
were captured with CCD  camera  and  analyzed  using  Image  pro  software.  The 
number of cells in the bright field and Hoechst-stained cells are counted and the 
percentage of apoptotic cells is calculated as: % apoptosis = (number of Hoechst 
positive  cells)  /  (number  of  cells  in  bright  field)  ×  100.  The results obtained are 
present in Table 14 and the images obtained are presented in Figs. 9 to 12. 
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5.5.4  Cell cycle analysis by Fluorescent Analysis Cell Sorting 
 The effects of HAEBD on cell cycle arrest of MCF-7 and HCT-116 cells 
were also examined by Fluorescent Analysis Cell Sorting Method (FACS). 
Table 6:  Reagents for cell cycle Analysis 
Reagent Preparation 
Ethanol (70%) 
 
700ml of absolute alcohol transferred into a 1L 
graduated cylinder. The final volume adjusted to 1L 
with purified or nuclease-free water. Cover the cylinder 
with parafilm and mix thoroughly by inversion. 
Ribonuclease (100?g/ml) Procured from Invitrogen, Cat. No. 1201 
Propidium iodide 
(50?g/ml) 
Prepared in phosphate buffered saline 
Trypsin-EDTA 
 
PBS-EDTA solution containing 0.25% trypsin was 
prepared and sterile filtered before use. 
PBS Readymade mix was procured from Invitrogen 
Triton X-100 0.1% Triton X 100 was prepared 
 
Procedure: In this method, cells (0.25×10
6
)  were  plated  in  100mm  tissue  culture  
plates, incubated overnight to adhere to the plate. Cells were exposed to various 
concentrations of hydro-alcoholic extracts of Boerhaavia diffusa Linn for 24h and 
washed with PBS. Fresh and complete medium was added and the cells were 
incubated for 24h. Cells were harvested with trypsin-EDTA, washed with PBS, 
counted, fixed with 100ml of PBS and 900ml of absolute ethanol and stored at 4ºC 
before DNA content analyses. Samples were stained with DNA staining solution 
containing 150mg/ml of propidium iodide, 0.1% triton X-100 and 1mg/ml of 
RNase-A (DNase free) (1 : 1 : 1 by volume) and incubated in the absence of light for 
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1h. The acquisition of the data was carried out with FACS Aria, Becton Dickinson, 
USA.
145, 146
 The results are presented in the Tables 15 & 16. 
5.6 IN VIVO PHARMACOLOGICAL SCREENING  
5.6.1 TOXICITY STUDIES 
 The types of toxicity tests which are routinely performed by 
pharmaceutical manufacturers in the investigation of a new drug involve acute, sub-
acute and chronic toxicity. The determination of acute oral toxicity is the initial 
screening step in the assessment and evaluation of the toxic characteristics of all 
compounds. Acute toxicity is involved in estimation of LD50 (the dose which has 
proved to be lethal (causing death) to 50% of the tested group of animals.
147
 
5.6.1.1 Experimental Animals 
 The  experiments  are  carried  out  after  getting  the  Institutional  Animal  
Ethics  Committee  approval  (App.  No.  G.  Nalini  /  TNMGRMU  /Ph.D  /  IAEC  /  
KMCP /112 / 2014-15). The animals were housed at central animal house, K.M. 
College of Pharmacy, Madurai, Tamil Nadu, India under standard conditions of 
temperature (27±2
?
C), relative humidity (44–56%) and light and dark cycles of 10 
and 14h respectively, for 1 week before and during the experiments. Animals were 
provided with standard diet (Hindustan Ltd. Bangalore, India), and water ad libitum.  
The food is withdrawn at 18–24h before the start of the experiment. All the 
experiments were performed in the morning according to the ethical guidelines for 
the care of the laboratory animals.
148 
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Fig. 4: Flow Chart for Acute Oral Toxicity Studies as per OCED guidelines 
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5.6.1.2 Acute toxicity study of hydro-alcoholic extract of Boerhaavia diffusa 
Linn  in mice 
 The evaluation of acute toxicity study was carried out as per Organization 
of Economic Co-operation and Development (OECD) guidelines 423 (Acute toxic 
class method). This stepwise procedure used 3 animals of a single sex per step and 
depending on the mortality and\or the moribund status of the animals, on average 2-
4 steps were necessary to allow judgment on the acute toxicity of the substance. The 
procedure based on biometric evaluation with fixed doses was adequately separated 
to enable a substance to be ranked for classification purpose and hazard assessment. 
The method was reproducible and was able to rank substances in a similar manner to 
the other acute toxicity testing methods.  
 The results obtained were used as a guideline to determine the dose and to 
predict the Maximum Tolerated Dose (MTD). The method used pre-defined doses 
and  the  results  allowed  the  substance  to  be  ranked  and  classified  according  to  the  
Globally Hormonised System for the classification of chemicals which caused acute 
toxicity. 
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Preparation of the extract 
 An aliquot quantity of the dried HAEBD powder was weighed and 
dissolved in 10% DMSO to get a stock solution of 2000mg/ml of hydro-alcoholic 
extract andwas stored at ?10°C.  The stock solution was further diluted to get the 
concentrations required.  
Procedure: Acute oral toxicity of hydro-alcoholic extract of  Boerhaavia diffusa  
was carried out as per OECD 423 guidelines on mice. The flow chart in Fig. 4 chart 
describes the procedure followed which is self explanatory.  The mice were fasted 
overnight and provided only water, after which the hydro-alcoholic extract of 
Boerhaavia diffusa Linn Boerhaavia diffusa was administered by gastric intubation 
orally  at  a  dose  of  50mg/kg  b.w.  The  animals  were  then  observed  for  14  days  and  
maintained with normal food.  
Observations: The animals were observed individually every 30min after dosing for 
the first  24h and thereafter daily for a total  of 14 days.  The time at  which signs of 
toxicity appear and disappear was observed systematically and recorded for each 
animal. Additional signs of toxicity such as changes in bodyweight, skin and fur, 
eyes and mucus membranes, respiratory system, circulatory system, ANS and CNS, 
somatomotor activity and behaviour pattern were also recorded. Any mortality 
during the experiment for 14 days were observed and recorded and the mortality of 
the animals in one step determines the next step and the results are presented in 
Table 17.  
If mortality was observed in 2 to 3 animals in 14 days, then the dose was said to be 
toxic dose. But when mortality of one animal was observed, then the same dose was 
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repeated again for confirmation. However, if mortality was not observed, the 
procedure was repeated for further higher doses such as 300 and 2,000mg/kg b.w.  
5.6.1.3 Sub acute toxicity study of hydro-alcoholic extract of Boerhaavia 
diffusa 
 The objective of carrying out the sub acute toxicity study is to determine 
the toxicity of the extract by observing changes that become apparent when the 
extract  is  administered  to  the  animal  continuously  over  a  long  period  of  time.  The  
method was performed according to OECD guidelines for testing of chemicals 423 
(OECD 2001).  
Procedure: Male and female Wistar rats weighing 180 ± 10g were used for the 
present study. The animals were divided into five groups of six animals each. The 
dose of the extract was calculated based on the body weight of the animal. The 
animals received treatment as per schedule given 
Name of the group (n=6) Treatment 
Group I         Received single daily dose of 0.5 ml of Tween 80 
orally for 20 days 
Group II Received 50mg/kg b.w. of the hydro-alcoholic extract 
of   Boerhaavia diffusa Linn  orally once daily for 20 
days 
Group III Received 100mg/kg b.w. of the hydro-alcoholic extract 
of Boerhaavia diffusa Linn  orally once daily for 20 
days 
Group IV Received 200mg/kg b.w. of the hydro-alcoholic extract 
of  Boerhaavia diffusa Linn orally once daily for 20 
days 
Group V Received 400mg/kg b.w. of the hydro-alcoholic extract 
of Boerhaavia diffusa Linn  orally once daily for 20 
days 
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Observations: The  signs  of  toxicity  such  as  changes  in  bodyweight,  skin  and  fur,  
eyes and mucus membranes, respiratory system, circulatory system, ANS and CNS, 
somatomotor  activity  and  behaviour  pattern  were  observed  systematically  and  
recorded for each animal. The animals were then weighed every five days, from the 
start of the treatment, to record the weight variation. At the end of the treatment, 
blood samples were collected by puncturing retro orbital plexus after mild anesthesia 
for biochemical analysis. The collected blood sample was centrifuged within 5min 
of collection at 4000g for 10min to obtain plasma, which was analyzed for total 
cholesterol, total triglyceride, HDL-cholesterol levels, LDL-cholesterol, plasma 
glucose, alanine aminotransferase (ALT), aspartate aminotransferase (AST), 
creatinine and urea. The results obtained were presented in Tables 18 to 22. 
5.6.1.4 Chronic toxicity study  
 The method was performed according to the Organization of Economic 
Co-operation and Development Guidelines for testing of chemicals 423 (OECD 
2000).  
Experimental protocol: The male and female Wistar rats weighing 180 ± 10g were 
randomly divided in to four groups of six each. Treatment schedule was adopted as 
given below. 
Name of the group (n=6) Treatment 
Group 1         Received single daily dose of 0.5 ml of Tween 80 orally 
for 90 days 
Group 2 Received 200mg/kg b.w. of the hydro-alcoholic extract 
of   Boerhaavia diffusa Linn    orally once daily for 90 
days 
Group 3 Received 400mg/kg b.w. of the hydro-alcoholic extract 
of Boerhaavia diffusa Linn  orally once daily for 90 days 
Group 4 Received 600mg/kg b.w. of the hydro-alcoholic extract 
of Boerhaavia diffusa Linn  orally once daily for 90 days 
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 The  extract  was  given  orally  to  rats  in  groups  2  to  4  at  doses  200,  400,  
600mg/kg b.w. respectively daily for 90 days while the control group received water 
only.  
Observations: The animals were observed daily for toxic manifestations. The body 
weight, signs of toxicity and mortality were observed daily. The results obtained are 
presented in Table 23. At  the  end  of  the  study,  all  rats  were  fasted  overnight  and  
anesthetized for blood collection. Heparinized blood samples were taken for 
determining complete blood count, red blood cell count, platelet count and red cell 
indices. The serum from non-heparinized blood was carefully collected for blood 
chemistry and enzyme analysis. The results are presented in Tables 24 & 25. 
5.7   IN VIVO ANTI TUMOUR ACTIVITY  
Principle: The tumor tissues proliferate rapidly and spread throughout the body 
resulting in death of the host. To  screen  anticancer  profile  of  any  study  agent  
induction of tumor in animals is an important step. Tumor induction can be achieved 
by various techniques like chemical induction using croton oil or 
dimethylbenz[a]anthracene (DMBA); viral induction using hepatitis B virus (HBV), 
hepatitis C virus (HCV) and mouse mammary tumor virus (MMTV) or cell line 
induced using Dalton’s Ascites Lymphoma (DAL) and Ehrlich Ascites Carcinoma 
(EAC)).  
 The induction of cancer in animals in the present study was carried out 
using Dalton’s Lymphoma ascites (DAL) and Ehrlich Ascites Carcinoma (EAC) cell 
lines and DMBA. The anticancer property of the extract is evaluated by comparing 
various hematological parameters, serum lipid and enzyme profile and derived 
parameters of the treated with untreated tumour induced animals.  
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5.7.1  Anti tumour activity against Dalton Ascitic Lymphoma (DAL) in 
mice
149
 
 The experimental protocol was approved by Institutional Animal Ethical 
Committee (App. No. G. Nalini /TNMGRMU /Ph.D /IAEC/KMCP/112/2014-15) 
and CPCSEA guidelines for maintenance of animals were adhered during the 
experiment. 
Tumour cell lines 
 Daltons Ascites lymphoma (DAL) cell lines obtained from Amala Cancer 
Research  Centre,  Trissur,  Kerala,  India  were  used  for  the  study.  The  cells  were  
maintained in vivo in Swiss albino mouse by injecting intraperitoneally the cells at a 
concentration of 1x10
6
cells/ml and the tumour was allowed to grow in the mouse for 
a minimum of seven days before the start of the study.
149
 After a week, the tumor 
cells were aspirated from the peritoneal region using saline and the viable cells were 
counted and diluted to get 1x10
6
 cells/ml/mouse and was used for the study.  
Preparation of extract  
 An aliquot quantity of the dried HAEBD powder was weighed and 
dissolved in 10% DMSO to get a solution of 200mg/ml of hydro-alcoholic extract of 
Boerhaavia diffusa Linn which was stored at ?10°C.   
Selection and Grouping of animals 
 Male Swiss albino mice (20-25g) were used for the study and the animals 
were segregated randomly into five groups, each group with 6 animals and housed in 
micro nylon boxes and labeled as group 1 to 5.  Before the commencement of the 
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study the animals were acclimatized in cages maintained in a hygienic and 
controlled environment of 25 ± 2°C temperature and 12h dark or light cycle. 
Animals were fed with healthy and standard laboratory diet with water ad libitum.  
Treatment protocol 
 The animals were divided into five groups were labeled and treated as per 
given treatment schedule.  
Name of the group (n=6) Treatment 
Group 1- Normal control Received normal diet and water   
Group 2 - Tumor control Received an injection of saline (5mg/ml) daily for 14 
days after 24h of injection of DAL cells (1× 10
6 cells)
 
intraperitoneally.  
Group 3 – Standard Received an injection of 5-flurouracil at 20mg/kg b.w. 
intraperitoneally daily for 14 days after 24h of injection  
of  DAL  cells  (1  x  10
6 
cells per mouse) 
intraperitoneally.
150 
Group 4 Received 200mg/kg b.w. hydroalcoholic extract of  
Boerhaavia diffusa Linn orally daily for 14 days after 
24h of injection of DAL cells (1 x 10
6 
cells per mouse) 
intraperitoneally. 
Group 5 Received 400mg/kg b.w. hydroalcoholic extract of  
Boerhaavia diffusa Linn orally daily for 14 days after 
24h of injection of DAL cells (1 x 10
6 
cells per mouse) 
intraperitoneally.
151 
 
Tumor induction and drug treatment 
 The animals in Group 2 to 5 were injected with DAL cell lines (1x10
6 
cells per mouse) intraperitoneally at the beginning of the study. After 24h of 
inoculation of DAL cells, the animals of group 2, 3, 4 and 5 were administered with 
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saline, 5-flurouracil, HAEBD (200mg/kg) and HAEBD (400mg/kg) respectively. All 
the treatments were given as once daily doses for 14 days.  
Sacrifice and blood collection procedure 
 After  the  last  dose  administration  on  14
th
 day, the animals were utilized 
for  evaluation  of  clinical  parameters.  The  animals  from  each  group  were  
anaesthetized using anesthetic ether and blood samples were collected from retro-
orbital plexus for evaluation of hematological, lipid and enzymatic parameters. 
Peritoneal fluid was also aspirated for determining the tumor cell count. Finally the 
animals were sacrificed by euthanasia and histological study was carried out to 
determine toxicity. The remaining animals from each group were utilized for 
determining the Mean Survival Time (MST) and percentage increase in life span. 
Determination of derived parameters 
 The derived parameters like analysis of body weight changes, survival 
time, percentage increase in life span and viable cell count were also determined.   
Body weight analysis 
 All the animals were weighed before dosing. By comparing the body 
weight of animals on 1
st
 day and 14
th
 day of study the average increase in body 
weight was calculated and presented in Table 26.   
Mean survival time (MST) 
 The mean survival time was calculated after dosing for 14 days. The day 
of death of each animal was noted and the meana survival time was calculated using 
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the formula: Mean survival time (MST) = Number of days of survival by each 
animal/Number of animals in that group. The results presented in the Table 26  
Percentage increase in life span  
 The percentage increase in life span for each treated group was calculated 
using the formula given below and the results are tabulated in Table 26.  
 
Tumor cell count 
 About  0.1mL  of  the  aspirated  peritoneal  fluid  from  each  mouse  was  
mixed with 0.1mL of 0.01%w/v tryphan blue and was diluted with 0.8mL of ice 
cold normal saline. After complete mixing, the cell suspension was kept aside for a 
minimum of 5min and maximum of 15min. One drop of this suspension was loaded 
in to Neubaeur chamber and viable cells were counted. Viable cells do not uptake 
the stain and will be visible as white color on blue background which was counted, 
calculated and results presented in Table 26. 
 
Evaluation of various parameters  
There is a marked increase in total white blood cell count and decrease in red cell 
count  and  hemoglobin  content  in  lymphomas  and  in  some  cases  there  is  also  an  
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increase of platelet count, serum cholesterol content and decrease in triglyceride 
level.  Lymphomas also exhibited marked elevation in liver enzymes. Hence these 
parameters were evaluated because of pathological variations exerted by 
lymphomas. 
(a) Determination of Hematological parameters  
 The hematological parameters like white blood cell (WBC) count, red 
blood cell (RBC count, hemoglobin (Hb) content, platelet count and packed cell 
volume (PCV) were determined using an autoanalyzer (Make and Model) and are 
reported in Table 27. The graphical representation of the same is presented in Fig. 13. 
(b) Determination of serum lipid and enzyme profile  
 The  serum  lipid  parameters  like  total  cholesterol  (TC)  content  and  
triglyceride content and serum enzymes such as aspartate amino transferase (AST) 
concentration, alanine amino transferase (ALT) concentration and alkaline 
phosphatase (ALP) concentration were also analyzed using autoanalyzer and reagent 
kits available and the results obtained are presented in Tables 28 and the graphical 
representation of the same is presented in Fig. 14. 
(d) Histopathological studies 
 A piece of liver sample was fixed in 10% formalin and 5µm section was 
obtained from the paraffin block. The thin sections were cut and then stained by 
haematoxylin and eosin and observed under light microscope. The 
photomicrographs of the same are presented in Figs. 15 to 19.  
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5.7.2 Effect of HAEBD on Ehrlich Ascitic Carcinoma in mice 
 Ehrlich ascites carcinoma is a spontaneous murine mammary 
adenocarcinoma adapted to ascites form and carried in outbred mice by serial 
intraperitoneal injection.  Ehrlich ascites tumor cells lack H-2 histocompatibility 
antigens and rapidly proliferate in almost any mouse host and hence used for 
chemotherapeutic studies.  
Experimental protocol  
 The experimental protocol was approved by Institutional Animal Ethical 
Committee (App. No. G. Nalini /TNMGRMU /Ph.D /IAEC/KMCP/112/2014-15) 
and CPCSEA guidelines for maintenance of animals were adhered during the 
experiment. 
Cell lines 
 Erlich Ascites Carcinoma (EAC) cell lines obtained from Amala Cancer 
Research  Centre,  Trissur,  Kerala,  India  were  used  for  the  study.  The  cells  were  
maintained in vivo in Swiss albino mice by intraperitoneal injection of 1ml 
containing 1x10
6
 EAC  cells  and  the  tumour  was  allowed  to  grow  in  mice  for  a  
minimum  of  7  days  before  the  study.
152 
While transferring the tumour cells to the 
grouped  animals,  the  EAC  cells  were  aspirated  from  peritoneal  cavity  of  the  mice  
using saline. The cell count was done and further dilutions were made, to get a 
concentration of 1x10
6
cells/ml/mouse.  
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Preparation of extract  
 An aliquot quantity of the dried HAEBD powder was weighed and 
dissolved in 10% DMSO to get a solution of 200mg/ml of hydro-alcoholic extract of 
Boerhaavia diffusa which was stored at ?10°C. 
Selection and Grouping of animals 
 Male Swiss albino mice (20-25g) were used for the study and the animals 
were segregated randomly into three groups, each group with 6 animals and housed 
in  micro  nylon  boxes.  The  cages  were  labeled  as  group  1  to  3.   Before  the  
commencement of the study the animals were acclimatized in cages maintained in a 
hygienic and controlled environment of 25 ± 2°C temperature and 12h dark or light 
cycle. Animals were fed with healthy and standard laboratory diet with water ad 
libitum.  
Treatment protocol 
 The animals divided into three groups were labeled and treated as 
mentioned below.  
Name of the group (n=6) Treatment 
Group 1 Tumor control EAC cells (1x10
6
 cells/mice) were injected into the 
right limb (thigh) intramuscularly. 
Group 2  
 
200mg/kg b.w. of hydro-alcoholic extract of 
Boerhaavia diffusa Linn  was injected  on  alternate 
days for 10 days into the right limb (thigh) 
intramuscularly after 24h of injection of EAC cells (1 x 
10
6 
cells per mouse) into the right limb (thigh) 
intramuscularly.  
Group 3 
 
400mg/kg b.w. of hydro-alcoholic extract of 
Boerhaavia diffusa Linn was injected  on alternate days 
for 10 days  into the right limb (thigh) intramuscularly 
after 24h of injection of EAC cells (1 x 10
6 
cells per 
mouse) into the right limb (thigh) intramuscularly 
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Tumor induction and drug treatment 
 The tumor cells (1x10
6
 cells/mice) were injected into the right limb 
(thigh) of all the animals intramuscularly at the beginning of the study. After 24h of 
inoculation of EAC cells, the animals of group 2 and 3 were administered 
intramuscularly with HAEBD (200mg/kg) and HAEBD (400mg/kg) respectively on 
alternate days.  All the treatments were given as once daily dose for 14 days.  
Measurement of tumour mass 
 The tumor mass was measured from the 11
th
 day of tumor induction. 
Diameter of the tumor was measured on every 5
th 
day for a period of 30 days using 
Vernier calipers and the volume of the tumor mass was calculated using the formula 
V= 4/3 ? r2 where r is the mean of r1 and r2 which are two independent radii of the 
tumor mass. The results are presented in table 29. 
5.8 EVALUATION OF HYDRO-ALCOHOLIC EXTRACT OF   
AGAINST 7, 12-DIMETHYL BENZ [A] ANTHRACENE (DMBA) 
INDUCED BREAST CANCER IN SWISS ALBINO MICE 
 The in vitro screening of the extract showed significant activity against 
MCF-7 cell lines and hence in vivo screening of the extract against DMBA induced 
breast cancer in Swiss albino mice was evaluated as breast cancer is the leading 
cause of death worldwide among women
153
.  
Technique for inducing breast cancer  
 The available mouse models for evaluation of breast cancer can be 
categorized into three main groups: (a) xenograft models (b) chemical, viral or 
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ionizing radiation induced models; and (c) genetically engineered mice (GEM) such 
as transgenics and knockouts 
154
 
 In the present study, in vivo anticancer activity was carried out using 7,12-
dimethyl benz [a] anthracene (DMBA) to induce breast cancer and studying the 
effect of extract on the same. 
5.8.1 Experimental procedure 
 The experimental protocol was approved by Institutional Animal Ethical 
Committee (App. No. G. Nalini /TNMGRMU /Ph.D /IAEC/KMCP/123/2014-15) 
and CPCSEA guidelines for maintenance of animals were adhered during the 
experiment.  
Selection and Grouping of animals 
 Swiss albino female mice weighing (30g) were procured from animal 
experimental laboratory and used throughout the study. The animals were housed in 
well ventilated large spacious polypropylene cages and had 12 ± 1h light and dark 
cycles throughout the experimental period. The animals received a balanced diet of 
commercially available pellet rat feed and water ad libitum.
155, 156 
 As  per  the  
standard practice, the mice were quarantined for 15 days before the commencement 
of the experiment.
157
  
Chemicals 
 DMBA were purchased from Sigma Chemicals Co. (St. Louis, MO, 
USA). All the other chemicals used in this study were of analytical grade available 
commercially. 
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Preparation of extract  
 An aliquot quantity of the dried HAEBD powder was weighed and 
dissolved in 10% DMSO to get a solution of 200mg/ml of hydro-alcoholic extract of 
Boerhaavia diffusa Linn and stored at ?10°C.   
Treatment protocol 
 The mice were segregated into 5 groups, each group comprising of 6 
animals each and the treatment schedule is as follows  
Name of the group (n=6) Treatment 
Group 1- Normal control Received vehicle 
Group 2 - Tumor control Received subcutaneous injection of DMBA at 7.5mg/kg 
b.w. once a week for four consecutive weeks.
159,160 
Group 3 – Standard Received subcutaneous injection of DMBA at 7.5mg/kg 
b.w. once a week for four consecutive weeks and  
injection vinblastin at 0.5 mg/kg body weight intra 
peritoneally once a week for 45 days.
161
 
Group 4 Treatment control Received subcutaneous injection of DMBA at 7.5mg/kg 
b.w. once a week for four consecutive weeks and 
200mg/kg b.w. hydroalcoholic extract of Boerhaavia 
diffusa Linn  orally daily for 45 days. 
Group 5 Treatment control 
 
 
Received subcutaneous injection of DMBA at 7.5mg/kg 
b.w. once a week for four consecutive weeks and  
400mg/kg b.w. hydroalcoholic extract of Boerhaavia 
diffusa Linn orally daily for 45 days. 
 
Tumor induction and drug treatment 
 DMBA (7.5mg/kg b.w.) was injected subcutaneously once a week for 
four consecutive weeks to all the animals of group 2 to 5.  The animals of group 1 to 
5 received vehicle, injection vinblastin at 0.5 mg/kg body weight intra peritoneally 
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once a week,
 161 
HAEBD 200mg/kg b.w. and HAEBD 400mg/kg b.w. orally daily 
for 45 days respectively. 
 
Observations: The experimental  rats  were  regularly  monitored  for  food  and  water  
consumption, the apparent signs of toxicity, weight loss, or mortality. Forty-five 
days after first dose administration of DMBA, the mice were starved overnight and 
anesthetized with diethyl ether and sacrificed by euthanasia method. The breasts 
were dissected out and a piece of the tissue was used for histopathological studies 
and the rest was used for estimating various biochemical parameters.   
Evaluation of derived parameters 
 The derived parameters such as body weight, tumour volume, percentage 
reduction of tumour volume were determined
162
.  
(a) Body weight analysis 
 All the animals were weighed every day before dosing. By comparing the 
body weight of animals on 1
st
 day and 45
th
 day of study the average increase in body 
weight is calculated and presented in Table 30.  
(b) Tumour volume 
 The tumour volume was measured weekly. Tumor volume was calculated 
using the formula
. 
(cc)  =  4/3  ?r  3. On  45th  day,  mice  were  sacrificed  and  tumours  
were removed from the animals and weighed. The tumour incidence and its 
percentage reduction were also recorded at the termination of the experiment.
163, 164
 
The results are presented in Table 30. 
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Evaluation of Biochemical Parameters 
 The following biochemical measurements were carried out in the mice 
breast tissues. Breast were dissected out, cut into small pieces with a heavy-duty 
blade and washed with ice-cold 0.9% NaCl solution. One hundred milligrams of the 
tissues were homogenized in 0.1M Tris–HCl buffer (pH 7.4). The homogenate was 
used for estimation of biochemical parameters.
165
 such as superoxide dismutase, 
catalase, glutathione peroxidaase and lipid peroxide was estimated in the breast of 
treated as well as untreated mice. The results are presented in Table 31.  
(a) Assay of superoxide dismutase (SOD)
 166 
Principle: Superoxide dismutase activity was measured by the method of Kakkar et 
al., (1984).
166 
The assay of SOD was based on the inhibition of the formation of 
NADH-phenazine methosulphate-nitroblue tetrazolium complex. The reaction was 
initiated by the addition of NADH. After incubation for 90sec, the reaction was 
stopped by the addition of glacial acetic acid.  The colour developed at the end of the 
reaction was extracted into butanol layer and measured at 560nm. 
Reagents 
? Sodium pyrophosphate buffer, 0.025M, pH 8.3 
? Phenazine methosulphate, 186?M 
? Nitroblue tetrazolium, 300mM 
? NADH-780mM 
? Glacial acetic acid 
? n-butanol 
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? Chloroform 
? Ethanol 
Procedure: 0.5ml of the tissue homogenate was diluted to 1ml with ice cold water. 
2.4ml of ethanol and 1.5ml chloroform (in chilled condition) were added and shaken 
for 1min at 4?C and then centrifuged. The supernatant was used for determination of 
SOD. To the supernatant, 1.2ml sodium pyrophosphate buffer, 0.1ml phenazine 
methosulphate, 0.3ml nitroblue tetrazolium and water was added to make a volume 
of 3.0 ml and the reaction was initiated by addition of 0.2ml NADH. The reaction 
was stopped by the addition of 1.0ml glacial acetic acid after incubation at 30?C for 
90sec.  The  reaction  mixture  was  shaken  with  4.0ml  of  n-butanol  and  allowed  to  
stand for 10min and then centrifuged. The colour produced in n-butanol layer was 
measured at 560nm using n-butanol as blank and a system devoid of enzyme was 
used as a control. The enzyme reaction which gave 50% inhibition of NBT reduction 
in one minute under the assay conditions was called as one unit of enzyme activity 
and expressed as units/mg protein. The results obtained are presented in Table 31. 
(b) Assay of catalase (CAT)
167
 
Principle: The method of Sinha (1972)
158
 was utilized for determining the activity 
of catalase. The dichromate in acetic acid when heated in the presence of hydrogen 
peroxide was converted to perchromic acid and then to chromic acetate which was 
measured at 620nm. Catalase enzyme splits hydrogen peroxide and the reaction 
stopped at different time intervals by addition of dichromate acetic acid mixture and 
the remaining hydrogen peroxide was estimated colorimetrically as chromic acetate. 
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Reagents 
? Phosphate buffer, 0.01M, pH 7.0 
? Hydrogen peroxide (H202) 0.2M 
? Potassium dichromate, 5% (w/v) 
? Dichromate acetic acid reagent  
? Standard hydrogen peroxide, 2mM 
Procedure: To 0.1ml sample in 6.0ml phosphate buffer, 0.4 ml hydrogen peroxide 
was added. The addition of 2ml dichromate-acid reagent at 15, 30, 45 and 60s 
stopped the reaction of catalase on hydrogen peroxide. The tubes were then kept in 
boiling water both for 10min and the colour developed was read at 620nm using 
reagent as blank. Hydrogen peroxide in the range of 2-10?M was used as a standard 
and treated in a similar manner. The activities were expressed as ?M  of  H2O2 
consumed/ minute/ mg protein. The results obtained are presented in Table 31. 
(c) Assay of glutathione peroxidase (Gpx)
168 
Principle: The method of Rotruck et. al., 1973 was utilized for determination of 
glutathione peroxidase activity. The sample allowed to react with H2O2 in presence 
of GSH for a specified time period and the remaining GSH content was measured.  
Gpx 
 2GSH+H2O2                     GSSG+2H2O 
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Reagents  
? Tris buffer, 0.4 M, pH 7.0 
? Sodium azide solution, 10 mM 
? Tricholoro acetic acid, 10% (w/v) 
? EDTA, 0.4 mM 
? H2O2 solution, 20 mM 
? Glutathione solution, 2 mM 
Procedure: The sample mixture contained tris buffer, EDTA, sodium azide, sample 
(tissue homogenate), GSH and hydrogen peroxide and incubated at 37 ?C for 10min 
along  with  a  tube  containing  all  the  reagents  except  the  sample.  After  10min,  the  
reaction was arrested by addition of 10% TCA centrifuged and the supernatant was 
assayed for GSH by the method of Beutler et al., 1963. The results obtained are 
presented in Table 31. 
(d) Assay of lipid peroxidase 
 Hydroperoxy lipids are the source for the formation of free radicals which 
attack  poly  unsaturated  fatty  acid  in  cell  membrane  leading  to  a  chain  of  chemical  
reaction called lipid peroxidation. Malondialdehyde is the major end product of LPO 
and readily reacts with thiobarbituric acid to form a pink coloured chromophore in 
acidic medium which was read at 530nm. 
Reagents 
? Tris–HCl (30mM) 
? Ferrous ammonium sulfate (0.16mM) 
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? Ascorbic acid (0.06mM) 
? n-butanol/pyridine (15:1, v/v) 
Procedure: The reaction mixture containing rat breast homogenate (0.1ml, 50%, 
w/v) in Tris–HCl (30mM), ferrous ammonium sulfate (0.16mM), ascorbic acid 
(0.06mM)and was incubated for 1h at 37
?
C, and the resulting thiobarbituric reacting 
substances (TBARS) was measured.
169
 An aliquot equivalent to 0.4ml of the 
reaction mixture was treated with sodium dodecyl sulfate (0.2ml, 8%), thiobarbituric 
acid (1.5ml, 0.8%) and acetic acid (1.5ml, pH 3.5) and made up to a total volume of 
4ml  by  adding  distilled  water,  and  then  kept  in  a  water  bath  at  95
?
C  for  1h.  After  
cooling, 1ml of distilled water and 5ml of n-butanol/pyridine (15:1, v/v) were added. 
The organic layer was separated after shaking and centrifugation. LPx activity was 
measured in terms of thiobarbituric acid formation and the color intensity measured 
spectrophotometrically at 530nm.
170
 The results are presented in the Table 31. 
Histopathological Examination 
 Mammary tissues were fixed in 10% buffered formalin, embedded in 
paraffin using a conventional automated system. Tissue fragments were fixed in 
formalin and 5µm section was obtained from the paraffin block and stained with 
haematoxylin and eosin for histologic examination. Breast tissue pathology and 
histologic  type  were  evaluated  by  application  of  the  same  pathologic  criteria  used  
for the classification of human tumours. Serial paraffin sections of each tissue image 
were captured by light microscopy. The photomicrographs of the breast tissue are 
presented in Fig. 20 to 24.  
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5.9 HEPATOPROTECTIVE AND ANTI-OXIDANT EFFECT OF 
HYDRO-ALCOHOLIC EXTRACT OF BOERHAAVIA DIFFUSA  
 Liver diseases remain one of the serious health problems. Acute hepatic 
failure (AHF) has become the focus of attention for researchers because of its 
extremely high mortality rate and the lack of ideal treatment in clinical medicine. 
Management of liver diseases is still a great challenge to the modern medicine. 
Natural treatments from medicinal plants are considered to be effective and safe 
medicaments for hepatotoxicity and the effectiveness of these plant products must be 
proved.  
 Hepatic injury may be caused by different agents such as viruses, 
chemicals, alcohol, autoimmune diseases and D-galactosamine. D-galactosamine 
(D-GalN) is a well-known hepatotoxicant. It induces liver injury closely resembling 
human viral-hepatitis with necrosis, inflammation and regeneration. The toxicity of 
D-GalN  is  associated  with  the  depletion  of  uridine  pools,  limited  ribonucleic  acid  
(RNA) and protein synthesis thus overall affecting hepatocellular function.
  
5.9.1  Experimental procedure 
 The experimental protocol was approved by Institutional Animal Ethical 
Committee (App. No. G. Nalini /TNMGRMU /Ph.D /IAEC/KMCP/42/2012-13) and 
CPCSEA guidelines for maintenance of animals were adhered during the 
experiment.  
Preparation of extract  
 An aliquot quantity of the dried HAEBD powder was weighed and 
dissolved in 10% DMSO to get a solution of 200mg/ml of hydro-alcoholic extract of 
Boerhaavia diffusa and was stored at ?10°C.   
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Selection and Grouping of animals 
 Swiss albino mice weighing (25-30g) were procured from animal 
experimental laboratory and used throughout the study. The animals were housed in 
well ventilated large spacious polypropylene cages and had 12 ± 1h light and dark 
cycles throughout the experimental period. The animals received a balanced diet of 
commercially available pellet rat feed and water ad libitum. The animals were 
acclimatized for 1 week before the study and had free access to standard laboratory 
feed and water ad libitum.  
Treatment protocol 
 The Swiss albino mice selected for the study were divided into five 
groups of six animals each and the treatment schedule given below was followed.  
Name of the group (n=6) Treatment 
Group 1- Normal control Received normal diet and water for 8 days 
Group 2 - Tumor control Received distilled water 5ml/kg b.w. p.o. for 8 days and 
D-galactosamine in distilled water at 200 mg/kg b.w 
intraperitoneally after one hour of vehicle on the 8th 
day.
171 
Group 3 – Standard Received  Vitamin  E  Pretreatment  for  8  days  and  D-
galactosamine in distilled water at 200mg/kg b.w 
p.o.after one hour of drug on the 8th day. 
Group 4  Received 200mg/kg b.w p.o.hydroalcoholic extract of 
Boerhaavia diffusa Linn orally daily for 8 days. A 
single dose of D-galactosamine in distilled water given 
intra peritoneally after one hour of drug on the 8th day. 
Group 5 Received 400mg/kg b.w. hydroalcoholic extract of 
Boerhaavia diffusa Linn orally daily for 8 days. A 
single dose of D-galactosamine in distilled water given 
intra peritoneally after one hour of drug on the 8th day.  
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Drug treatment 
 The animals of group 2 to 5 received distilled water, vitamin E, HAEBD 
200mg/kg and HAEBD 400mg/kg orally respectively for 8 days. On the 8
th
 day, all 
the animals belonging to group 2 to 5 received D-galactosamine after 1h after 
administration of the last dose of the treatment. 
 
(a) Determination of Biochemical Parameters 
 On  the  9th  day  after  overnight  fast  all  animals  were  sacrificed  using  
ketamine HCl and blood was withdrawn by cardiac puncture and allowed to clot for 
30min at room temperature. The serum was separated by using cooling centrifuge 
and used for the assay of marker enzymes namely AST, ALT, ALP, TP, TB, GGPT 
and total albumin. Different biochemical parameters like alanine transaminase 
[ALT], aspartate transaminase [AST],
172,173
 alkaline phosphatase [ALP],
174
 ?–
glutamyltransferase [?GTP], bilurubin,175 total protein were estimated using serum. 
The results are presented in Table 32 and the graphical representation of the same is 
presented in Fig. 25. 
 
  
(b) Determination of enzymatic antioxidants in liver homogenate 
 The livers were dissected out immediately, washed with ice-cold saline 
and 10% homogenates in phosphate buffer solution (PH 7.4) were prepared. The 
following biochemical measurements were carried out in the liver tissues. Liver 
homogenate was used for the assay of MOA while some fraction of homogenates 
were centrifuged at 2500 rpm for 10 min at 4
0 
C using refrigerated centrifuge, and 
the supernatants were used for the assay of Superoxide dismutase (SOD), catalase 
(CAT), Glutathione peroxidase (GPx).
176, 177 
 by standard methods using enzyme 
assay kits. The enzyme assays were performed on a semi-autoanalyser ERBA 
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Chem7. The results are presented in Table 33 and the graphical representation of the 
same are presented in Figs. 26 to 29. 
 
  
(c) Determination of non enzymatic antioxidants in liver homogenate 
 The non enzymatic antioxidants glutathione, vitamin E and vitamin C in 
liver homogenate was estimated.  
(i)  Estimation of glutathione (GSH)
178
 
Principle: In this method, a yellow colour is developed when dithio dinitro bis-
benzoic acid (DTNB) is added to the compounds containing sulphydryl groups and 
measured colorimetrically. 
Reagents 
? Phosphate buffer, 0.2M, pH 8.0  
? TCA, 5%(w/v) 
? Ellman's reagent 
? Disodium hydrogen phosphate (Na2HPO4 ). 0.3M, pH 8.0 
? Standard glutathione solution 
? Precipitating reagent 
Procedure: To the homogenized tissue in phosphate buffer, 3.0ml of precipitating 
reagent was added and mixed thoroughly. It was allowed to stand for 5min and 
centrifuged. A set of standard glutathione solutions (20-100?g) was taken and made 
upto  2ml  with  distilled  water.  2ml  of  the  supernatant  along  with  2ml  of  blank  
containing distilled water was also taken. To all the tubes 4.0ml 0.3M disodium 
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hydrogen phosphate and 1ml of DTNB reagent were added. The colour developed 
was read at 412nm. The reduced glutathione levels were expressed as mg/g wet 
tissue. The results obtained are presented in Table 34. 
(ii)  Estimation of Vitamin E (?-Tocopherol) 179 
Principle: In this method,  the reduction of ferric ions to ferrous ions by tocopherol 
and the formation of a pink coloured complex with 1,10-phenanthroline-ortho 
phosphoric acid is measured at 520nm.  
Reagents 
? Petroleum ether :  60- 80 ?C 
? Double distilled ethanol. 
? 2, 2’ dipyridyl solution: 0.2% in double distilled ethanol. 
? Ferric chloride solution: 0.5% in double distilled ethanol. 
? Stock  standard:  10  mg  of  ? – tocopherol in 100 mL of distilled 
ethanol. 
? Working standard: Stock solution was diluted with ethanol to a 
concentration of 10 ?g/ml. 
Procedure: To 0.5ml of sample, 1.5ml of ethanol was added, mixed and 
centrifuged. The supernatant was evaporated and to the precipitate, 3ml of petroleum 
ether, 0.2ml of 2, 2’ dipyridyl solution and 0.2ml of ferric chloride solution were 
added and kept in dark for 5 min. An intense red colour was formed. Then 4ml of n-
butanol was added to all the tubes and mixed well. Standard tocopherol in the range 
of 10-100?g was taken and treated similarly along with a blank containing only the 
reagent. The colour in the n-butanol layer was read at 520 nm. The values were 
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expressed as mg/dl for plasma or mg/100g of wet tissue. The results obtained are 
presented in Table 34. 
(iii)  Estimation of Vitamin C
180
 
Principle: In this reaction mixture consist of ethanol, petroleum ether, batho 
phenanthroline, ferric chloride, and O-phosphoric acid. The colour developed was 
measured at 530nm. Vitamin C values were expressed as mg/dl. 
Reagents 
? TCA: 6% 
? 2, 4 DNPH reagent: 2.0 g of DNPH was dissolved in 100 mL of 9 N 
sulphuric acid. To this, 4.0 g of thiourea was added and mixed. 
? Sulphuric acid : 85% 
? Stock ascorbic acid solution: 10 mg of L-ascorbic acid in 100 mL of 
4% TCA. 
? Working ascorbic acid solution: 1 in 10 dilution of stock ascorbic 
acid solution with 4% TCA to obtain a concentration of 0.1 mg/mL. 
Procedure 
 To 0.5ml of sample, 1.5ml of 4% TCA was added and allowed to stand 
for 5min and centrifuged. To the supernatant, 0.3g of acid washed norit was added, 
shaken vigorously and filtered. This converts ascorbic acid to dehydroascorbic acid. 
0.5ml of the filtrate was taken and 0.5ml of DNPH was added, stoppered and placed 
in a water bath at 37?C for exactly 3h. After 3h the tubles were removed and placed 
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in ice-cold water. 2.5mL of 85% sulphuric acid was added drop by drop and the 
contents of the tubes were mixed well and allowed to stand at room temperature for 
30min. A set of standards containing 20-100?g of ascorbic acid were taken and 
processed  similarly  along  with  a  blank  containing  2ml  of  4%  TCA.  The  color  
developed was read at 540nm. The values were expressed as mg/dl of plasma or 
mg/100g of wet tissue. The results obtained are presented in Table 34. 
Histopathological examination
181
  
 The livers from each group was aseptically excised and stored separately 
for analysis of oxidative stress-related biomarkers and in phosphate-buffered 
formalin (10%) for histopathological evaluation. The micro photographs are 
presented in Figs. 30 to 34.  
5.10  STATISTICAL ANALYSIS 
 The statistical analysis was done by using Graphpad instat software. The 
statistical comparisons between control and treatment mean values of two 
parameters were analyzed using the Student’s t-test. Multiple comparisons were 
done using ANOVA. The differences were statistically significant at P < 0.01; P < 
0.05.  
5.11 ISOLATION AND CHARACTERIZATION OF COMPOUNDS 
FROM HYDROALCOHOLIC EXTRACT OF   (HAEBD) 
 The in vitro and in vivo screening of the extract HAEBD revealed that the 
extract possessed anticancer, antioxidant, and hepatoprotective activities and hence 
was  subjected  to  column  chromatographic  separation  for  isolation  of  the  active  
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principle and spectroscopic techniques were used for elucidation of the structure of 
the isolated compounds.  
5.11.1  Isolation of Compounds by Column Chromatography 
Preparation of Admixture: 20g of HAEBD was admixed with 20g silica gel 
(60/120 meshes) to get homogeneous mixing.  
Column Packing: About 200g of silica gel (70/325 meshes) was taken in an 
appropriate column and packed very cautiously without air suds using hexane as 
filling solvent and kept aside for 1h and then 20g of HAEBD admixed with silica 
gel was added at the top of the column and separation of compounds was started by 
the eluting with hexane, then with mixtures of hexane and ethyl acetate of increasing 
polarity. Finally the column was washed with ethyl acetate and ethanol.  All the 
column fractions were collected separately and concentrated and subjected to thin 
layer chromatographic identification of spots using different mobile phase. The 
fractions having same profile was mixed together and concentrated under reduced 
pressure. One concentrated fraction was further subjected to chromatographic 
separation using 2.4 diameter columns with 50g of Silica gel (60-120 mesh) packing 
of a column height of 20cm. The columns were eluted with a mixture of ethyl 
acetate and hexane as per scheme given in table 4. The fractions obtained when 
column was eluted with a mixture of hexane and ethyl acetate (95:5) was 
concentrated and a white crystalline powder obtained was termed as compound I 
and the fractions obtained when column was eluted with a mixture of hexane and 
ethyl acetate (80:20) was concentrated and a pale white crystalline powder obtained 
was termed as compound II. The samples were subjected to melting point 
determination and spectral studies such as IR, NMR and Mass for the identification 
of the structure.  
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Table 7: Scheme for column elution for the fraction obtained from HAEBD  
S. No Number of 
fractions 
% of solvent 
(hexane: ethyl acetate) 
TLC spot 
1 1-60 100:000   
2 60-86 95:05  Compound I 
3 87-100 90:10  
4 101-120  85:15   
5 121-140  80:20  Compound II 
6 141-170  75:25   
7 171-256 70:30   
8 257-290 000:100   
 
5.11.2 Analysis of isolated compounds using various Analytical Techniques  
 The melting point of the compounds was recorded for identification and 
extent of purity. Various spectral studies such as IR, NMR and Mass were studied to 
determine and confirm the structural aspects of the compound I and II isolated from 
HAEBD
182
 
(a) Determination of Melting Point  
 The melting points of the isolated compounds were recorded using 
Toshniwal melting point apparatus.  
(b) Spectral Analysis of the Compounds Using FT- IR  
 An IR spectrum of the compounds I and II isolated from the HAEBD was 
recorded using a Nicolet 170SX FT IR spectrophotometer. The spectral resolution 
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for the Nicolet 170SX was 0.25cm
-1 
and the spectral data was stored in the database 
at  an  interval  of  0.5cm
-1 
at 4000-2000cm
-1 
and of 0.25cm
-1 
at 2000-400cm
-1
. The 
solid amorphous powders of the compounds were measured by using KBr disc 
method. The IR spectra of the isolated compounds I & II are depicted in Figs. 35 & 
39 and the IR spectral data of the isolated compounds are presented in Tables 35 & 
38. 
(c) Spectral Analysis of the Compounds Using 
1
H NMR  
 The 
1
H NMR spectrum of the compounds I and II separated from the 
HAEBD was recorded using a JEOL AL-400 (399.65 MHz) NMR spectrometer. 
The  measuring  conditions  for  the  spectra  were  as  follows  pulse  repetition  time  of  
30s, flip angle of 22.5-30.0 degrees. The long pulse repetition time and small flip 
angle is used to ensure precise relative intensities. The 
1
H NMR chemical shifts are 
refernce to TMS in organic solvent.   The 
1
H NMR spectra of the isolated 
compounds I & II are depicted in Figs. 36 & 40 and the 
1
H NMR spectral data of 
the isolated compounds are presented in Tables 36 & 39. 
(d) Spectral Analysis of the Compounds Using 
13
C NMR  
 The
13
C  NMR  spectrum  of  the  compounds  I  and  II  isolated  from  the  
HAEBD was recorded with a Bruker AC-200 spectrometer (50.323 MHz) Pulse 
flips angle of 22.5 - 45 degrees, a pulse repetition time of 4-7sec and a resolution of 
0.025-0.045ppm by which the measuring conditions for the most of the spectra were 
followed. The 
13
C NMR spectra of the isolated compounds I & II are depicted in 
Figs. 37 & 41 and the 
13
C NMR spectral data of the isolated compounds are 
presented in Tables 37 & 40. 
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(e) Spectral Analysis of the Compounds Using Mass Spectroscopy  
 The  mass  spectra  of  the  compounds  I  and  II  that  were  isolated  from the  
HAEBD was recorded with a JEOL JMS-700 by mass spectrophotometer electron 
impact method where an electron is accelerating voltage of 75eV and an ion 
accelerating voltage of 8-10Kv. The pool inlet systems were used for which the 
active range for the peak intensities were 3 digits and the accuracy of the mass 
number was 0.5. The MS spectra of the isolated compounds I & II are depicted in 
Figs. 38 & 42.  
5.12 EVALUATION OF IN VITRO ANTICANCER ACTIVITY OF 
ISOLATED COMPOUND 
 The isolated compound I was further subjected in vitro anticancer 
activity against human colon cancer cell line HCT-116 by MTT assay and chromatin 
condensation. The results obtained are presented in table Tables 41 & 42 and the 
graphical representation of the same is presented in Fig. 43 & 44.  
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CHAPTER 6 
RESULTS AND ANALYSIS 
 
6.1  PERCENTAGE YIELD OF HYDRO-ALCOHOLIC EXTRACT OF 
BOERHAAVIA DIFFUSA 
 The extraction of powdered material by hot continuous percolation 
method with a mixture of ethanol and distilled water (50: 50) and removal of solvent 
gave a dark green extract  which  was  freeze  dried  to  get  a  powder  which  was  
greenish black. The powder when weighed was found to be 3.3g and the 
percentage yield was found to be 16.5%.    
6.2  PHYTOCHEMICAL STUDIES   
 The preliminary phytochemical analysis of the hydro-alcoholic extract of 
Boerhaavia diffusa Linn. showed the presence of carbohydrates, glycoside, 
alkaloids, tannins, amino acid and flavonoids.  
Table 8 Qualitative chemical analysis of hydro alcoholic extract of 
Boerhaavia diffusa Linn 
S. No. Phytoconstituents Presence / Absence 
1 Alkaloids + 
2 Glycosides + 
3 Flavanoids + 
4 Tannins and Phenolic Compounds + 
5. Saponins + 
6. Triterpenoids + 
7.  Proteins and amino acids + 
8. Carbohydrates + 
9. Gums and Mucilage - 
(+) presence and (-) absence of phytoconstituents 
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6.3  IN VITRO ANTIOXIDANT ACTIVITY OF HYDRO-ALCOHOLIC 
EXTRACTS OF BOERHAAVIA DIFFUSA LINN 
 The in vitro antioxidant  activity  of  HAEBD was studied using total 
reduction capacity by reduction of ferric ions, superoxide anion scavenging method, 
DPPH scavenging method, hydrogen peroxide scavenging method and the results 
obtained presented in Tables 9 to 12. 
6.3.1 Effect of HAEBD in total reduction capability by potassium 
ferricyanide reduction method 
 The effect of HAEBD on total reduction capability by using potassium 
ferricyanide reduction method was evaluated and the results are presented in Table 
9. HAEBD showed a reduction potential of 2.180 ± 0.082 at a concentration of 
75µg/ml.  The results were comparable to that of standard antioxidants such as L-
ascorbic  acid  and  BHA.  The  order  of  reduction  capacity  of  HAEBD and standard 
antioxidants os : BHA > HAEBD > L-ascorbic acid.  
Table 9: Effect of HAEBD on total reduction capability of ferric ions 
Concentration 
(?g.ml-1) 
Absorbance @ 700nm 
L-Ascorbic acid BHA HAEBD 
25 0.832 ± 0.010 1.565 ± 0.068 1.045 ± 0.015 
50 1.325 ± 0.018 2.050 ± 0.082 1.570 ± 0.055 
75 2.030 ± 0.022 2.920 ± 0.034 2.180 ± 0.082 
Note: Value are expressed as mean ± S.E.M and n=3.  
6.3.2 Effect of HAEBD on superoxide anion radical scavenging activity 
 The effect of HAEBD on superoxide anion radical scavenging activity 
was evaluated and the percentage inhibition was determined and compared with 
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same concentrations of standard antioxidants such as BHA and L-ascorbic acid and 
it was observed that HAEBD showed superoxide radical scavenging activity (Table 
10) and  the order of superoxide radical scavenging activity of HAEBD and standard 
antioxidants was: BHA > L-ascorbic acid >HAEBD.  
Table 10: Effect of HAEBD on superoxide anion radical scavenging activity 
Concentration 
(?g/ml) 
% inhibition of superoxide generation 
L-Ascorbic acid BHA HAEBD 
25 10.185 ±1.235 14.220 ± 1.320 0.990 ± 0.315 
50 15.855 ±1.525 18.340 ± 1.660 3.760 ± 0.065 
75 18.190 ± 1.780 25.420 ± 1.750 18.630 ± 1.125 
100 27.320 ± 2.105 51.590 ± 2.740 19.255 ± 1.320 
250 69.180 ± 3.120 83.120 ± 3.110 35.455 ± 1.555 
500 77.515 ± 3.420 88.755 ± 3.255 70.020 ± 1.650 
Note: Value are expressed as mean ± S.E.M, and n=3.  
6.3.3  Effect of HAEBD on free radical (DPPH) scavenging activity 
 The effect of HAEBD on DPPH radical scavenging activity was studied 
and the results presented in Table 11. The percentage inhibition of free radical 
generation by HAEBD was determined and compared with same concentrations of 
standard antioxidants such as BHA and L- ascorbic acid.  It was observed that 
HAEBD at 500?g/ml scavenged 70.020 ± 1.650% of DPPH radical and the order of 
free radical scavenging activity of HAEBD and standard antioxidants was L-
ascorbic acid > HAEBD > BHA.  
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Table 11:  Effect of HAEBD on DPPH radical scavenging activity 
Concentration (?g/ml) % inhibition of free radical generation 
L-Ascorbic acid BHA HAEBD 
25 50.705±1.215 44.960±1.505 30.125±1.205 
50 54.310±1.285 56.520±1.355 31.145±1.245 
75 58.405±1.360 59.625±1.445 32.280±1.310 
100 59.410±1.385 65.340±1.730 49.220±1.705 
250 65.620±1.760 68.720±1.850 66.355±1.815 
500 67.225±1.885 70.265±1.885 68.420±1.945 
     Note: Value are expressed as mean ± S.E.M and n=3.  
6.3.4 Hydrogen peroxide scavenging activity of HAEBD 
 The effect of HAEBD on hydrogen peroxide radical scavenging activity 
was evaluated and the results are presented in Table 12.  The percentage inhibition 
of hydrogen peroxide scavenging of HAEBD was determined and compared with 
standard antioxidants such as BHA and L-ascorbic acid. It was observed that the 
HAEBD showed scavenging activity at all concentrations and the result was almost 
similar to L-ascorbic acid and BHA. The order of hydrogen peroxide scavenging 
activity of HAEBD and standard antioxidants was BHA > L-ascorbic acid > 
HAEBD.  
Table12 :  Effect of HAEBD on hydrogen peroxide scavenging 
Concentration 
(?g/ml) 
% inhibition of H2O2 generation 
L-Ascorbic acid BHA HAEBD 
25 14.520±1.070 14.220±1.215 7.010±0.590 
50 23.255±1.490 18.315±1.480 15.310±1.110 
75 34.920±1.850 36.420±2.560 30.120±1.275 
100 48.165±2.125 45.540±2.620 32.075±1.815 
250 55.410±2.375 55.635±2.780 46.150±2.215 
500 59.820±2.570 60.620±2.850 56.220±2.340 
Note: Value are expressed as mean ± S.E.M and n=3.  
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6.4 IN VITRO ANTICANCER ACTIVITY OF HYDRO-ALCOHOLIC 
EXTRACT OF BOERHAAVIA DIFFUSA LINN (HAEBD) 
 The effect of HAEBD on  the  growth  of  breast  cancer  cell  line  MCF-7  
and colon cancer cell line HCT-116 cells were examined by the MTT assay, cell 
morphological analysis, chromatin condensation by Hoest staining and cell cycle 
analysis. The results are presented in Tables 13 to 16 and the photomicrographs are 
presented in Figs. 5 to 12.  
Effect on cell viability by MTT assay  
 The percentage cell survival and percentage cytotoxiity was calculated 
and the results are presented in Table 13. From the Table 13, it can be observed the 
extract exhibited significant cytotoxicity and the IC50 value was calculated using the 
regression equation y=3.14x+16.02 for MCF-7 cell lines and y = 0.294x + 14.81 for 
HCT-116 cell lines. The IC50 value was found to be 108.22 and 119.69µg/ml for 
MCF-7 and HCT-116 cell lines respectively.  
Table 13: Effect of HAEBD on MCF-7 and HCT-116 cell viability by MTT 
assay 
Concentration 
of HAEBD in  
µg/ml 
% Cell survival % Cytoxicity 
MCF -7 HCT – 116 MCF -7 HCT – 116 
50 52.67 ± 1.29 54.63 ± 0.83 47.33 ± 1.29 45.37 ± 1.45 
100 43.83 ± 1.20 49.80 ± 0.70 56.17 ± 1.20 50.20 ± 1.21 
200 28.88 ± 0.93 33.11 ± 1.38 71.12 ± 0.93 66.89 ± 2.40 
IC50   108.22µg/ml 119.69µg/ml 
Note: Percentage of cell survival was calculated from control.  
Values are expressed as mean ± S.E.M and n=3.  
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Effect on cell morphology studies 
 The effect of HAEBD on the cell morphology of MCF-7 and HCT-116 
cells was examined using phase-contrast microscope. The microphotographs are 
presented in Figs.  5  &  6 for  MCF-7  and  Figs.  7  &  8 for HCT-116. The untreated 
MCF-7 cells exhibited typical growth patterns and a smooth, flattened morphology 
with  central  nuclei  (Fig. 5).  When treated with HAEBD, MCF-7 cells exhibited 
condensed chromatin, apoptotic morphological changes with protrusion of plasma 
cell membrane and detachment from the surface. In addition, it showed apoptotic 
bodies with cytoplasmic condensation indicating apoptosis like changes (Fig. 6). 
These observations provide evidence that an apoptotic pathway was triggered with 
the HAEBD treatment in breast cancer cell line MCF-7. Similar results were 
observed with HCT-116 cells on treatment with HAEBD (Fig. 7). The untreated 
HCT-7 cells showed normal growth patterns and a smooth, flattened morphology 
with central nuclei (Fig. 8).  When the cells were treated with the extract, the cells 
showed condensed chromatin and apoptotic changes.   
Effect on chromatin condensation and apoptosis measurement 
 The effects of HAEBD on chromatin condensation and apoptosis of 
MCF-7 and HCT-116 cells were examined by using Hoest staining technique. The 
nucleus of HAEBD treated cells showed condensed chromatin, which was strongly 
bound to fluorescent Hoest dye and allowing non apoptotic cells to be discriminated 
from apoptotic ones. The images of chromatin condensation observed with MCF-7 
cells are presented in Figs. 9 & 10 and with HCT-116 in Figs. 11 & 12 and the 
percentage chromatin condensation obtained is presented in Table 14.  
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Table 14: Effect of HAEBD on chromatin condensation and apoptosis using 
Hoest dye staining 
Name of the extract 
% chromatin condensation 
MCF-7 cell lines HCT-116 cell lines 
HAEBD (50µg/ml) 69.00 ± 0.90 58.20 ± 0.94 
Note: Cells with condensed and fragmented nuclei were counted in five different 
fields among a total of 200 cells. Values are expressed as mean ± S.E.M. 
n=3. 
Effect on cell cycle analysis 
 The effects of HAEBD on cell cycle arrest of MCF-7 and HCT-116 cells 
were examined by flow cytometry of propodium iodide stained cells. The results 
obtained are presented in Table 15 &16.  From the table, it can be seen that the 
treatment of HAEBD at 50µg/ml for 24h induced a significant accumulation of cells 
at the G0 phase of the cell cycle, suggesting that observed cytotoxicity of HAEBD 
was due to induction of cell death.  
Table 15 Effect on cell cycle distribution in breast cancer cell line MCF-7 cell 
lines 
Treatment 
Cell cycle phase 
G1 S G2 G0 
CONTROL 60 15.8 22.7 0.8 
HAEBD (50µg/ml) 66.6 14.3 18.6 0.3 
 
Table 16:  Effect on cell cycle distribution in colon cancer cell line HCT-116 
cell lines 
Treatment 
Cell cycle phase 
G1 S G2 G0 
CONTROL 61.9 7.4 27.4 1.3 
HAEBD(50µg/ml) 58.1 25.7 16.4 1.1 
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6.5 TOXICITY STUDIES  
(a)  Acute toxicity studies 
 In acute toxicity studies, no mortality or morbidity were observed in 
animals throughout the 14 days period following the single oral administration of the 
extract (Table 17).   The  animals  did  not  show  any  changes  in  general  appearance  
during the observation period. Morphological characteristics such as fur, skin, eyes 
and nose appeared normal. No tremors, convulsion, salivation, diarrhea, lethargy or 
unusual behaviors such as self-mutilation, walking backward and so forth were 
observed. Gait and posture, reactivity to handling or sensory stimuli, grip strength 
was also normal.  
Table 17: Acute toxicity studies of hydro-alcoholic extract  of B. diffusa Linn 
on mice 
Group(n=3) 
Dose 
(mg/kg) 
Sign of Toxicity 
(ST/NB) 
Mortality 
(D/S) 
Group I 0 0/3 0/3 
Group II 300 0/3 0/3 
Group III 2000 0/3 0/3 
   Note: ST- sign of toxicity; NB- normal behaviour; D- died; S- survived 
(b)  Sub acute toxicity studies 
 The results obtained for the effect on body weight, biochemical, liver 
parameters and haematological parameters in sub chronic toxicity study are 
presented in Tables 18 to 22.  
(i) Effect of HAEBD on body weight changes in rats 
 The  effect  on  body  weight  changes  (Table 18) were observed and no 
significant increase in body weight in all the animals studied was seen. 
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Table 18: Effects of HAEBD on body weight changes in rats in sub acute 
toxicity studies 
Treatment (n=6) 
mg/kg b.w. 
Day 1 Day 5 Day 10 Day 20 
Control 185.10±6.5 188.45 ±6.20 191.08 ±6.40 196.3±6.58 
HAEBD50 190.22 ±6.8 192.32 ±6.34 195.25 ±6.72 198.28±6.75 
HAEBD100 188.40 ±6.2 190.26 ±6.46 193.50±7.05 195.30±6.38 
HAEBD200 192.34 ±7.2 195.10±6.55 198.20 ±7.22 200.42±7.20 
HAEBD400 186.65 ±6.1 189.4  ±6.44 191.64±6.32 202.65±7.35 
Note: Values are expressed as mean ± SEM. Statistical  analysis was carried out 
using one way ANOVA method where ** p <0.01;*p <0.05. 
(ii)  Effect of HAEBD on the weight of organs  
 The effects of HAEBD on the weight of kidney, heart, liver and brain of 
the rats were observed and no significant changes in the weight of various organs of 
the  animals  (Table 19) occurred with higher doses of the extract (400mg/kg b.w.) 
and macroscopic examination did not show any changes in colour of the organs of 
the treated animals when compared to control. 
Table 19: Effect of HAEBD on kidney, heart, liver and brain of rats in sub 
acute toxicity studies 
Treatment (n=6) 
mg/kg b.w. 
Heart (g) Kidney (g) Liver(g) Brain (g) 
Control 0.32 ± 0.02 0.63 ± 0.01 3.23 ± 0.02 0.64 ± 0.03 
HAEBD 50  0.33 ± 0.01 0.78 ± 0.02 3.38 ± 0.01 0.65 ± 0.1 
HAEBD100 0.34 ± 0.02 0.76 ± 0.03 3.34 ±0.01 0.66 ± 0.2 
HAEBD200  0.33 ± 0.01 0.70 ± 0.03 3.28 ± 0.01 0.72 ± 0.06 
HAEBD400  0.32 ± 0.01 0.72 ± 0.01 3.32 ± 0.02 0.74 ± 0.05 
Note: Values are expressed as mean ± SEM. Statistical  analysis was carried out 
using one way ANOVA method where ** p <0.01;*p <0.05. 
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(iii)  Effect of HAEBD on Biochemical profiles of rats   
 The effect of HAEBD on various biochemical parameters of 
experimental rats was observed and there was significant decrease (p < 0.05) in 
plasma glucose level in treated rats especially at higher dose (400mg/kg) compared 
to  control  rats.  A  significant  decrease  (p  <  0.05)  in  plasma  total  cholesterol  (TC)  
triglyceride (TG) and LDL cholesterol levels and significant increase (p< 0.05) in 
HDL cholesterol levels were observed in all the treated animals when compared to 
control animals (Table 20).  
Table 20: Effect of HAEBD on biochemical parameters in sub acute toxicity 
studies 
Treatment 
mg/kg b.w. 
(n=6) 
Glucose 
(mg/dl) 
Cholesterol 
(mg/dl) 
Triglyceride 
(mg/dl) 
HDL 
(mg/dl) 
LDL 
(mg/dl) 
Control 90.62 ± 0.65 38.60 ± 0.55 25.25 ± 0.50 136.20± 0.55 80.10 ± 1.80 
HAEBD 50 88.50 ± 0.56 22.80± 0.20
*
 12.20± 0.22
*
 175.30±0.70
*
 67.65 ± 1.10* 
HAEBD 100 85.40 ± 0.48 23.75± 0.24
*
 12.40± 0.28
*
 165.20±0.82
*
 65.80 ± 1.22* 
HAEBD 200 86.20± 0.52
*
 30.20 ± 0.28 16.85± 0.35
*
 184.25±0.88
*
 44.60 ± 1.05* 
HAEBD 400 84.22± 0.42
*
 29.75 ± 0.26 16.30± 0.32
*
 182.3 ± 0.85
*
 42.50 ± 0.95* 
Note: Values are expressed as mean ± SEM. Statistical  analysis was carried out 
using one way ANOVA method where *p <0.05. 
 The levels of AST, ALT and ALP were normal in the HAEBD treated 
animals when compared to the animals in the control group and the same can be 
seen in Table 21. 
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Table 21: Effect of HAEBD on AST, ALT, ALP, TP and albumin in rats in sub 
acute toxicity studies 
Treatment 
mg/kg b.w. 
(n=6) 
AST 
(IU/l) 
ALT 
(IU/l) 
ALP 
(IU/l) 
TP 
(g/l) 
Albumin 
(g/l) 
Control 323.4 ±10.47 68.4 ± 3.19 255.60 ± 8.78 68.86 ± 3.30 35.11 ± 2.33 
HAEBD 50  315.4 ± 9.81 66.6 ± 2.16 263.00 ± 2.74 69.33 ± 2.30 36.25 ± 2.60 
HAEBD100 318.2 ± 7.47 64.0 ± 3.02 257.60 ± 6.98 79.12 ± 2.80 34.25 ± 3.00 
HAEBD200 309.0 ± 7.70 59.5 ± 2.85 262.00 ± 5.50 69.20 ± 3.30 36.22 ± 2.80 
HAEBD 
400  
319.0 ±  8.99 61.4 ± 3.54 269.44 ± 4.40 70.00 ± 2.60 35.45 ± 2.70 
Note: Values are expressed as mean ± SEM. Statistical  analysis was carried out 
using one way ANOVA method where *p <0.05 and ** p <0.01 
(iv)   Effect of HAEBD on Hematological parameters in rats   
 The effect of HAEBD on hematological parameters was studied and the 
results obtained are presented in Table 22.  From the  table 22, it can be observed 
changes in haemoglobin content and RBC count and decrease in the WBC count in 
group treated 200 and 400mg/kg b.w of HAEBD compared to normal control group 
but these changes were within the normal limits.  There was no significant change in 
the calcium level in all the treated animals compared to the control. 
Table 22:  Effect of HAEBD on Hematological parameters in sub acute toxicity 
studies 
Treatment 
mg/kg b.w.(n=6) 
Haemoglobin 
(mg/dl) 
RBC 
(10
6
 /mm
3
) 
WBC 
(10
6 
/mm
3
) 
Calcium 
(mg/dl) 
Control 11.2± 0.20 9.06± 0.02 11.3± 0.03 9.05 ±0.02 
HAEBD50  10.6 ± 0.20
*
 8.57 ± 0.04
*
 7.4 ± 0.03
*
 9.05 ± 0.02 
HAEBD100  12.4 ± 0.12
*
 8.32 ± 0.02
*
 8.2 ± 0.30
*
 9.00 ± 0.30 
HAEBD200 11.8 ± 0.20
*
 9.16 ± 0.12
*
 10.2 ± 0.02
*
 9.68 ± 0.03 
HAEBD400 12.6 ± 0.30
*
 9.55 ± 0.45
*
 9.91 ± 0.12
*
 9.42 ± 0.22 
Note: Values are expressed as mean ± S.E.M.  Statistical analysis carried out 
using one way ANOVA method where *p < 0.05 and **p < 0.01 
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(c)  Chronic toxicity studies 
 The results obtained for chronic toxicity study i.e. the effect on body 
weight, biochemical parameter and hematological parameters are presented in 
Tables 23 to 25.  
(i)  Behavourial Changes 
 All of the rats fed with the extracts showed normal general behavior, 
respiratory pattern, cardiovascular signs, motor activities, reflexes, and normal 
change in skin and fur. 
(ii)   Effect of HAEBD on the body weight in chronic toxicity studies 
 The body weights and body weight gain of rats at various concentrations 
of HAEBD (200, 400 and 600 mg/kg body weight) are listed in Table 23. The rats 
showed  a  slight  increase  in  body  weight  but  were  not  significantly  different  from  
those of the control. 
Table 23:  Effect of HAEBD on the body weight in chronic toxicity studies 
Treatment (n=6) 
(Dose in mg/kg) 
Day 0 Day 90 
Control  215.65 ± 6.45 267.70 ± 7.90 
HAEBD @ 200  219.35 ± 6.40 272.20 ± 8.20 
HAEBD @ 400  222.80 ± 6.56 270.20 ± 8.30 
HAEBD @ 600  228.22 ± 6.80 275.35 ± 7.52 
        Note: Values  are  expresses  as  mean  ±  S.E.M.  Not  significant  from  normal  
control 
(iii)  Effect of HAEBD on Hematological parameters in rats  in chronic 
toxicity studies 
 The effect of HAEBD on hematological parameters were studied and the 
results obtained are presented in Table 24   From the table  24  , it can be observed 
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that there was a slight difference in the values of the hematological parameters such 
as hemoglobin content, RBC and WBC when compared to normal control group but 
were within the normal range. 
Table 24: Effect of HAEBD on Hematological Parameters in chronic toxicity 
studies 
S. 
No 
Parameters Control 
Drug Concentration (mg/kg) 
200 400 600 
1 White blood 
cells(X10
3
/µl) 
8.20 ± 0.30 8.15 ± 0.20 8.18 ± 0.13 8.26 ± 0.16 
2 Hemoglobin(g/dl) 10.10 ± 0.14 9.60 ± 0.26 9.70 ± 0.30 9.80 ± 0.20 
3 Mean corpuscular 
volume 
60.35 ± 0.40 59.20 ± 0.55 58.72 ± 0.36 59.58 ± 0.20 
4 Mean corpuscular 
hemoglobin 
conc.(g/dl) 
34.60 ± 0.44 32.10 ± 0.30 33.20 ± 0.12 33.82 ± 0.86 
5 Platelet(X10
5
/µl) 5.70 ± 0.23 5.15 ± 0.15 5.46 ± 0.20 5.70 ± 0.14 
6 Red  blood 
cell(X10
6
/µl) 
3.70 ± 0.26 4.10 ± 0.25 4.65 ± 0.10 4.82 ± 0.42 
Note: Values are expressed as mean ± S.E.M.  No significant difference from 
normal control 
 (iv)  Effect of HAEBD on Blood chemical values in chronic toxicity 
studies     
 The effect of HAEBD on various blood chemical values of experimental 
rats is presented in table 25.  It can be observed that there was no significant change 
in plasma glucose, creatinine, total protein level in treated rats when compared to 
control rats while the level of blood urea nitrogen showed a significant decrease in 
the HAEBD treated groups.  The levels of AST, ALT and ALP were normal in the 
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HAEBD treated animals when compared to the animals in the control group and the 
same can be seen in Table 25. 
Table 25: Effect of HAEBD on Blood chemical values in chronic toxicity studies 
S. 
No 
Parameters Control 
Drug Concentration (in mg/kg) 
200 400 600 
1 Glucose(mg/dl) 145.56 ± 8.52 143.30 ± 2.85 148.40 ± 0.40 153.80 ± 3.90 
2 BUN (mg/dl) 32.40 ± 1.40 18.16 ± 0.80 19.50 ± 0.36 20.45 ± 0.20 
3 Creatinine 
(mg/dl) 
0.42 ± 0.06 0.46 ± 0.05 0.48 ± 0.07 0.39 ± 0.02 
4 Total protein 
(g/dl) 
5.50 ± 0.20 5.45 ± 0.28 5.64 ± 0.32 5.86 ± 0.10 
5 Albumin (g/dl) 3.72 ± 0.16 3.70 ± 0.43 3.68 ± 0.24 3.85 ± 0.18 
6 Total bilirubin 
(mg/dl) 
0.18 ± 0.10 0.16 ± 0.14 0.15 ± 0.15 0.14 ± 0.10 
7 AST(u/i) 142.30±10.80 130.34 ±16.42 136.60 ±18.40 142.40 ± 17.30 
8 ALT(u/i) 83.40 ± 4.26 76.5 ± 3.50 74.40 ± 3.65 77.80 ± 3.66 
9 ALP(u/i) 71.40 ± 2.66 61.40 ± 2.40 61.70 ± 2.43 63.43 ± 2.46 
Note: Values  are  expresses  as  mean  ±  S.E.M.  Not  significantly  different  from  
normal control 
 
6.6 ANTI TUMOUR ACTIVITY OF HYDRO-ALCOHOLIC 
EXTRACT OF BOERHAAVIA DIFFUSA LINN AGAINST 
DALTON ASCITIC LYMPHOMA  
(i)   Effect of HAEBD on survival time and tumor growth 
 The effect of HAEBD on survival of DAL tumor bearing mice is shown 
in Table 26. In the DAL induced tumor control group, the average life span of 
animal was found to be 46% whereas HAEBD at the dose of 200and 400 mg/kg 
body weight increased the life span to 80and 86% respectively. However, the 
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average life span of 5-flurouracil treated animals was found to be 90% indicating its 
potent antitumor nature. The antitumor nature of HAEBD was evidenced by the 
significant reduction in percentage increase in body weight of animal treated with 
HAEBD at the dose of 200 and 400mg/kg body weight when compared to DAL 
tumor bearing mice. It was also supported by significant reduction in packed cell 
volume and viable tumor cell count in both treatments when compared to the DAL 
tumor control (Table 26).   
Table 26: Effect of HAEBD on life span, body weight and cancer cell  count in 
DAL induced tumour in mice 
Treatment 
(n = 6) 
Mean survival 
time 
% ILS Life 
span 
Increase in Body 
weight ( in g) 
Cancer cell 
count ml X 10
6
 
G1 >>30days 100 2.22 ± 0.68 - 
G2 15 46 9.44 ± 0.86
a**
 2.75 ± 0.40
a**
 
G3 29 90 5.66 ± 0.42
b**
 1.30 ± 0.40
b**
 
G4 27 80 6.22 ± 0.60
b**
 1.65 ± 0.45
b**
 
G5 28 86 5.80 ± 0.80
b**
 1.50 ± 0.30
b*
 
Note: G1 – Normal Control, G2 – Cancer Control, G3 – Positive control, G4 –  
HAEBD treatment 200mg/kg, G5 – HAEBD treatment 400mg/kg 
All values are expressed as mean ± SEM for 6 animals in each group. 
**a – Values are significantly different from control (G1) at P < 0.001 
**b – Values are significantly different from cancer control (G2) at P < 0.001 
(ii)  Effect  of  HAEBD  on  hematological  parameters  on  DAL  induced  
tumour in mice 
 The total WBC count significantly increased while RBC, hemoglobin 
and platelets decreased in the DAL group compared to control group. The treatment 
of extract at the dose 200and 400mg/kg significantly increased the hemoglobin 
content, RBC, platelets and decreased WBC count to about near normal values. 
HAEBD administration at the dose 200 and 400mg/kg significantly reduced PCV 
content. These results suggest the anticancer nature of the HAEBD but however 
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standard 5-FU at the dose of 20mg/kg body weight produced better result in all these 
parameters. (Table 27) 
Table 27: Effect of HAEBD on hematological parameters on DAL induced 
tumour in mice 
Treatment 
Total WBC 
cells/cu.mm 
RBC Count 
mill/cu.mm 
Hemoglobin 
g/dl 
PCV % 
Platelets 
Lakhs/cu.mm 
G1 10.85 ± 0.86 4.68 ± 0.46 12.05 ± 0.45 15.80 ± 1.55 3.35 ± 0.36 
G2 14.05 ± 1.42
 a** 
2.30 ± 0.15
 a** 
7.30 ± 0.30
 a**
 31.60 ± 2.60
 a**
 1.75 ± 0.18
 a**
 
G3 11.42 ± 0.95
 b**
 3.95 ± 0.32
 b**
 11.6 ± 0.35
 b**
 18.30 ± 1.10
b**
 2.80 ± 0.22
b** 
G4 12.80 ± 1.02
 b**
 3.25 ± 0.22
 b**
 10.05 ± 0.18
b**
 21.26±1.45
b**
 2.15±0.12
b**
 
G5 12.10 ±0.98
b**
 3.60±0.28
b**
 11.05±0.26
b**
 20.55±1.38
b**
 2.45 ±0.16
b**
 
Note: G1 –  Normal  Control,  G2 –  Toxic  Control,  G3 –  Positive  control,  G4 – 
Treatment control (HAEBD 200mg/kg), G5 – Treatment control (HAEBD 
400mg/kg). 
All values are expressed as mean ± SEM for 6 animals in each group. 
**a – Values are significantly different from normal control (G1) at P < 0.001 
**b – Values are significantly different from toxic control (G2) at P < 0.001 
Fig.13: Effect of HAEBD on Heamtological parameters on DAL induced 
tumour in mice 
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(iii)  Effect  of  HAEBD  on  Biochemical  Parameters  in  DAL  induced  
tumour in mice 
 The  inoculation  of  DAL cells  caused  significant  increase  in  the  level  of  
total cholesterol, aspartate amino transferase (AST), alanine amino transferase 
(ALT), alkaline phosphatase (ALP) in tumor induced animals (G2) when compared 
to the normal group.  The treatment with HAEBD at the dose of 200 and 400mg/kg 
body weight significantly reversed these changes towards the normal level as shown 
in Table 28 and the graphical representation of the same is presented in Fig. 14. All 
these values were found to be significant. The treatment with standard 5-
Fluorouracil also gave similar results.         
Table 28: Effect of HAEBD on serum enzymes and lipid proteins in DAL 
induced tumour in mice 
Treat 
ment 
Cholesterol 
(mg/dl) 
TGL 
(mg /dl) 
AST 
(U/L) 
ALT 
(U/L) 
ALP 
(U/L) 
G1 110.15 ±1.66 125.5 ± 2.40 38.50 ± 1.25 33.40 ±1.26 126.20 ± 1.20 
G2 
145.65 ± 
2.45
a**
 
210.20 ± 
4.25
a**
 
88.10 ± 
1.85
a**
 
58.20 ± 
1.75
a**
 
225.30 ± 
3.35
a**
 
G3 
116.55 ± 
0.92
b**
 
162.85 ± 
3.15
b**
 
56.20 ± 
1.68
b**
 
42.30 ± 
1.63
b**
 
160.40 ± 
1.45
b**
 
G4 
134.52 ± 
1.50
b**
 
172.95 ± 
3.22
b**
 
71.80 ± 
2.25
b**
 
50.20 ± 
1.88
b**
 
185.30 ± 
1.68
b**
 
G5 
128.60 ± 
1.42
b**
 
166.30 
±2.78
b**
 
64.40 ± 
1.91
b**
 
46.40 ± 
1.70
b**
 
178.52 ± 
1.55
b**
 
Note: G1 – Normal Control, G2 – Toxic Control, G3 – Positive control, G4 –  
Treatment (HAEBD 200mg/kg), G5 – Treatment  (HAEBD 400mg/kg) 
All values are expressed as mean ± SEM for 6 animals in each group. 
**a – Values are significantly different from normal control (G1) at P < 0.001 
**b – Values are significantly different from toxic control (G2) at P < 0.001 
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Fig.  14:  Effect  of  HAEBD  on  serum  enzymes  and  lipid  proteins  in  DAL  
induced tumour in mice 
 
Histopathology of the liver 
 The photographic representations of the histological sections of the livers 
are presented in Figs. 15 to 19.  The  section  of  the  liver  of  the  mice  belonging  to  
Group 1 showed the presence of sheets of hepatocytes separated by sinusoids, portal 
vein and portal tract appeared normal (Fig. 15), while the liver sections of tumour 
control i.e. animals of Group 2 presented hepatic congestion at sinusoids and the 
portal vessel, pericentre globular micro-steatosis, Kupffer cell proliferation, 
hepatocyte diffuse necrosis and mononuclear infiltrate(Fig. 16). The liver sections of 
animals treated with 5 fluorouracil i.e. Group 3 presented mild hepatic congestion at 
sinusoids and the portal  vessel,  pericentre globular micro-steatosis,  no Kupffer cell  
proliferation, mild hepatocyte diffuse necrosis and mononuclear infiltrate (Fig. 17) 
while sections of liver of animals of Group 4 and 5 treated with HAEBD presented 
moderate hepatic congestion at sinusoids and the portal vessel, pericentre globular 
micro-steatosis, less Kupffer cell proliferation, moderate hepatocyte diffuse necrosis 
and mononuclear infiltrate (Fig. 18 & 19). 
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6.7 ANTI TUMOUR ACTIVITY OF HYDRO ALCOHOLIC 
EXTRACT OF BOERHAAVIA DIFFUSA LINN AGAINST 
EHRLICH ASCITIC CARCINOMA (EAC) IN MICE 
 The effect of HAEBD in Ehrlich ascetic carcinoma was studied and the 
effect on tumour volume is presented in Table 29.  From  the  table,  it  can  be  
observed that the solid tumor volume induced by EAC cells was found to be 
significantly increased from day 0 to day 30 in Group 2 animals. However, the 
tumor volume was significantly decreased in animals treated with 5 fluorouracil and 
HAEBD at 200 and 400mg/kg body weight. A significant reduction in solid tumor 
volume was seen from day 15 to the end of the experiment. About 27% and 30% 
reduction in tumor volume was observed with HAEBD treatment at 200 and 
400mg/kg body weight respectively on the day 30 of the experiment (Table 29). 
Table 29: Effect of HAEBD on solid tumor volume on EAC induced tumour 
Treat 
ment 
Dose 
Solid tumor Volume (ml) % 
reduction of 
tumour 
volume on 
30
th
 day 
15
th
 Day 20
th
 Day 25
th
 Day 30
th
 Day 
G1 
2 ml/kg 
Saline 
2.65 ± 0.20 3.60 ± 0.28 4.70 ± 0.32 5.80 ± 0.16 100 
G2 
5FU 
20 mg/kg 
2.52 ± 0.18 3.48 ± 0.24 3.25 ± 0.18 3.85 ± 0.06**a 33.62 
G3 
200 mg/kg 
HAEBD 
2.40 ± 0.16 3.40 ± 0.22 3.60 ± 0.22 4.20 ± 0.09**a 27.59 
G4 
400 mg/kg 
HAEBD 
2.68 ± 0.22 3.32 ± 0.18 3.40 ± 0.20 4.10 ± 0.07**a 29.31 
G1 – Normal Control, G2 – Standard control (5-Flurouracil 20mg/kg) 
G3 – Treatment (HAEBD 200mg/kg), G4 – Treatment (HAEBD 400mg/kg) 
All values are expressed as mean ± SEM for 6 animals in each group. 
**a – Values are significantly different from cancer control (G1) at P < 0.01 
 
Chapter 6             Result and Analysis 
 
102 
6.8 EVALUATION OF HYDRO ALCOHOLIC EXTRACT OF 
BOERHAAVIA DIFFUSA LINN AGAINST 7, 12-DIMETHYL 
BENZ [A] ANTHRACENE (DMBA) INDUCED BREAST CANCER 
IN SWISS ALBINO MICE 
 The effect of HAEBD on body weight, protection percentage and tumour 
volume in DMBA induced breast cancer in mice and the enzymatic antioxidants in 
the breast tissue homogenate was studied and results presented in Tables 30 & 31.  
(i)  Effect of body weight and tumour volume  
 The body weight was significantly decreased in tumor induced animals 
when compared to normal control (P < 0.01). Tumor promotional stage is a 
reversible stage in multistage carcinogenesis and therefore, it is the most suitable 
stage for the anti-carcinogenic agent to prevent, reverse, or slow down the process of 
carcinogenesis. Animals in the breast cancer control Group 2 attain the promotional 
stage  tumor  after  45  days.  At  the  end  of  the  experiment  in  non-treated  DMBA  
induced breast tumors increased to the maximum in terms of tumor incidence 
(100%) and tumor multiplicity compared to the normal control rats.  
 A significant reduction in tumor volume was observed in Group 3 
(37.85%) of tumor reduction after 45 days treatment whereas HAEBD (200 mg/kg, 
orally) treated animals achieved a significant decrease (24%) in the mammary tumor 
size with change in the total body weight of the animals (G2). However, HAEBD at 
a dose of 400mg/kg treated group achieved 31.70% breast tumor reduction after 45 
days as shown in Table 30. 
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Table 30: Effect of HAEBD on body weight and tumour volume in DMBA 
induced breast cancer in mice 
Group 
Body 
Weight 
(mg) 
Day 1 
Body Weight 
(mg) 
Day 45 
Average 
increase in 
Body weight 
(%) 
Tumour 
Volume (mm) 
Reduction 
of tumour 
percentage 
(%) 
G1 27.6 ± 0.88 30.5 ± 1.40 9.5 - - 
G2 23.2 ± 0.05 50.3 ±1.65
*a 
54 46.78 ± 1.88
*a 
100.00 
G3 26.7 ± 0.75 36.0 ±1.44
**b 
26 9.07 ±1.54
**b 
37.84
 
G4 28.5 ±0.52 40.5 ±1.50
**b 
29 35.54 ± 0.86
**b 
24.02
 
G5 29.4±0.64 38.0 ±1.48
**b 
22 31.95 ± 0.94
**b 
31.70
 
Note: G1  –  Normal  Control,  G2  –  Toxic  Control,  G3  –  Positive  control,  G4  –  
Treatment (HAEBD 200mg/kg), G5 – Treatment (HAEBD 400mg/kg) 
Values are expressed as Mean ± SEM.Values are found out by using one way 
ANOVA followed by NewmannKeul’s multiple range tests. 
*a – values are significantly different from Normal control at p< 0.001. 
*b – values are significantly different from Toxic control (G2) at p< 0.001.   
(ii)  Antioxidant activity  
 Free radical scavengers such as superoxide dismutase (SOD), catalase 
(CAT), glutathione peroxidase (GPx) and lipid peroxide (LPx) levels were recorded 
and results  presented in Table 31 showed a significant reduction in the activities of 
antioxidant enzymes like SOD, CAT, GPX in DMBA induced breast cancer in mice 
whereas the values were significantly elevated after treatment with HAEBD (200 & 
400mg/kg). Mice treated with standard drug vinblastin (G3) also showed similar 
changes. The GPx level was equally increased in vinblastin in both doses of 
hydroalcoholic extract of Boerhaavia diffusa therapy  groups versus cancer control 
rats. The level of LPx rises in DMBA induced breast cancer animals which was 
much influenced by the chemical carcinogen in the control animals, whereas 
significant reduction was observed in the mice treated with vinblastin and both doses 
of hydroalcoholic extract of Boerhaavia diffusa Linn. 
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Table 31: Effect of HAEBD on enzymatic antioxidants in the DMBA induced 
breast cancer tissue of control and experimental animals 
Group 
SOD (units/mg 
protein) 
CAT (?mol H2O2 
consumed/[min(mg 
protein)] ) 
GPx (?g GSH 
utilized/[min (mg 
protein)]) 
LPO (n mol MDA 
found / [min/ (mg 
protein)]) 
G1 3.75 ± 0.08 45.85 ± 0.47 3.83 ± 0.10 0.75 ± 0.02 
G2 1.53 ± 0.07
**a 
14.51 ±1.08
**a 
2.09 ± 0.03
**a 
2.16 ± 0.07
**a 
G3 3.20 ± 0.06
**b 
37.91± 0.78
**b 
3.55 ± 0.07
**b 
1.11 ± 0.04
**b 
G4 2.80 ± 0.07
**b 
27.71 ± 0.65
**b 
3.06 ± 0.04
**b 
1.46 ± 0.04
**b 
G5 3.14 ± 0.06
**b 
34.05 ± 0.72
**b 
3.22 ± 0.02
**b 
1.35 ± 0.02
**b 
Note: G1  –  Normal  Control,  G2  –  Toxic  Control,  G3  –  Positive  control,  G4  –  
Treatment (HAEBD 200mg/kg), G5 – Treatment (HAEBD 400mg/kg) 
Values are expressed as Mean ± SEM. Values are found out by using one way 
ANOVA followed by Newmann Keul’s multiple range tests.  
 *a – values are significantly different from Normal control at p< 0.001. 
*b – values are significantly different from Toxic control (G2) at p< 0.001. 
(iii)  Histopathology of Breast tissue 
 The histological section of the breast tissue of experimental mice from 
normal animals in Group 1 is shown in Fig. 20. This revealed the presence of 
normal ductules, ducts and fibrous stroma and alveolar structure of mammary tissue 
with  epithelial  cells  of  breast  parenchyma  of  uniform  appearance.  The  sections  of  
the mammary tissue of mice in tumour control G2 revealed the presence of major 
lesions which were mostly carcinomas and exhibited an identical nuclear pattern 
with predominant epithelial cell and fibrous tissue surrounding the mammary ducts. 
It also exhibited a mixed structural pattern with invasion of neighbouring tissues and 
intense stromal desmoplastic reaction (Fig. 21).  The sections of mammary tissue 
when treated with vinblastin G3 showed mild ductular proliferation with focal 
epithelial hyperplasia, breast parenchyma with ductules, ducts and fibrous stroma 
(Fig. 22).    The  sections  of  Group  4  and  5  treated  with  HAEBD showed tubules 
formation, reduced intra-tumor vascularization and reduced proliferation and 
replacement by normal ductular and alveolar structure of mammary tissue (Figs. 23 
& 24).   
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6.9 HEPATOPROTECTIVE AND ANTI-OXIDANT EFFECT OF 
BOERHAAVIA DIFFUSA LINN HYDRO-ALCOHOLIC 
EXTRACT OF BOERHAAVIA DIFFUSA LINN 
 The  effect  of  the  hepatoprotective  and  anti  oxidant  effect  of  HAEBD  
against D-galactosame induced hepatotoxicity was studied and results and 
observations are presented in this section.  
(i)   Biochemical observations in mice intoxicated with D-galactosamine 
and pretreatment of HAEBD 
 The  effect  of  HAEBD  and  Vitamin  E  pretreatment  on  biochemical  
parameters in mice intoxicated with D-galactosamine is presented in Table 32 and 
the graphical representation is depicted in Fig. 25. A significant increase in (p < 
0.01) serum aspartate transaminase (AST), alanine transaminase (ALT), alkaline 
phosphatase (ALP), total bilirubin (TB) and gamma-glutamyl transpeptidase 
(GGTP) and significant decrease in (p < 0.01) total protein (TP) and total albumin 
(TA) levels were observed in animals treated with galactosamine 25mg/kg (Group 
II) as compared to normal control group (Group1). Pretreatment with hydroalcoholic 
extract of Boerhaavia diffusa Linn (HAEBD) at a dose 200 and 400mg/kg orally for 
8 days decreased  the levels of above indices like AST, ALT, ALP, TB, GGTP and 
increased the levels of TP and TA significantly (p < 0.01)in Group 4 and 5. 
 Vitamin-E pretreatment produced significant decrease in (p< 0.01) serum 
AST, ALT, ALP, TB, GGTP and significant increase in TP and TA at (p< 0.01) in 
Group 3. 
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Table 32: Effect of HAEBD and Vitamin E pretreatment on biochemical 
parameters in mice intoxicated with D-galactosamine 
Parameters 
Treatment 
G1 G2 G3 G4 G5 
AST 
(IU/mL) 
44.40±1.45 106.90±3.40*a 58.05 ± 1.80*b 66.60 ± 2.10*b 61.90 ± 1.95*b 
ALT 
(IU/mL) 
29.15±1.05 92.55 ± 3.25*a 40.60 ± 2.10*b 52.75 ± 2.80*b 45.85 ± 2.60*b 
ALP 
(IU/mL) 
22.65±1.30 140.15±5.30*a 53.40 ± 2.40*b 66.40 ± 2.95*b 58.50 ± 2.65*b 
TP 
(gm/dl) 
5.15 ± 0.12 3.15±0.22*a 3.90 ± 0.25*b 4.50 ± 0.30*b 4.05 ± 0.27*b 
TB 
(mg/dl) 
1.90 ± 0.10 4.30±0.20*a 2.70 ± 0.15*b 3.22±0.18*b 2.90 ±  0.16*b 
GGTP 
(mg/dl) 
95.80±2.65 170.25±5.85*a 120.20±3.10*b 138.15±3.65*b 128.90±3.25*b 
Total Albumin 
(g/dl) 
3.75±0.16 2.15 ± 0.10*a 2.85 ± 0.15*b 2.50±0.14*b 2.30 ± 0.12*b 
Note: G1 – Normal Control, G2 – Toxic Control, G3 – Positive control,  
G4 – Treatment (HAEBD 200mg/kg), G5 – Treatment (HAEBD 400mg/kg) 
Values are expressed as Mean ± SEM.Values are found out by using one way 
ANOVA followed by NewmannKeul’s multiple range tests. 
*a – values are significantly different from Normal control at p< 0.01. 
*b – values are significantly different from Toxic control (G2) at p< 0.01.  
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Fig. 25: Graphical representation of the effect of HAEBD and Vitamin E 
pretreatment on biochemical parameters in mice intoxicated with D-
galactosamine 
 
(ii)  Effect  of  HAEBD  and  Vitamin  E  pretreatment  on  enzymatic  
antioxidants in the liver homogenate of the mice intoxicated with D-
galactosamine 
 In  liver homogenate, there was significant decrease in SOD, CAT and 
GPx levels and increase in LPO levels in animals treated with galactosamine 
(Group 2)  as  compared  to  normal  control  group  (Group 1) (Table 33) and the 
grapahical representations of the same are presented in Figs. 26 to 29.  The 
pretreatment with hydro-alcoholic extract of Boerhaavia diffusa Linn (HAEBD) at a 
dose of 200 and 400mg/kg orally for 8 days increased the levels of SOD, CAT and 
GPx levels and decreased the levels of LPO significantly (p<0.01) in Group 4 and 
5. Vitamin E pretreatment also produced significant increase in (p<0.01) liver 
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homogenate  enzymes  such  as  SOD,  CAT,  GPx  levels  and  decreased  the  levels  of  
LPO significantly (p < 0.01) in Group 3.  
Table 33: Effect of HAEBD and vitamin E pre-treatment on enzymatic 
antioxidants in D-galactosamine induced hepatotoxicity 
Group 
SOD 
(U/mg)Protein 
CATALASE 
(U/mg)Protein 
GPX 
(U/mg)Protein 
MOA 
(U/mg)Protein 
G1 130.30±2.45 288.40±4.40 1.15±0.09 3.90±0.22 
G2 66.20±1.30*a 190.80±2.75*a 0.35±0.02*a 7.40±0.45*a 
G3 86.05±1.60*b 258.40±3.90*b 0.88±0.06*b 4.50±0.30*b 
G4 95.45±1.95*b 235.15±3.50*b 0.55±0.04*b 5.25±0.38*b 
G5 90.65±1.75*b 242.75±3.65*b 0.70±0.07*b 4.80±0.32*b 
Note: G1 – Normal Control, G2 – Toxic Control, G3 – Positive control,  
G4 – Treatment (HAEBD 200mg/kg), G5 – Treatment (HAEBD 400mg/kg) 
Values are expressed as Mean ± SEM. Values are found out by using one way 
ANOVA followed by Newmann Keul’s multiple range tests. 
*a – values are significantly different from Normal control at p< 0.01. 
*b – values are significantly different from Toxic control (G2) at p< 0.01.  
          
(iii)  Effect of HAEBD and Vitamin E pretreatment on non enzymatic 
 antioxidants in the liver homogenate of the mice intoxicated with D-
 galactosamine 
             The levels of non-enzymatic antioxidants such as reduced glutathione, 
Vitamin C and Vitamin E in the liver homogenate of D-galactosamine induced 
hepatotoxic rats showed significant decrease (p<0.01) when compared to normal 
control animals (Table 34). The levels of non-enzymatic antioxidants in D-
galactosamine hepatotoxic rats significantly increased on pretreatment with 
Boerhaavia diffusa Linn  (HAEBD) at both doses tested when compared with 
untreated hepatotoxic mice. 
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                         Fig 26 :Effect of HAEBD & Vit-E pretreated on SOD 
 
Fig 27  :Effect of HAEBD & Vit-E pretreated on CAT 
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Fig 28  :  Effect of HAEBD  & Vitamin-E pretreatment on Gpx 
      
Fig 29 :  Effect of HAEBD  & Vitamin-E pretreatment on MOA 
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Table 34: Effect of HAEBD on non-enzymatic antioxidant levels in the liver 
tissue of D-galactosamine induced hepatotoxicity 
Group 
Glutathione mg/100g 
tissue 
Vitamin C 
mg/100g tissue 
Vitamin E 
mg/100g tissue 
G1 130.60±3.60 0.80±0.10 5.95±0.70 
G2 73.40±1.75*a 0.30±0.03*a 2.30±0.30*a 
G3 110.25±2.70*b 0.70±0.07*b 5.60±0.55*b 
G4 97.30±2.15*b 0.62±0.04*b 4.95±0.40*b 
G5 90.60±1.95*b 0.66±0.06*b 5.20±0.60*b 
Note: G1 – Normal Control, G2 – Toxic Control, G3 – Positive control,  
G4 – Treatment (HAEBD 200mg/kg), G5 – Treatment (HAEBD 400mg/kg) 
Values are expressed as Mean ± SEM.Values are found out by using one way   
ANOVA followed by NewmannKeul’s multiple range tests. 
*a – values are significantly different from Normal control at p< 0.01. 
*b – values are significantly different from Toxic control (G2) at p< 0.01.  
(iii)  Histopathological observations   
 The histology of liver sections of normal control animals (Group 1) 
showed normal liver architecture with central vein, well preserved cytoplasm and 
prominent nucleus and nucleolus (Fig. 30) while the liver sections of galactosamine 
treated animals (Group 2) showed hepatic cells with serum toxicity characterized by 
inflammatory cell collection, scattered inflammation across liver parenchyma, focal 
necrosis and swelling up of vascular endothelial cells (Fig. 31).   The  vitamin  E  
(Group 3) exhibited protection from galactosamine induced changes in the liver 
(Fig. 32) while hydro-alcoholic extract of Boerhaavia diffusa Linn  (HAEBD) 
pretreatment at a dose of 200and and 400mg/kg (Group  4  and  5) appeared to 
significantly prevent the galactosamine toxicity as revealed by the hepatic cells with 
well-preserved cytoplasm. HAEBD pretreatment also caused marked decrease in 
inflammatory cells (Figs. 33 & 34).  
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6.10  ISOLATION AND CHARACTERISATION OF ISOLATED 
COMPOUNDS  
 The HAEBD was subjected to column chromatographic separation using 
mixtures of solvents as mobile phases. The fractions having same profile was mixed 
together and concentrated under reduced pressure. The fractions so obtained were 
re-chromatographed. The fractions obtained when column was eluted with a mixture 
of hexane and ethyl acetate (95:5) was concentrated and a white crystalline powder 
obtained was termed as compound I and the fractions obtained when column was 
eluted with a mixture of hexane and ethyl acetate (80:20) was concentrated and a 
pale white crystalline powder obtained was termed as compound II.  
The isolated Compound I and Compound II were characterized by spectral studies 
like FT-IR, 
1
HNMR, 
13
CNMR and MS analysis.  
Characterization of Compound I 
Colour: White crystalline powder 
Melting point: 226.5ºC 
IR spectral analysis of the compound I 
             The IR spectrum of compound I is presented in Fig. 35 showed a broad 
absorption banding the range 3446–3385cm
-1
 which may be due to the presence of 
phenolic hydroxyl groups. A sharp absorption band at 1654cm
-1
 indicated the 
presence of carbonyl group. Absorption bands at the range 1612, 1591 and 1475 cm
-
1
were observed which may be due to the stretching and bending vibrations of 
aromatic (C=C) ring systems. A sharp and strong absorption at 1124cm
-1
 due to C-
O-C stretch vibration of C-O-CH3 function was also observed (Table 35) 
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Table 35: Interpretation of IR values of compound I 
S. No. Wave number (cm
-1 
) Functional Group 
1. 3446 – 3385 O-H group 
2. 1654 >C=O 
3. 1612, 1591 and 1475 C=C (aromatic) 
4. 1124 C-O-C  of C-OCH3 
 
Fig. 35: IR spectrum of isolated compound I 
 
1
H NMR spectral analysis of the compound 1  
 
 The 
1
HNMR chemical shift values (DMSO-d6, 500 MHz) are tabulated in 
Table 36. The
1
HNMR spectrum of the compound I depicted in Fig. 36 showed  a  
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singlet at a value of ?12.48 due the presence of phenolic hydroxylic group at C-3 
position. This down field shift is due to the presence of carbonyl group which is 
conjugated to the hydroxyl group. Broad humps at 10.67 and 9.36ppm equivalent to 
one proton are due to the presence of hydroxyl groups of phenolic nature at C-4’, C-
3’ positions respectively. A doublet of doublet (dd) at ?7.55–7.53 and a doublet (d) 
at ?7.68–7.67 equivalent to one proton due to the protons at C-6 and C-5 positions 
respectively were observed. A doublet (d) at ?6.48 and ?6.18equivalent one proton 
were for protons present in C-5’ and C-6’ positions respectively. A singlet (s) at 
?6.89 and ?6.87equivalent to one proton were assigned to protons in C-2’ and C-8 
positions respectively. A singlet (s) at ?3.84 equivalent to three protons was assigned 
to the methoxy protons. 
Table 36: Interpretation of 
1
HNMR data of compound I 
S. No Chemical shift value (in ppm) Assignment 
1 12.48 s, 1H, C3-OH 
2 10.67 br. hump,1H,C4-OH 
3 9.36 br. hump, 1H, C3 –OH 
4 7.68-7.67 d,1H, C5-H 
5 7.55-7.53 dd, 1H, C6-H 
6 6.89 s, 1H,  C2-H 
7 6.87 s, 1H, C8-H 
8 6.40 d, 1H, C5-H 
9 6.18 d, 1H, C6-H 
10 3.84 s,3H, C7-OCH3 
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Fig. 36:   
1
HNMR spectrum of isolated compound I 
 
13
C NMR spectral analysis of Compound I 
 The 
13
CNMR chemical shift values (DMSO-d6, 500 MHz) are presented 
in Table 37. The 
13
CNMR spectrum of compound I is depicted in Fig. 37.  It 
accounted for 15 carbon atoms and also the one carbon of methoxy group. The 
chemical shift value and their corresponding assignments are presented in the 
experimental section. 
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Table 37: Interpretation of 
13
CNMR data of compound I 
S. No 
? value  
(in ppm) 
Assignment 
S. No 
? value 
(in ppm) 
Assignment 
1 174 C4 9 121 C8 
2 163 C3 10 119 C7 
3 160 C’4 11 115.58 C’5 
4 156 C’3 12 115.06 C’6 
5 147 C’1 13 102 C’2 
6 146 C2 14 98 C’6 
7 145 C5 15 93 C10 
8 135 C6    
 
Fig: 37: 
13
C NMR spectrum of isolated Compound I 
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Mass spectral analysis of the Compound I 
 The mass spectrum of compound I is  presented in Fig. 38.  The peak at 
m/z value of 300.08 (M
+
) is the molecular ion peak & the base peak (100%) of 
isolated compound corresponded to the molecular ion peak. The mass of the parent 
molecular ion was corresponding to the mass of the molecular formula C16H12O6.  
Fig. 38: Mass spectrum of isolated compound I 
 
 Based on the all spectral data, the tentative structure of compound I has 
been proposed as 3,3’, 4’-trihydroxy-7-methoxy flavonone.  
 The molecular formula of the compound 1 was deduced as C16H12O6 and 
the structure of the isolated compound was elucidated to be 3, 3’, 4’-trihydroxy-7-
methoxy flavonone 
OOH3C
O
OH
OH
OH
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3, 3’, 4’-trihydroxy-7-methoxy flavonone 
Characterization of Compound II 
Colour:  Pale yellow 
Melting point: 280ºC 
IR spectral analysis of the compound II 
 The IR spectral data is given in Table 38. The spectrum depicted in Fig. 
39 showed a broad band between 3248 and 3147cm
-1
which  was  attributed  to  OH  
stretching of carboxylic acid. The bands at 1832 and 1732cm
-1
 are due to the 
asymmetrical and symmetrical C=O stretching vibration of acyclic carboxylic acid. 
The absorption bands at 1560 and 1544cm
-1
 are due to the OH in-plane bending 
vibrations. The absorption bands in the range 1521–1400 cm
-1
 are due to the 
methylene (-CH2-) and methyl (-CH3-) bending modes indicating that the molecule 
may contain both –CH2- and –CH groups.  Further, the bands at 3095 and 2983cm
-1
 
represented the symmetric and asymmetric stretching vibrations of C-H of alkyl 
groups. 
Table 38: Interpretation of IR values of compound II 
S. No. Wave number (cm
-1 
) Functional Group 
1. 3248 and 3141 O-H group 
2. 3095 and 2983 C-H stretch of alkyl group 
3. 1832 and 1732 >C=O 
4. 1560 and 1544 OH bending vibration 
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Fig. 39: IR spectrum of isolated compound II 
 
1
H NMR spectral analysis of Compound II 
 The 
1
HNMR chemical shift values (DMSO-d6, 500 MHz) are tabulated in 
Table 39. The  spectrum  of  the  compound  II  in  Fig. 40 showed  a  multiplet  at  
?7.27ppm equivalent to 2 protons which may be attached to ?, ? – unsaturated 
carbon atoms with respect to carboxylic acid group. The chemical shift at the range 
?5.00 to 3.00ppm appeared as multiplets equivalent to 28 protons indicate the 
presence of methylene groups. The multiplet centered at ?1.39ppm equivalent to 3 
protons is due to methyl group. 
Table 39: Interpretation of 
1
HNMR data of compound II 
S. No Chemical shift value (in ppm) Assignment 
1 7.20 m, 2H, -C3=C2-H 
2 5.00 – 3.84 m, 28H, -CH2- 
3 1.39 s,3H, -CH3 
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Fig. 40:  
1
H NMR spectrum of isolated compound II 
 
13
C NMR spectral analysis of Compound II 
 The 
13
CNMR chemical shift values (DMSO-d6, 500 MHz) are presented 
in Table 40. The  spectrum showed the presence of 18 carbon atoms in compound 
II. The chemical shift values and their corresponding assignments are presented in 
Table 40. 
Table 40: Interpretation of 
13
CNMR data of compound II 
S. No 
? value 
(in ppm) 
Assignment S. No 
? value 
(in ppm) 
Assignment 
1 172 C1 10 46 C10 
2 128.78 C2 11 45.68 C11 
3 128.27 C3 12 45.20 C12 
4 126 C4 13 44 C13 
5 67 C5 14 33 C14 
6 65 C6 15 28 C15 
7 64 C7 16 27 C16 
8 63.89 C8 17 24.81 C17 
9 63.38 C9 18 24.01 C18 
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Fig: 41: 
13
C NMR spectrum of isolated compound II 
 
Mass spectral analysis of the Compound II 
 The mass spectrum of the isolated compound II is presented in Fig. 42.  
The peak at m/z value of 282(M
+
) is the molecular ion peak. The base peak (100%) 
of isolated compound corresponded to the molecular ion peak. The mass of the 
parent molecular ion is corresponding to the mass of the molecular formula 
C18H34O2. 
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Fig. 42:  MS spectrum of isolated compound II 
 
 Based on the spectral (IR, 
1
HNMR, 
13
CNMR and MS) data, the 
molecular formula was deduced to be C18H34O2 and the structure of the compound 
II was elucidated to be octadeca-2-enoic acid 
H3C OH
O
 
Octadeca-2-enoic acid 
6.11  IN VITRO ANTICANCER ACTIVITY OF ISOLATED 
COMPOUND I AGAINST HCT-116 CELL LINES 
 The effect of compound I on apoptosis of colon cancer cell line HCT-116 
was assessed by MTT assay as discussed in section in vitro anti  cancer  activity  of  
the extract. The effect of compound I was assessed at a concentration of 50 and 
100µM/ml at different time intervals such as 24h and 48h. From the results, it was 
observed that the highest percentage of cell death of 86.2 and 94.5 was observed 
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with 100µM/ml while the percentage of cell death was 58.5 and 77.8 with 50µM/ml 
at 24 and 48h respectively. The results are presented in Table 41 and the graphical 
representation in Fig. 43. 
Table 41: Effect of isolated Compound I against HCT-116 cell lines 
Study Period 
( in hours) 
% of Cell death of HCT-116 
50µM/ml 100µM/ml 
24 58.50 ± 1.50 86.20 ± 1.60 
48 77.80 ± 2.90 94.50 ± 3.51 
      Note: Percentage of cell death was calculated from control.  
      Values are expressed as mean ± S.E.M. n=3.  
Effect of compound I on chromatin condensation of HCT-116  
 The effect of compound 1 on  chromatin  condensation  of  HCT-116  cell  
lines was assessed by fluorescent microscopy using bis benzamide (Hoest-33342) at 
a concentration of 50 and 100µM/ml at time intervals of 24 and 48h. From the 
results it was observed that the highest percentage of chromatin condensation was 
observed with 100µM/ml. The results are depicted in Fig. 44. 
Table 42: Effect of isolated compound I on chromatin condensation of HCT-
116 cell line 
Study Period (in 
hours) 
% of chromatin condensation of HCT-116 
50µM/ml 100µM/ml 
24 38 ± 1.20 68 ± 2.45 
48 45 ± 2.40 74 ± 3.20 
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Fig. 43: Graphical representation of effect of compound I against HCT-116 
cell lines on cell viability   
 
Fig. 44: Graphical representation of effect of the isolated compoundon 
chromatin condensation 
 
 The results indicated that the isolated compound 3, 3’, 4’-trihydroxy-7-
methoxy flavonone showed in vitro cytotoxic effect against the cell line HCT-116.  
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CHAPTER 7 
DISCUSSION 
 
             Cancer is a major life-threatening health problem throughout the world 
and is characterized by uncontrolled proliferation of cells. Among various types of 
cancer, the breast cancer is a major type of cancer next to lung cancer,
183
 and the 
mortality is 30% in females  and a  small but increasing number is from men
184 
and 
it is a major public health problem in the  developing countries like India.  Every 
year 75,000 new cases of breast cancer are reported in India and may further 
increase due to various factors like environmental pollution, food habits, 
consumption of genetically modified food stuff etc. Breast cancer is both genetically 
and histopathologically heterogeneous, and the mechanism(s) underlying breast 
cancer development remains unclear
185
 but the involvement of several genes i.e. 
either activated or inactivated are there to promote malignancy.
186
 Colorectal cancer 
metastases result in a significant number of cancer related deaths and colon cancer is 
commonly ascribed to the transformation of normal colon epithelium to 
adenomatous polyps and ultimately invasive cancer. 
 The search for anti-cancer agents from plant sources started in the 1950s 
by the discovery and development of the vinca alkaloid, vincristine, and the isolation 
of the cytotoxic podophyllotoxins.
187-190
 Among them,  the  agents  that  alter  the  cell  
cycle  have  been  of  special  interest,  since  cell  cycle  regulation  is  the  basic  
mechanism underlying cell fate, i.e., proliferation, differentiation or acquired 
death.
191
 In cancer therapy, one approach to suppress tumour growth is by activating 
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the apoptotic machinery in the cell,
192
 i.e. by the activation of an intrinsic cellular 
suicide programme when the cells are no longer needed or when they are seriously 
damaged.
193
  
 A successful anticancer drug should kill or incapacitate cancer cells 
without causing excessive damages to normal cells and this is achievable by 
inducing apoptosis in cancer cells
194
  and hence in vitro anticancer activity was 
studied using cell lines such as human colon carcinoma (HCT-116) and Michigan 
cancer foundation (MCF-7). The human colorectal carcinoma cell line HCT-116 
demonstrate primary tumour growth, invasion and peritoneal spread while the MCF-
7 cell line, a  widely  studied  epithelial  cancer  cell  line  derived  from  breast  
adenocarcinoma is useful for in vitro breast cancer studies because it retains several 
characteristics particular to the mammary epithelium such as invasion, colony 
formation and metastatis and is also easy to propagate and doubles within 30 to 40h.   
 The effect of HAEBD on  the  growth  of  breast  cancer  cell  line  MCF-7  
and colon cancer cell line HCT-116 cells were examined by the MTT assay. MTT 
assay is used to measure the mitochondrial activity in viable cells based on the 
activity of mitochondrial dehydrogenase enzyme that reduces the yellow tetrazolium 
MTT into purple formazan crystal. The amount of the purple formazan formed 
indicates the number of metabolically active viable cells
195
.  The  results  of  the  
inhibitory effect of HAEBD on MCF-7 and HCT-116 extract are presented in Table 
13 showing  the  cell  viability  of  each  cell  line  after  24h  treatment  with  different  
concentration of the extracts. The IC50 value of HAEBD on MCF-7 and HCT-116 
was found to be 108.22µg/ml and 119.69µg/ml.  
 In cell morphological studies, untreated MCF-7 retained its normal 
angular or polygonal shape and has intact and large vesicular nuclei with prominent 
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nucleoli.(Fig. 5) On HAEBD treatment MCF-7  cells exhibited condensed 
chromatin, apoptotic morphological changes with protrusion of plasma cell 
membrane In addition, it showed apoptotic bodies with cytoplasmic condensation 
indicating apoptosis like changes (Fig. 6) These observations provide evidence that 
an apoptotic pathway was triggered with the HAEBD treatment in breast cancer cell 
line MCF-7. The studies indicate that the HAEBD primarily possesses apoptosis 
activity and possesses cell cycle inhibitory activity.  
 Although significant results were demonstrated indicating that the 
HAEBD exhibited cytotoxic effect on colon cancer cell line, it should be noted that 
using MTT assay is not possible to differentiate between cell growth inhibition and 
an increase in cell death. In cell morphological analysis, most of the HCT-116 
appeared as normal angular and spindle shapes in control (Fig. 7). Most of the cells 
lost these features after treatment with increasing concentrations of the extract (Fig. 
8). Cell shrinkage with lesser cytoplasm mass and even apoptotic bodies were 
observed. (Fig. 8) These morphological changes of the cells observed after treatment 
with  the  extract  has  provided  some  insight  on  the  effect  of  the  extract  against  the  
HCT116.  
 The fluorescent microscopic analysis indicates that HAEBD has 
promising cytotoxic effect in MCF-7 and HCT-116 cell lines. The cytotoxicity 
potential of HAEBD is closely associated with chromatin condensation, which is the 
hallmark for apoptosis. Caspases are important cysteine proteases activated during 
apoptosis (Figs. 9 to 12).  The effect of HAEBD cell cycle arrest was done by flow 
cytometry. The apoptotic sub G0 population was enhanced in HAEBD treated cells 
even at 50?g/ml concentration. This study hypothesized that HAEBD exerts its anti-
cancer effects through the induction of cell cycle arrest and apoptosis on cancer 
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cells. The cytotoxic effect on cancer cell could be due the presence of flavonoids and 
phenolic compound in hydroalcoholic extract of Boerhaavia diffusa.  
 The HAEBD showed promising in vitro anti cancer activity against 
MCF-7 and HCT-16 cell lines, in vivo pharmacological screening of the extract for 
anticancer and hepatoprotective effect was studied. The first step of in vivo 
pharmacological screening is to determine the toxicity of the extract which includes 
evaluation of acute, sub-acute and chronic toxicity in experimental animals. The 
highest overall concordance of toxicity in animals in comparison with humans is 
with hematological, gastrointestinal and cardiovascular adverse effects while certain 
adverse effects in humans, especially hypersensitivity and idiosyncratic reactions, 
were poorly correlated with toxicity observed in animals.
196 
 
 In the present acute toxicity study of HAEBD as per OECD 423 
guidelines, no mortality was observed in both the animals of control group as well as 
animals treated with a maximum dose of 2000mg/kg throughout the 14 days period 
following the single oral administration of the extract. No tremors, convulsion, 
salivation, diarrhea, lethargy or unusual behaviors such as self-mutilation. As no 
overt signs of acute toxicity or death were observed in mice treated with a hydro-
alcoholic extract of Boerhaavia diffusa upto a dose of 2000mg/kg, hence one tenth 
of 2000mg/kg i.e. 200mg/kg was selected as a minimum dose for animal studies.
197 
 In sub-chronic toxicity study, HAEBD at  doses  of  50,  100,  200  and  
400mg/kg administered orally daily for 20 days did not result in any mortality in the 
tested animals. The effects of HAEBD on organ weight and macroscopical changes 
of the rats did not show much difference in all the groups. The changes in body 
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weight can be used as an indicator of adverse effects of drugs and chemicals. 
198-200
 
but in the present study, the animals treated with HAEBD showed normal growth 
pattern and body weight compared with control rats treated with normal saline.  
 The haematopoietic and leucopoietic systems are the most sensitive 
targets for toxic compounds and an important index of physiological and 
pathological status in man and animal and hence analysis of change in hematological 
system has a higher predictive value for human toxicity, when data are translated 
from animal studies
196 
No significant changes in the levels of WBC, RBC were 
observed between control and test groups following repeated administration of 
HAEBD. Interestingly, significant increase in the levels of haemoglobin was found 
in treatment with HAEBD at a dose of 400mg/kg (Table 22). The possible reason 
could be that one of the constituents of HAEBD may increase the absorption of 
iron.
201
 Therefore,  it  is  possible  to  assume  that  the  extract  is  non  haematotoxic.  A  
significant  decrease  (p  <  0.05)  in  plasma  glucose  level  in  HAEBD treated rats 
especially at higher dose (400mg/kg) compared to control rats.  
 If the extracts were toxic then there would also be liver impairment due 
to changes in enzymes like ALP, AST and ALT.
202
 Serum cholesterol and proteins 
are mainly regulated via synthesis in the liver and increase or decrease in serum 
concentration of these constituents also suggests liver toxicity. In the present study a 
significant decrease (p<0.05) in plasma total cholesterol (TC), triglyceride (TG) and 
LDL cholesterol levels and significant increase (p < 0.05) in HDL cholesterol levels 
were observed in all the treated animals when compared to control animals (Table 
21) and AST, ALT and ALP levels were normal in the HAEBD treated animals  
when compared to control animals (Table 21).  
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 In chronic toxicity study for 90 days, the doses of 200, 400 and 600 
mg/kg/day of HAEBD were chosen for the experiment which were equivalent to 
2.83 to 3.72 times of the normal human dose (crude plant material, 3–9g/day for 
adults).
203
 The animals treated with HAEBD at  all  three  doses  had  no  signs  of  
behaviour changes and toxic signs. The treated groups revealed that there was slight 
increase in body weight. However, the result from animal health monitoring in the 
entire period of 90 days showed no sign of morbidity and diseases. The increase of 
body  weight  may  have  resulted  from  physiological  changes  in  rats  such  as  
metabolism, food and water intake. The albino Wistar rats were healthy which was 
concluded by the normal appearance of general behavior, respiratory pattern, 
cardiovascular signs, motor activities, reflexes, and normal change in skin and fur. 
 The hematological values of the extract treated groups were normal in 
comparison to control group. Significantly, some values were different from those of 
the  control  group  such  as  RBC,  MCV,  MCHC,  and  platelet  in  HAEBD treatment 
group  from  that  of  control  group  but  such  values  are  within  the  normal  ranges  
(Table 24). These variations may have resulted from normal variation among animal 
groups. 
204, 205 
Therefore, these results suggested that the extract did not cause 
hematological or immunological defects in rats. Furthermore, blood chemical 
examination was performed in order to evaluate any toxic effects on liver and 
kidney. In this study, the levels of these blood chemical values showed minor 
changes and remained within the normal range.
206-208 
In conclusion, the HAEBD 
given orally to Wistar rats did not produce any toxicity. 
 
 The in vivo anti  cancer  activity  of  HAEBD was  carried  out  using  DAL 
induced lymphoma, EAC induced carcinoma, DMBA induced breast cancer models 
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and hepatoprotective effect was carried out using D-galactosoamine induced 
hepatotoxicity model.  
 The effect of HAEBD in DAL induced lymphoma was evaluated. The 
intraperitoneal inoculation of DAL cells in mice produced an enormous increase in 
the tumour cell count which indicates that there is progression of cancer in mice. 
The reliable criteria for judging the value of any anticancer drug are the prolongation 
of  the  life  span  of  animals  and  tumour  volume.  The  ascitic  fluid  is  the  direct  
nutritional source for tumour cells and rapid increase in ascitic fluid volume with 
tumour growth is generally observed. The treatment with HAEBD inhibited the 
viable tumor cell count and increased the life span to 80% and 86% at the dose of 
200 and 400 mg/kg respectively indicating its potent antitumor nature. This was also 
evidenced by significant reduction in body weight of animal treated with HAEBD in 
tumour bearing mice (Table 26). It may be concluded that HAEBD by decreasing 
the nutritional fluid volume and arresting the tumour growth increases the life span 
of DAL bearing mice. Thus, hydro-alcoholic extract of Boerhaavia diffusa Linn has 
antitumor activity against DAL bearing mice        
 The major problems that are being encountered in cancer chemotherapy 
are myelo suppression and anaemia.
209 
The anaemia encountered in tumour bearing 
mice is mainly due to reduction in RBC or haemoglobin percentage, and this may 
occur either due to iron deficiency or due to haemolytic or myelopathic condition.
210
 
In tumour bearing mice, it was found that there was increase in WBC count, and 
decrease in haemoglobin content and RBC count. The treatment with HAEBD 
reversed the haemoglobin (Hb) content, RBC and WBC count to near normal levels. 
It also significantly reduced PCV content to 21.26 ± 1.45 and 20.55 ± 1.38%. All 
these results suggest the anticancer nature of the HAEBD and also indicated that the 
extract possessed protective action on the hemopoietic system (Table 27). 
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 The biochemical examination of DAL inoculated animals showed 
marked changes indicating the toxic effect of the tumour. It has been reported that 
the presence of tumour in the human body or in the experimental animals is known 
to affect function of the liver by increasing the levels of total cholesterol, TG, AST, 
ALT, ALP in serum of tumour bearing animals. The HAEBD treatment brought 
about significant reversal of these changes towards normal values (Table 28) 
indicating a protective effect on liver enzymes.  
 The effect of HAEBD on EAC induced solid tumour was investigated 
and treatment with HAEBD at a dose of 200 and 400mg/kg body weight showed 
27.59 and 29.31% reduction in solid tumor volume respectively on day 30 (Table 
29) of the experiment when compared to control animals.  
 The effect of HAEBD on DMBA induced Breast cancer was evaluated. 
Breast cancer is one of the most common cancers in women and is responsible for 
20% of all female cancers.
211 
The medicinal plant extracts may be a potential source 
for alternative novel treatment of breast cancer and natural antioxidants from plant 
sources have been viewed as promising therapeutic drugs. DMBA is a potent 
carcinogen induces numerous lesions in rat mammary gland. Metabolism of DMBA 
by the mixed function oxidase system often results in the formation of oxy radicals 
‘‘O2
•-
,  H2O2, and •OH,’’ which bind covalently to nucleophilic sites on cellular 
macromolecules there by eliciting cancerous responses.
212
 Increase in both ROS and 
Ca
2+
 generation was observed in DMBA. The excessive ROS signal can cause Ca
2+
 
overload, mitochondrial depolarization and DNA damage leading to apoptotic cell 
death which determines cancer progression.
213, 214  
The animals when treated with 
DMBA attained a promotional stage tumour after 45 days. Therefore, the tumour 
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promotional stage is a reversible stage in the multistage carcinogenesis and the most 
suitable stage for the anti-carcinogenic agent to prevent, reverse, or slow down the 
process of carcinogenesis.  
 The DMBA tumour induced group showed a severe body weight loss 
when compared to control rats. The tumour volume also increased in toxic group. 
The treatment with vinblastin and both doses of hydro-alcoholic extract of 
Boerhaavia diffusa reduced the breast tumour by an average of 37, 24 and 32% 
respectively. The body weight had also slightly increased, the tumour volume 
decreased, and the percentage of tumour inhibition was significant (p < 0.05) as 
shown in Table 30.  
 Oxidative stress is an imbalance between reactive oxygen species and the 
antioxidant defense mechanisms of a cell or tissue, which leads to lipid peroxidation, 
DNA damage, and the inactivation of many enzymes.
215
 The enzymatic antioxidant 
defense system is the natural protector against lipid peroxidation that includes 
superoxide dismutase (SOD), catalase (CAT) and glutathione peroxidise (GPx). 
Reduction in the activity of these enzymes may result in a number of deleterious 
effects due to the accumulation of superoxide radicals and H2O2.   
 Superoxide dismutase (SOD) is a major intracellular enzyme, which 
protects the system against oxygen free radicals which damages the membrane and 
its biological structure by catalyzing the dismutation of superoxide free radical and 
anions to H2O2 and oxygen. A significant reduction in the activity of antioxidant 
enzyme SOD was observed in cancer-bearing animals (1.53 ± 0.07) when compared 
to normal control animals (3.75 ± 0.08). The treatment with vinblastin and HAEBD 
(200 and 400mg/kg) significantly elevated the values to near normal i.e. 3.2 ± 0.06, 
2.8 ± 0.07 and 3.14 ± 0.06 respectively. 
Chapter 7                                Discussion 
 
134 
 Catalase (CAT) is an enzyme located in the organelle called perioxosme 
and present in all major body organs of animals. It primarily decomposes hydrogen 
peroxide to H2O at a much faster rate, sharing the function with glutathione 
peroxidise
216
.   A  significant  decrease  of  the  amount  of  catalase  was  observed in 
cancer-bearing animals (14.51 ± 1.08) when compared to normal control animals 
(45.85 ± 0.47). The treatment with vinblastin and HAEBD (200 and 400mg/kg) 
significantly elevated the values to near normal level i.e. 37.91 ± 0.78, 27.71 ± 0.65 
and 34.05 ± 0.72 respectively. 
 Another enzyme glutathione peroxidise (GPx) is an important defense 
enzyme against oxidative damage and this in turn requires glutathione as a cofactor. 
Glutathione is one of the essential compounds for maintaining cell integrity because 
of its reducing properties and participation in the cell metabolism. GPx catalyse the 
oxidation  of  GSH  to  GSSG  at  the  expense  of  H2O2
215 
and  also  react  with  H2O2 to 
prevent intracellular damage.
217-219
  Glutathione peroxidase may play an important 
role in the removal of lipid hydroperoxides. The balance between these enzymes is 
important for the efficient removal of oxygen radicals from tissues.
220 
A significant 
reduction in the amount of GPx was observed in cancer-bearing animals (2.09 ± 
0.03) when compared to normal control animals (3.83 ± 0.1). The treatment with 
vinblastin and HAEBD (200 and 400mg/kg) significantly elevated the values to 
near normal level i.e. 3.55 ± 0.07, 3.06 ± 0.04 and 3.22 ± 0.02 respectively. 
 Lipid peroxidation is regarded as deleterious proces
221  
leading to 
structural modification of complex lipid protein assemblies such as bio membranes 
and lipoproteins and is associated with cellular malfunction. Hydroperoxy lipids are 
the source for the formation of free radicals which attack poly unsaturated fatty acid 
in cell membrane leading to a chain of chemical reaction called lipid peroxidation. 
Increased lipid peroxidation in various tissues cause functional degradation and 
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increase oxidative stress. Malondialdehyde is the major end product of LPO and 
readily reacts with DNA to form DNA-MDA adduct. Increased lipid peroxidation 
alters membrane fluidity and membrane potential and thereby leading to loss of 
cellular function and cell death
222
.   Elevated  level  of  lipid  peroxide  (LPO)  was  
observed in DMBA induced tumour bearing animals (2.16 ± 0.07) when compared 
to normal control animals (0.75 ± 0.02).  A reduction of lipid peroxides was 
recorded on treatment with vinblastin (1.11 ± 0.04) and both doses of hydro-
alcoholic extract of Boerhaavia diffusa treated group i.e. 1.46 ± 0.04 and 1.35 ± 0.02 
respectively which were near normal when compared to animals in normal control 
group.  
 DMBA-induced carcinogenesis is associated with invasive ductal 
carcinomas, fibroadenomas, adenomas, and papillomas. The ductal hyperplasia 
induced by DMBA has been discovered to be a precursor to the development of 
ductal carcinoma. The presence of proliferating cells in the stroma as well as among 
the epithelial and myoepithelial cells strongly suggests that the carcinogen acts on 
different cells in the breast tissue and, although the stroma itself does not undergo 
neoplastic transformation, it plays an important role in the carcinogenic process.  
 The histological examination of the breast tissue of DMBA induced 
tumour showed the presence of lobular alveolar hyperplasia, fibro-adenomatoid 
hyperplasia, fibro adipose stroma and proliferating ductules suggesting a neoplastic 
transformation which is an indication of DMBA induced cell proliferation (Fig. 21).  
The breast tissue of animals treated with vinblastin and HAEBD showed the 
presence of mild ductular proliferation with mild epithelial hyperplasia (Fig. 22 to 
24).  
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 From the results, it can be inferred that hydro-alcoholic extract of 
Boerhaavia diffusa positively modulated the antioxidant activity by quenching and 
detoxifying the free radicals induced by DMBA.  The antioxidant activity is well 
correlated  with  anticancer  activity,  since  the  free  radicals  are  one  of  the  major  
contributing factor for development of cancer.
223-226
 The production of ROS might 
be  reduced  and  the  level  of  antioxidant  enzymes  such  as  SOD,  CAT  and  GPx  
increased which can directly counter the oxidant attack and protect cells against 
LPO and DNA damage. The attenuation of DMBA induced oxidative stress by the 
plant extract could be attributed to the antioxidants activity of flavonoids, 
terpenoids, phenolic compounds and alkaloids present in the B. diffusa plant, which 
is known to quench the free radicals by maintaining antioxidants levels. 
 Liver is the vital organ of metabolism and excretion. While inducing 
cancer either by DAL, EAC and DMBA, free radicals generated might affect the 
function of liver. In order to protect the animals from liver toxicity, it is essential to 
analyse the hepatoprotective action of hydro-alcoholic extract of Boerhaavia 
diffusa. D-galactosamine induced liver damage reflects disturbances of liver cell 
metabolism which lead to characteristic changes in the serum enzyme activities. 
Elevated serum enzymes are indicative of cellular leakage and loss of functional 
integrity of the hepatocyte
227
and estimation of these enzymes in the serum is useful 
as a quantitative marker of the extent and type of hepatocellular damage.  
 In D-galactosamine induced liver toxicity group, there was significant 
decrease in SOD, CAT and GPx levels and increase in LPO levels in liver 
homogenate. Pre-treatment with hydro alcoholic extract of Boerhaavia diffusa Linn 
(HAEBD) at a dose of 200 and 400mg/kg orally for 8 days increased the levels of 
SOD, CAT and GPx levels and decreased the levels of LPO significantly (p<0.01) in 
Group 4 and 5. (Table 33) Treatment with HAEBD and Vitamin-E showed a 
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significant reduction in lipid peroxidation which might be due to the antioxidant 
ability of these compounds and free-radical scavenging effects. Pre-treatment with 
HAEBD at a dose 200 and 400mg/kg orally for 8 days also decreased the levels of 
AST,  ALT,  ALP,  TB,  GGTP  and  increased  the  levels  of  TP  and  TA  significantly  
(p<0.01).  
 The second line of defense consists of the non-enzymic scavenger’s 
glutathione, ascorbic acid, and ?-tocopherol, which scavenge residual free radicals 
escaping from decomposition by the antioxidant enzymes. The levels of non-
enzymatic antioxidants such as reduced glutathione, Vitamin C and Vitamin E in the 
liver homogenate of D-galactosamine induced groups were significantly reduced. 
(Table 34) whereas it is increased on pretreatment with HAEBD.  
 Glutathione a major non-protein thiol in living organism plays a central 
role in coordinating the antioxidant defense process and reacts directly with reactive 
oxygen species and electrophilic metabolites thereby protecting the essential thiol 
group from oxidation, and serves as a substrate for several enzymes including 
glutathione peroxidase. Apart from glutathione, ?-tocopherol and ascorbic acid are 
important free-radical scavengers which protect cell membrane against toxic agents. 
Vitamin C functions as a free-radical scavenger of oxygen radicals and successfully 
prevents detectable oxidative damage under all types of oxidative stress. Thus 
glutathione in blood keeps up the cellular levels of the active form of vitamin C. The 
observed decrease in the levels of ?-tocopherol and ascorbic acid in the D-
galactosamine mice might be due to an antioxidant defense against increased ROS 
or due to a decrease in glutathione levels in D-galactosamine-hepatotoxic mice.
228
 
The present study observed an increase in the levels of these antioxidants in 
HAEBD and Vitamin E administered mice.  
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 Histological studies of HAEBD pre-treatment revealed the regeneration 
of hepatocytes and also a marked decrease in inflammatory cells which might be due 
to the antioxidant ability of these compounds and free-radical scavenging effects. 
The ability of HAEBD to enhance the levels of antioxidants along with its anti-lipid 
peroxidative activity suggests that the extract might be potentially useful in 
counteracting free-radical-mediated tissue damage caused by hepatotoxicity (Fig.31 
to 34) . Studies on the anti-oxidative potency of various flavonoids have confirmed 
the importance of hydroxyl groups present in it. 
 In addition the in vivo determination of antioxidant defense system in 
DAL and DMBA induced tumour models and D-galactosoamine induced 
hepototoxicity model, in vitro determination of antioxidant activity was also carried 
out. The in vitro free radical scavenging activity against DPPH, hydrogen peroxide 
scavenging effect, superoxide radical scavenging activity and reduction capacity of 
ferric ion to ferrous ion was carried out to correlate the antioxidant potential of the 
hydro-alcoholic extract of Boerhaavia diffusa Linn.  
 The measurements of the reductive ability of ferric ion to ferrous ion in 
the presence of HAEBD was investigated and found to have significant reducing 
ability at a concentration of 75?g/ml. The higher the absorbance value the greater 
the reduction capacity. The order of reduction activity of the HAEBD and the 
standard antioxidants were: BHA > HAEBD > L-ascorbic acid.  
 The effect of HAEBD on superoxide anion radical scavenging activity 
was evaluated and the maximum percentage inhibition was found to be 70.020 ± 
1.650 for a concentration of 500µg/ml and the order of superoxide radical 
scavenging activity of HAEBD and  standard  antioxidants  was:  BHA  >  L-ascorbic  
acid >HAEBD.  
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  The extract showed a significant (p?0.01) free radical scavenging activity 
against DPPH radical and the maximum percentage inhibition for a concentration of 
500µg/ml was 68.42 ± 1.945.  The order of free radical scavenging activity of 
HAEBD and standard antioxidants was L-ascorbic acid > HAEBD > BHA.  
 The extract showed a significant (p?0.01) hydrogen peroxide scavenging 
effect at all concentrations and the maximum percentage inhibition of hydrogen 
peroxide observed for a concentration of 500µg/ml was 56.22 ± 2.340. The order of 
hydrogen peroxide scavenging activity of HAEBD and standard antioxidants was 
BHA > L-ascorbic acid > HAEBD.  
 Antioxidants play a prominant role in protecting the human body against 
damage from reactive oxygen species 
228
and the activity is attributed to various 
mechanisms, such as prevention of chain initiation, binding of transition metal ion 
catalysts, decomposition of peroxides, prevention of continued hydrogen abstraction, 
reductive capacity and radical scavenging 
229
Superoxide anion radicals are produced 
endogenously by flavoenzymes like xanthine oxidase, which convert hypoxanthine 
to xanthine and subsequently to uric acid in ischemia-reperfusion. The reduction in 
absorbance at 560nm with antioxidants indicates the consumption of superoxide 
anion in the reaction mixture. The possible mechanism might be that plant extracts 
scavenging O2?? or inhibiting the xanthine oxidase activity.  H2O2 is highly 
important because of its ability to penetrate biological membranes. H2O2 itself is not 
very reactive, but can be toxic to cell because it may give rise to hydroxyl radical in 
the cells. HAEBD showed a significant (p?0.01) scavenging activity and the results 
were almost similar to L-ascorbic acid and BHA. It can be a better alternative and 
potential antioxidant for medicinal purposes.  
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 Plants containing phenolic compounds, flavonoids.
230
 phenolic 
glycosides, phytosterols and triterpenes 
231,232
 have been reported to exhibit strong 
antioxidant properties and also shown to possess antimalignant and antitumour 
effects. The phytochemical analysis of HAEBD showed the presence of phenolic 
compounds and flavonoids. The other phytoconstituents include phytosterols, 
alkaloids, protein and amino acids, glycoside, saponins and tannins (Table  8). The 
biochemical and histopathological studies also supported its antitumor, 
hepatoprotective  and antioxidant properties.  
 The extract HAEBD showed promising anti cancer activity and hence 
was subjected to separation for isolation by column chromatography and 
characterization of active constituents by  spectral  analysis  like  IR,  
1
HNMR and 
13
CNMR and MS analysis. The separation of the extract by column chromatography 
and analysis by thin layer chromatography led to the isolation of two compounds 
named as Compound I and Compound II.  
 The Compound I isolated was a white crystalline powder with a melting 
point  of  226.5ºC and  was  identified  to  be  a  flavonoid.  The  IR spectrum (Fig. 35) 
showed a broad absorption banding the range 3446–3385cm
-1
 indicating the 
presence of phenolic hydroxyl groups, a sharp absorption band at 1654cm
-1
 
indicating the presence of carbonyl group and absorption at 1612, 1591 and 1475cm
-
1
 which may be due to the stretching and bending vibrations of aromatic (C=C) ring 
systems. A sharp and strong absorption at 1124cm
-1
 due to C-O-C stretch vibration 
of C-O-CH3 function was also observed.  The analysis of 
1
HNMR spectrum (Fig. 
36) revealed the presence of phenolic hydroxylic group by the appearance of a 
singlet at a value of ?12.48 with a broad hump centered at 10.67 and 9.36. This 
down field shift is due to the presence of carbonyl group which is conjugated to the 
hydroxyl group. A singlet (s) at ?3.84 equivalent to three protons was assigned to the 
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methoxy protons. The 
13
CNMR spectrum (Fig. 37) accounted for the presence of 
15 carbons. In the mass spectrum (Fig. 38), the peak at m/z value of 300.08 (M
+
) is 
the molecular ion peak.  The molecular formula of the compound 1 was deduced as 
C16H12O6  and  based on the spectral data, the structure of the compound I was 
elucidated to be 3, 3’, 4’-trihydroxy-7-methoxy flavonone 
OOH3C
O
OH
OH
OH
 
3, 3’, 4’-trihydroxy-7-methoxy flavonone 
 The compound II was a pale yellow amorphous powder with a melting 
point of 280ºC. The IR spectrum (Fig. 39) showed a broad band between 3248 and 
3147cm
-1
 indicated the OH stretching of carboxylic acid. The bands at 1832 and 
1732cm
-1
 were due to C=O stretching vibration of acyclic carboxylic acid. The 
absorption bands at 1560 and 1544cm
-1
 were due to the OH and at the range 1521–
1400cm
-1
 were due to the methylene (-CH2-) and methyl (-CH3-). The 
1
HNMR 
spectrum (Fig. 40) of the compound II showed a multiplet at ?7.27ppm equivalent 
to 2 protons which may be attached to ?, ? – unsaturated carbon atoms with respect 
to carboxylic acid group. The chemical shift at the range ?5.00 to 3.00ppm indicated 
the presence of methylene groups. The multiplet centered at ?1.39ppm may due to 
methyl group. The 
13
CNMR spectrum (Fig. 41) showed the presence of 18 carbon 
atoms in compound II. The signals at ?128.78 and ?128.27 corresponded to ?, ? – 
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unsaturated carbon atoms.  In the mass spectrum (Fig. 42), the peak at m/z value at 
282(M
+
)  was  the  molecular  ion  peak  corresponding  to  the  mass  of  the  compound.  
The molecular formula was deduced to be C18H34O2 and the structure of the 
compound II was elucidated to be octadeca-2-enoic acid  
H3C OH
O
 
Octadeca-2-enoic acid 
 The isolated compound I was evaluated for potential in vitro anti cancer 
activity against HCT-116 cell lines by MTT assay and chromatin condensation by 
fluorescent microscopy. The compound I exhibited 58.50% cell death at the end of 
24h and 77.80% cell death at 48h for a concentration of 50µM/ml while it showed 
86.20% cell death at the end of 24h and 94.50% cell death at the end 48h for a 
concentration of 100µM/ml. The effect of compound 1 on chromatin condensation 
of HCT-116 cell lines was assessed by fluorescent microscopy using bis benzamide 
(Hoest-33342) at a concentration of 50 and 100µM/ml at time intervals of 24 and 
48h. A 74% chromatin condensation was observed at a concentration of 100µM/ml. 
The results suggest that Compound I namely 3, 3’, 4’-trihydroxy-7-methoxy 
flavonone, a flavonoid exhibited potential cytotoxic effect.  
 From the  results  obtained  it  can  be  seen  that  HAEBD had  a  potent  anti  
cancer activity in both in vitro and in vivo models tested. It had also hepatoprotective 
and antioxidant effect. The results suggest that the extract may bring about the anti 
cancer effect through scavenging the free radicals produced and also by triggering 
apototic pathway. The isolated compound also had in vitro cytotoxic effect.   
Chapter 8       Summary and Conclusion 
 
143 
 
CHAPTER 8 
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 In the present investigation, entitled “Antitumour and Antioxidant and 
Hepatoprotective activity of Boerhaavia diffusa Linn against Dalton Ascitic 
Lymphoma (DAL) and Ehrlich Ascites Carcinoma (EAC) and D-
Galactosamine induced toxicity in Swiss albino mice” the aerial parts of 
Boerhaavia diffusa were screened for anticancer activity.  
 The dried powder of aerial parts of Boerhaavia diffusa was defatted 
using petroleum ether and then extracted with a mixture of alcohol and water and the 
percentage yield of hydro-alcoholic extract was found to be 16.5% and the 
phytochemical screening of HEABD showed the presence of phenolic compounds, 
flavonoids, fixed oil, phytosterols, alkaloids, proteins, carbohydrates, tannins and 
saponins.. 
 The hydro-alcoholic extract of Boerhaavia diffusa was then subjected to 
in vitro antioxidant studies. The extracts were tested for their total reduction 
capability and screened for the antioxidant potential against hydrogen peroxide, 
DPPH and superoxide anion. The percentage inhibition of HAEBD was determined 
and compared with standard antioxidants such as BHA and L-ascorbic acid.  The 
present studies indicated that HAEBD had equivalent antioxidant potential as 
standard antioxidant L-ascorbic acid and the same may be attributed to the presence 
of flavonoids and phenolic compounds. 
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 The hydro-alcoholic extract of Boerhaavia diffusa was subjected to in 
vitro cytotoxic activity on cell lines MCF-7 and HCT-116 by MTT assay, cell 
morphological studies, studies on chromatin condensation, apoptosis measurement 
and cell cycle analysis.  From the results obtained, it may inferred that HAEBD 
exhibited marked cytotoxicity on MCF-7 and HCT-116 cell lines. Significant 
morphological changes were observed with HAEBD in a concentration dependent 
manner when tested against both the cell lines. The studies also indicated that the 
HAEBD primarily possessed apoptosis activity and cell cycle inhibitory activity. 
50µg/ml of HAEBD significantly increased the percentage of HCT-116 cells with 
condensed nuclei. The loss of chromatin integrity may be due to activation of 
caspases.  
 The in vivo pharmacological screening of the HAEBD was then carried 
out.  The first  step was to determine the toxicity of the extract.  The toxicity studies 
included acute, sub-acute and chronic toxicity study of HAEBD and were 
executed as per OECD 423 guidelines for safe dose administration to animals. No 
mortality or morbidity was observed in animals when tested in acute toxicity 
studies. The results of sub-acute toxicity studies suggested that HAEBD was non 
toxic to the haematopoietic and leucopoietic system. The haematopoietic and 
leucopoietic systems are the most sensitive targets for toxic compounds and an 
important index of physiological and pathological status in man and animal.  
 In chronic toxicity study for 90 days, the doses of 200, 400 and 600 
mg/kg/day crude extract were chosen for the experiment. The animals treated with 
HAEBD at all three doses had no signs of behavioural changes and toxic signs. The 
treated groups revealed no significant differences in body weight gain. However, the 
results from animal health monitoring in the entire period of 90 days showed no sign 
of morbidity and disease.  
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 The main objective of the study is to evaluate in vivo anticancer activity 
of hydro-alcoholic extract of Boerhaavia diffusa (HAEBD) by studying the effects 
on Dalton Ascitic Lymphoma (DAL), Ehrlich Ascites Carcinoma (EAC) induced 
tumour and DMBA induced breast cancer.   
 In DAL induced tumour model, the tumour was induced by injecting 
DAL cells and after 14 days of treatment with the extract, the serum enzymes, lipid 
profile, haematological, clinical and derived parameters were determined using the 
blood. The treatment with HAEBD inhibited the viable tumour cell count, reduced 
nutritional fluid volume, arrested tumour growth and increased the life span of the 
tumour bearing mice.  It also restored the hemoglobin content, RBC and WBC count 
to near normal levels which clearly indicated that the extract possessed protective 
action  on  hemopoietic  system.  An  abnormal  lipid  profile  has  been  associated  with  
Dalton Ascitic Lymphoma and the enzyme levels markedly increased in tumour 
bearing mice. The significant reversal of these changes towards normal values by 
HAEBD treatment indicated a protective effect on liver enzymes. Flavonoids show 
chemopreventive role in cancer through their effects on signal transduction in cell 
proliferation and angiogenesis. It  can be concluded that hydro-alcoholic extract of 
Boerhaavia diffusa Linn showed antitumor activity against DAL bearing mice.  
 In Ehrlich Ascites Carcinoma (EAC) induced tumour model, a 
significant reduction in solid tumour volume in (EAC) was observed in animals 
treated with HAEBD at 400mg/kg body weight.  
 In DMBA induced breast cancer model, the treatment of female mice 
with DMBA induces the development of hyperplastic lesions like alveolar/ductal 
hyperplasia, benign tumours such as adenoma and malignant neoplasms like 
adenocarcinomas similar to those seen in humans. After 45 days of treatment with 
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HAEBD in tumour induced mice, the altered levels of body weight, tumour volume 
and tumour size had shown improvement. The breast tissue homogenate was used 
for estimation of biochemical parameters like superoxide dismutase, catalase, 
glutathione peroxidaase and lipid peroxide in treated and untreated mice. The 
administration of vinblastin and HAEBD significantly reversed the alteration of the 
enzymes to near normal level in cancer bearing animals. Thus it can be concluded 
that HAEBD has potential anticancer effect due to their ability to act as antioxidant 
by quenching and detoxifying the free radicals induced by DMBA.  
            Many cancer agents used in today’s medicine produce liver toxicity and 
hence it was decided to identify whether the extract had liver protective action and 
the hepatoprotective effect of HAEBD against D-galactosamine induced toxicity in 
mice was studied. After treatment with HAEBD in D-galactosamine induced 
hepatotoxicity, the biochemical parameters and level of antioxidants were 
determined. Significant increases in the levels  of  SOD,  CAT,  GPx and non-
enzymatic antioxidants and reduction in lipid peroxidation were observed on 
HAEBD and Vitamin E administration. Therefore the present study corroborated the 
protective action of HAEBD in D-galactosamine intoxication of mice which might 
be due to the presence of polyphenols and flavonoids. 
 The HAEBD showed anti cancer potential and hence was subjected to 
column chromatography for isolation of the compounds and spectral studies such as 
IR, NMR and MASS for characterization of the compounds. Two compounds were 
isolated Compound I, a flavonoid was characterized as 3,3’,4’-trihydroxy-7-
methoxy flavonone  while Compound II, fatty acid was characterized as octadeca-
2-enoic acid using like IR, 
1
HNMR, 
13
CNMR and MS spectral analytical 
techniques.   
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              The isolated Compound I was subjected to in vitro cytotoxic potential 
against cell lines HCT-116 to assess the role in apoptosis.  The compound had a 
significant cytotoxic effect and chromatin condensation which is a well known 
indicator for apoptosis. A concentration of 100µM/ml significantly increased the 
percentage of dead cells in HCT-116 thus exhibiting an in vitro cytotoxic potential.  
             It can be concluded that the hydro-alcoholic extract of Boerhaavia 
diffusa Linn had significant effect on in vitro and in vivo anti cancer models and also 
possessed hepatoprotective effect. These findings provided scientific evidence for 
the traditional use of Boerhaavia diffusa as a natural anti-carcinogenic agent in the 
treatment of cancer and as hepatoprotective. Active compounds contained in the 
plant  are  still  to  be  isolated  and  structure  elucidated  scientifically.  Further,  in-vivo 
studies are needed to explore the possible mechanism of action of isolated 
compounds derived from the plants against carcinoma.  
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CHAPTER 9 
RECOMMENDATIONS 
      
? In in vitro studies, plant exerted marked cytotoxic effects, so further 
investigation to be done on different cell lines. 
? The in vitro anti cancer activity of the isolated compound to be 
carried out using different cell lines.  
? Further, in-vivo studies are needed to explore the possible mechanism 
of action of isolated compound. 
? Many bioactive components present in the plant needs to be isolated 
and screened to prove potential source for cancer. 
? Interest can be developed in areas like molecular level studies due to 
its diverse medicinal uses in traditional folk medicines. 
 
  
Fig.5: Cell Morphology of untreated cells of MCF-7 cell lines 
 
 
 
                Polygonal shaped cells with intact nuclei with prominent nucleoli 
 
Fig. 6: Cell Morphology of HAEBD treated cells of MCF-7 cell lines 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Arrow indicates round apoptotic bodies and formation of membrane blebs 
87A 
Fig.7: Cell Morphology of untreated cells of HCT-116 cell lines 
 
Normal angular and spindle shape cell with intact nuclei 
Fig 8: Cell Morphology of HAEBD treated cells of HCT-116 cell lines 
 
Arrow indicates nuclear condensation and cell shrinkage 
87B 
Fig. 9: Apoptotic effect of untreated cells of MCF-7 cell lines 
 
 
Fig. 10: Apoptotic effect of HAEBD treated cells of MCF-7 cell lines 
 
            Condensed chromatin and nuclear fragmentation seen  
87C 
Fig.11: Apoptotic effect of untreated cells of HCT-116 cell lines 
 
 
Fig.12: Apoptotic effect of HAEBD treated cells of HCT-116 cell lines 
 
Nuclear fragmentation and condensed chromatin seen 
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Fig. 15:Section of liver tissue of Normal control animal 
 
Section shows (1)Portal tract and (2) Hepatocytes separated with sinusoid 
 
Fig. 16: Section of liver tissue of DAL tumour induced animals 
 
 
Hepatic Infiltration with focal necrosis seen 
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Fig.  17: Section of liver tissue of DAL tumour induced animal treated with 5-
fluorouracil 
 
Mild Hepatic infiltration with bile duct and sinusoidsseen 
Fig.  18: Section of liver tissue of DAL tumour induced animal treated with 
200mg/kg b.w. of HAEBD 
 
Reduced necrosis and lobular hepatocytes seen 
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Fig.  19: Section of liver tissue of DAL tumour induced animal treated with 
400mg/kg b.w. of HAEBD 
 
Hepatic regeneration separated by sinusoids with portal vein seen 
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Fig. 20:Normal control breast tissue section (G1) of mouse 
 
Sections show(1) Fibrous stroma (2) Alveolar structure of epithelial cells of breast 
parenchyma(3)Normal ductules and ducts 
 
Fig. 21: DMBA induced breast cancer tissue section (G2) of mouse 
 
 
Sections shows (1)Abundant fibrous stroma(2) Proliferated ductules 
(3)Invasive ductal carcinoma of hyperchromatic tumor 
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Fig. 22: Vinblastin treatedDMBA induced breast cancertissue section (G3) of 
mouse 
 
 
Sections show mild ductular proliferation, reduced ductules& ducts and fibrous 
stroma. 
 
 
Fig. 23: HAEBD (200mg/kg) treatedDMBA induced breast cancertissue section 
(G4) of mouse 
 
Sections shows reduced proliferation and recovery of normal breast 
parenchyma with ductules, ducts and fibrous stroma 
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Fig. 24: HAEBD (400mg/kg) treatedDMBA induced breast cancertissue section 
(G5) of mouse 
 
 
 
 
Sections show breast parenchyma with regularductules, ducts and fibrous stroma 
 
 
  
1 
104C 
Fig.30: Section of the liver of Normal control (G1)animals 
 
Section shows (1) Portal tract and (2) Hepatocytes separated with sinusoid 
Fig. 31: Section of the liver of D-galactosamine induced hepatotoxic liver of 
(G2)animals 
 
Section shows hepatic Infiltration & Portal inflammation 
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Fig. 32: Section of the liver of  Vitamin E pretreatment  of D-galactosamine 
induced hepatotoxic liver of (G3)animals 
 
Section shows decreased infiltration and Hepatic regeneration 
Fig. 33: Section of the liver of HAEBD (200mg/kg)  pretreatment of D-
galactosamine induced hepatotoxic liver of (G4)animals  
 
Section shows mild infiltration and Hepatic regeneration 
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Fig. 34: Section of the liver of HAEBD (400mg/kg)  pretreatment of D-
galactosamine induced hepatotoxic liver of (G5)animals 
 
 
Section shows reduced inflammation and necrosis 
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ABSTRACT 
The present study aims to evaluate the antitumor activity of hydro alcoholic extract of whole plant 
of Boerhaavia diffusa linn on Dalton Ascitic Lymphoma (DAL) and Ehrlich Ascitic carcinoma 
(EAC) in Swiss Albino mice model.The tumor was induced in mice by intraperitoneal injection of 
DAL (1X106cells/mouse). Hydro alcoholic extract of Boerhaavia diffusa linn (HAEBD) was 
administered to the experimental animals at a dose of 200mg/kg & 400mg/kg after 24 h of DLA 
induced tumor inoculation. The activity was assessed by increase in life span, average decrease in 
body weight, tumor weight, tumor volume, viable cell count, packed cell volume, hematological 
and biochemical parameters.The potency of the extract was compared with standard 5-flurouracil 
(20mg/kg I.P).HAEBD treatment showed significant increase in the life span, decrease the cancer 
cell count and tumor weight in the DLA tumor induced mice. The results showed decrease in tumor 
volume and cell viability. The antitumor effect of HAEBD was also evaluated by assessing 
hematological parameters and biochemical parameters.  Hematological parameters like red blood 
cell count, hemoglobin content and platelets cell values were restored to near normal level by 
HAEBD in tumor induced mice. In addition, HAEBD brought back the altered levels of liver 
enzyme towards normal value. Histopathological studies also reveals the normal architecture of 
liver tissues.In conclusion, the present study results revealed that Hydro alcoholic extract of 
Boerhaavia diffusa linn possessed significant antitumor activity against DAL and EAC models in 
mice. 
Keywords: Boerhaavia diffusa linn, Dalton’s Ascitic lymphoma, Erhlich Ascitic Carcinoma, 5- 
Fluoro uracil, Tumour volume, Life span 
INTRODUCTION 
Cancer continues to represent the largest cause of mortality in the world and claims over 6 million 
lives every year [1].It is a type of hyper proliferative disorder that involves transformation, 
dysregulation of apoptosis, proliferation, invasion, angiogenesis and metastasis. In recent times, the 
Nalini G et al  Asian Pacific Journal of Pharmacy & Phytochemistry             2 
 
trend in cancer research is shifting towards identifying new medicines from natural resources for the 
management of cancer. Therefore there is a constant demand to develop new, effective, and 
affordable anticancer drugs [2].Though Chemotherapy is now being used as a standard treatment 
method drugs obtained from medicinal plants play a crucial role in the treatment of cancer [3].  
Moreover, current anti- cancer regimens are frequently associated with significant levels of toxicity 
and the emergence of drug resistance. Plant derived from natural products such as flavonoids, 
terpenoids, and steroids etc. have received considerable attention in recent years due to their diverse 
pharmacological properties including antioxidant and antitumor activity [4,5].In the treatment of 
cancer, many herbal remedies have been employed in various medical systems for the treatment and 
management of different diseases. Boerhaavia diffusa Linn is one of the renowned medicinal plants 
used to treat large number of human ailments. Boerhaavia diffusa Linn, Nyctaginaceae, commonly 
known as 'Punarnava' in the Indian system of medicine. It is a perennial creeping herb found 
throughout the waste land of India. The whole plant of B. diffusa has been employed for the 
treatment of various disorders like liver disorders, gastrointestinal disorders, and heart diseases. The 
roots are reputed to be diuretic and laxative and are given for the treatment of anasarca, ascites and 
jaundice [6]. The plant has also been screened for anti-inflammatory, antimicrobial, 
immunosuppressive, hepatoprotective, antitumorogenic, anti-leprotic and anti-asthmatic activities 
[7-10]. Boerhaavia diffusa Linn contains large number of phytoconstituents, like flavonoids, 
alkaloids, steroids, triterpenoids, lipids, lignins, carbohydrates, proteins and glycoproteins [11,12]. 
MATERIALS AND METHOD 
Collection and Authentication of Plant 
Whole plant of Boerhaavia diffusa Linn was collected from local traders, Tamil Nadu. The plant 
material was taxonomically identified and authenticated by Dr.Stephan, Botanist, American college, 
Madurai and the voucher specimens (KMCP/GN/BD/0290) were retained in the Institute for future 
reference. The whole plant of Boerhaavia diffusa linn was dried in shade, milled into coarse powder 
by a mechanical grinder and stored in closed vessel for further use. 
Experimental animals  
Male Swiss albino mice (20-25 gm) were produced from animal experimental laboratory, and used 
throughout the study. They were housed in micro nylon boxes in a control environment (temp 
25±2°C) and 12 hrs dark /light cycle with standard laboratory diet and water ad libitum. The 
experimental protocol was approved by Institutional animal ethical committee 
(Reg.no.661/02/C/CPCSEA&19/07/2002).App.no.G.Nalini/TNMGRMU/Ph.D/IAEC/KMCP112/20
14-15). CPCSEA guidelines were adhered during the maintenance and experiment. As per the 
standard practice, the mice were segregated based on their gender and quarantined for 15 days 
before the commencement of the experiment. They were fed on healthy diet and maintained in 
hygienic environment in our animal house [13]. 
Plant crude extract 
About 500gm of air dried coarse powder of Boerhaavia diffusa linn were soaked in the extractor 
and macerated for 30 hrs with petroleum ether and then it is refluxed successfully with chloroform; 
benzene then extracted with alcohol and water (70:30) by continuous hot percolation method using 
soxhlet apparatus for 72 hrs separately. Hydro alcoholic extracted of Boerhaavia diffusa linn was 
filtered and concentrated in vacuum using rotary flask evaporator under reduced pressure.  Then the 
extract of Boerhaavia diffusa linn concentrated to brownish residue stored in air tight container. 
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Induction of Tumour using DAL & EAC cells 
Dalton’s Lymphoma ascites (DLA) and Ehrlich Ascites Carcinoma (EAC) cells were obtained 
courtesy of Amla Cancer Research center, Thrissur, Kerala, India. The cells were maintained in 
vivo in swiss albino mice by intra peritoneal transplantation. While transforming the tumour cells to 
the grouped animal, the DLA cells were aspirated from peritoneal cavity of the mice using saline. 
The cell count was done and further dilutions were made, so that total cells should be 1x106 cells 
/ml/mouse. This volume was given intraperitoneally and the tumour was allowed to grow in the 
mice for a minimum of seven days before starting the study [15-18]. 
Treatment Protocol  
Swiss Albino mice were divided in to five group of six each. All the animals in four groups (G2-
G4) were injected with DLA cells (1 x 106 cells per mouse) intraperitoneally, except the normal 
control group. After the inoculation the groups were treated as given below. 
Group 1 served as Control.  
Group 2 served as Tumor control. Group 1 and 2 receives normal diet and Water. 
Group 3 served as the positive control, was treated with injection 5-fluorouracil at 20 mg/kg body 
weight, Intraperitoneally. [19]  
Group 4 served as treatment control, which was treated with Hydro alcoholic extract of Boerhaavia 
diffusa Linn (HAEBD) at a dose of 200 mg/kg body weight, given through orally.  
Group 5 served as treatment control which was treated with Hydroalcoholic extract of Boerhaavia 
diffusa linn (HAEBD) at a dose of 400 mg/kg of body weight, given through orally. In this study, 
drug treatment was given after 24 h of inoculation, once daily for 14 days. On day 15, the following 
derived parameters were estimated [20]. 
Derived parameters 
Body weight 
All the mice were weighed, from day1 to 14th day of the study. Average increase in body weight on 
the 15th day was determined. 
Percentage increase in life span (ILS) 
The effect of HAEBD on tumor growth was monitored by recording the mortality daily for 6 weeks 
and percentage increase in life span (ILS) was calculated [21]. 
%ILS = 1001x
groupcontrolofspanLife
grouptreatedofspanLife 
 
Effect of HAEBD on Survival Time 
% ILS was calculated by the following formula 
Increase in lifespan = [(T - C) / C] x 100 
   Where T = number of days the treated animal survived. 
              C = number of days control animals survived. 
 
Evaluation of Clinical Parameters 
Cancer cell count  
The fluid (0.1ml) from the peritoneal cavity of each mouse was withdrawn by sterile syringe and 
diluted with 0.8 ml of ice cold Normal saline or sterile Phosphate Buffer Solution and 0.1 ml of 
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tryphan blue (0.1 mg/ml) and total numbers of the living cells were counted using heamocytometer 
[22-27] 
      No of cells Dilution 
      Cell count = ------------------------------------------              
                           Area × Thickness of liquid film 
Hematological parameters 
The effect of HAEBD on hematological parameters was studied in the mice of all groups. In this 
study, the drug treatment was given 24 h after inoculation, once daily for 14 days. On day 14th after 
the last dose, all mice from each group were sacrificed by euthanasia. Blood was withdrawn from 
each mouse by retro orbital puncture method and Hematological parameters, biological parameters 
enzyme and lipid profile were analyzed [27-28].   
Serum enzyme and lipid profile 
The effect of HAEBD on serum enzyme and lipid profile including total cholesterol, TG. AST, 
ALT, ALP was evaluated. All biochemical investigations were done by using COBAS MIRA 
PLUS-S Auto analyzer from Roche Switzerland. Hematological test are carried out in COBAS 
MICROS OT 18 from Roche. Newly added Hi-Tech instruments MAX MAT used for an auto 
analyzer for all biochemistry investigations in blood sample [29-32]. 
Effect of HAEBD on Solid Tumor 
Mice were divided into three groups (n=6). Tumor cells (1x106 cells/mice) were injected into the 
right limb (thigh) of all the animals intramuscularly. The mice of Group I were tumor control. 
Group II and Group Ш received HAEBD (200&400mg/kg) orally for 5 alternative days. Tumor 
mass was measured from the 11th day of tumor induction. Diameter of the tumor was measured on 
every 5th day for a period of 30 days using Vernier calipers and the volume of the tumor mass was 
calculated using the formula V= 4/3  r2 where r is the mean of r1 and r2 which are two independent 
radii of the tumor mass. 
Histopathological examination 
A piece of liver, samples were fixed in 10% formalin for Histopathological examination. The thin 
sections were cut and then stained by Haematoxylin and Eosin and observed under light microscope 
[33]. 
Statistical analysis 
The results were expressed as Mean± S.E.M and analyzed with one way analysis of variance 
(ANOVA) between the groups and followed by Newman keul’s multiple range tests. Probability 
values P< 0.05 were considered as significant. 
RESULTS  
Effect of HAEBD on survival time & Tumor Growth 
The effect of HAEBD on survival of DAL tumor bearing mice were shown in Table1.In the DLA 
tumor control group, the average life span of animal was found to be 46%. Whereas HAEBD at the 
dose of 200mg/kg and 400 mg/kg significantly increase the life span to 80% and 86% respectively. 
However the average life span of 5- FU treatment was found to be 90%, indicating its potent 
antitumor nature. The antitumor nature of HAEBD was evidenced by the significant reduction in 
percent increase in body weight of animal treated with HAEBD at the dose of 200mg/kg and 400 
mg/kg body weight when compared to DLA tumor bearing mice. It was also supported by the 
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significant reduction in packed cell volume and viable tumor cell count in both the extent of 
treatment when compared to the DLA tumor control. (Table No: 1).   
Effect of HAEBD on Hematological Parameters 
In Hematological parameter the total WBC count was significantly increased, where as RBC, Hb, 
and Platelets were decreased in the DLA control group compared to the normal control group. 
Treatment with HAEBD at the dose (200mg/kg and 400 mg/kg) significantly increases the Hb 
content, RBC, Platelets and significantly decreased the WBC count to about near normal values. 
Also HAEBD significantly reduced PCV content to 21.26±1.45% and 20.55±1.38%. All these 
results suggest the anticancer nature of the HAEBD.  
Effect of HAEBD on Biochemical Parameters 
The inoculation of DLA cells caused significantly increase in the level of total Cholesterol, 
Aspartate amino Transferase, Alanine amino Transferase, Alkaline Phosphatase in the tumor 
control animals (G2), when compared to the normal group. Treatment with HAEBD at the dose of 
200mg/kg and 400 mg/kg body weight significantly reversed these changes towards the normal 
level. (Table No.3) All these value were found to be significant. 
Effect of HAEBD on EAC Induced Solid Tumor 
In the tumor control animals the solid tumor volume induced by EAC cells was found to be 
significantly increased from day 0 to day 30. However, the tumor volume was significantly 
decreased in animal treated with HAEBD at 200mg/kg and 400 mg/kg body weight. A significant 
reduction in solid tumor volume was seen from day 15 to the end of the experiment. About 27% and 
30% reduction in tumor volume was observed with HAEBD treatment respectively on the day 30 of 
the experiment (Table No.4). 
Table No.1 Effect of HAEBD on the life span, body weight and cancer cell count of tumor 
induced mice. 
Treatment Number of 
animals 
% ILS Life span Increase in Body 
weight grams 
Cancer cell count 
ml X 106 
G1 6 >>30 days 2.22±0.68 - 
G2 6 46% 9.44±0.86a** 2.75±0.40a** 
G3 6 90% 5.66±0.42b** 1.30±0.40b** 
G4 6 80% 6.22±0.60b** 1.65±0.45b** 
G5 6 86% 5.80±0.80b** 1.50±0.30b* 
G1 – Normal Control, G2 – Cancer Control, G3 – Positive control, G4 – Treatment control (HAEBD 
200mg/kg) G5 – Treatment control (HAEBD 400mg/kg) 
All values are expressed as mean ± SEM for 6 animals in each group. 
**a – Values are significantly different from control (G1) at P < 0.001 
**b – Values are significantly different from cancer control (G2) at P < 0.001 
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Table No. 2. Effect of HAEBD on hematological parameters 
Treatment Total WBC Cells /mlx103 
RBC Count 
Mill/cumm 
Hb 
Gm/dl PCV % 
Platelets 
Lakhs/cumm 
G1 10.85 ±0.86 4.68±0.46 12.05 ±0.45 15.80±1.55 3.35±0.36 
G2 14.05 ±1.42a** 2.30±0.15a** 7.30  ±0.30 31.60±2.60a** 1.75±0.18a** 
G3 11.42 ±0.95b** 3.95±0.32b** 11.6 ±0.35b** 18.30±1.10b** 2.80±0.22b** 
G4 12.80±1.02b** 3.25±0.22b** 10.05±0.18b** 21.26±1.45b** 2.15±0.12b** 
G5 12.10 ±0.98b** 3.60±0.28b** 11.05±0.26b** 20.55±1.38b** 2.45 ±0.16b** 
G1 – Normal Control, G2 – Toxic Control, G3 – Positive control, G4 – Treatment control (HAEBD 
200mg/kg), G5 – Treatment control (HAEBD 400mg/kg) 
All values are expressed as mean ± SEM for 6 animals in each group. 
**a – Values are significantly different from normal control (G1) at P < 0.001 
**b – Values are significantly different from toxic control (G2) at P < 0.001 
 
Table No.3. Effect of HAEBD on Serum Enzymes and Lipid Proteins 
 
G1 – Normal Control, G2 – Toxic Control, G3 – Positive control, G4 – Treatment control (HAEBD 
200mg/kg), G5 – Treatment control (HAEBD 400mg/kg) 
All values are expressed as mean ± SEM for 6 animals in each group. 
**a – Values are significantly different from normal control (G1) at P < 0.001 
**b – Values are significantly different from toxic control (G2) at P < 0.001 
 
Table No. 4   Effect of HAEBD on Solid Tumor Volume 
G1 – Normal Control, G2 – Treatment control (HAEBD 200mg/kg),  
G3 – Treatment control (HAEBD 400mg/kg) 
All values are expressed as mean ± SEM for 6 animals in each group. 
**a – Values are significantly different from cancer control (G1) at P < 0.01 
 
Treatment Cholesterol (mg/dl) 
TGL 
(mg /dl) 
AST 
(U/L) 
ALT 
(U/L) 
ALP 
(U/L) 
G1 110.15±1.66 125.5±2.40 38.50 ±1.25 33.40 ±1.26 126.20 ±1.20 
G2 145.65±2.45a** 210.20±4.25a** 88.10±1.85a** 58.20±1.75a** 225.30±3.35a** 
G3 116.55±0.92b** 162.85±3.15b** 56.20 ±1.68b** 42.30±1.63b** 160.40±1.45b** 
G4 134.52±1.50b** 172.95±3.22b** 71.80 ±2.25b** 50.20±1.88b** 185.30±1.68b** 
G5 128.60±1.42b** 166.30±2.78b** 64.40±1.91b** 46.40 ±1.70b** 178.52±1.55b** 
Treatment Dose 
Solid tumor Volume (ml) 
15th Day 20th Day 25th Day 30th Day 
G1 2 ml/kg Saline 2.65±0.16 3.60±0.16 4.70±0.20 5.80±0.16 
G2 200 mg/kg HAEBD 2.40±0.18 3.40±0.25 3.60±0.18 4.20±0.08**a 
G3 400 mg/kg HAEBD 2.68±0.20 3.32±0.18 3.40±0.15 4.10±0.05**a 
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HISTOPATHOLOGY 
G1-Section show structure of liver with sheets of hepatocytes seperated by sinusoids cartial vein & 
portal tract appear normal.G2- Section shows structure of liver presented hepatic congestion at 
sinusoids and the portal vessel, pericentre globular micro-steatosis, Kupffer cell proliferation, 
hepatocyte diffuse necrosis and mononuclear infiltrate.G3-Section show structure of liver presented   
mild hepatic congestion at sinusoids and the portal vessel, pericentre globular micro-steatosis, No 
Kupffer cell proliferation, mild hepatocyte diffuse necrosis and mononuclear infiltrate.G4- Section 
show structure of liver presented moderate hepatic congestion at sinusoids and the portal vessel, pe-
ricentre globular micro-steatosis, less Kupffer cell proliferation, moderate hepatocyte diffuse 
necrosis and mononuclear infiltrate.G5- Section show structure of liver presented moderate hepatic 
congestion at sinusoids and the portal vessel, pericentre globular micro-steatosis, less Kupffer cell 
proliferation, moderate hepatocyte diffuse necrosis and mononuclear infiltrate. 
 
DISCUSSION  
In the present study inoculation of DAL cells in mice produced an enormous increase in the tumour 
cell count which indicated that there is progression of cancer in mice. Treatment with Hydro 
alcoholic extract of Boerhaavia diffusa Linn inhibited the viable tumor cell count and increased the 
life span of the tumor bearing mice. The reliable criteria for judging the value of any anticancer 
drug are the prolongation of the life span of animals. Ascitic fluid is the direct nutritional source for 
tumor cells and rapid increase in ascitic fluid with tumor growth would be a means to meet the 
nutritional requirement of tumor cells.It may be concluded that the Hydro alcoholic extract of 
Boerhaavia diffusa Linn by decreasing the nutritional fluid volume and arresting the tumor growth 
increases the life span of DAL bearing mice. Thus, Hydro alcoholic extract of Boerhaavia diffusa 
Linn has antitumor activity against DAL bearing mice. 
Usually, in cancer chemotherapy the major problems that are being encountered are of myelo 
suppression and anemia. [34] The anemia encountered in tumor bearing mice its mainly due to 
 
G1 Normal G2 Toxic 
 
G3 standard 5-FU 
20mg/kg 
 
G4 HAEBD 200mg/kg 
 
G5 HAEBD 
400mg/kg 
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reduction in RBC or hemoglobin percentage, and this may occur either due to iron deficiency or due 
to hemolytic or myelopathic condition.[35] In tumor bearing mice, it was found that there was 
increase in WBC count, and decrease in Hb content and RBC count. Treatment with Hydro 
alcoholic extract of Boerhaavia diffusa Linn brought back the hemoglobin (Hb) content, RBC and 
WBC count more or less to normal levels. This clearly indicates that Hydro alcoholic extract of 
Boerhaavia diffusa Linn possess protective action on the hemopoietic system. 
In the present study, the biochemical examination of DLA inoculated animals showed marked 
changes indicating the toxic effect of the tumor. It was reported that the presence of tumor in the 
human body or in the experimental animals is known to affect may function of the liver. An 
abnormal lipid profile has been associated with cancer. Therefore liver enzymes level markedly 
increased in tumor bearing mice. The significantly elevated level of total cholesterol, TG, AST, 
ALT, ALP in serum of tumor inoculated animal indicated liver damage and loss of functional 
integrity of cell membrane. The significant reversal of these changes towards the normal by 
HAEBD treatments indicates a protective effect on liver enzymes. 
Presence of Boeravinone, Punarnavine, Punarnavoside, a phenolic glycoside phytosterols, 
triterpenes, flavonoids and glycosides shown to possess antimalignant & antitumour effects. 
Flavonoids show chemopreventive role in cancer through their effects on signal transduction in cell 
proliferation and angiogenesis. [36] 
CONCLUSION 
In the conclusion, The Hydro alcoholic extract of the plant Boerhaavia diffusa Linn possess 
significant anti-cancer activity against DLA and EAC induced in mice.  This herb was effective in 
inhibiting the tumor growth in ascitic and solid tumor models. The biochemical and 
Histopathological studies also supported its antitumor properties. However, further investigations 
required to isolate and identify the active constituents responsible for its anti-cancer activity. 
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activation by cytochrome P450 enzymes to acquire
carcinogenicity  results in the formation of oxidative free
radicals.9 Breast cancer and cancer related diseases have been
treated using surgery, chemotherapy, and radiation therapy, or
a combination of these. Despite these therapeutic options,
cancer remains associated with high mortality. Bioactive
compounds from plant origin have the potential to subside the
biochemical imbalances induced by various toxins associated
with free radicals. They provide protection without causing
any side effects and therefore, development of drugs from
plantproducts is desired. For that account natural antioxidants
from plant sources have been viewed as promising therapeutic
drugs.10 Boerhaavia diffusa one of the famous medicinal plant
belonging to the family Nyctaginacea known to have
medicinal properties It has a long history of uses by indigenous
and tribal people and in Ayurvedic or natural herbal
medicines.11Phytochemical investigation reveals that the plant
contains a large number of compoundssuch as flavonoids,
alkaloids, steroids, triterpenoids, lipids, lignins, carbohydrates,
proteins, and glycoproteins.12The plant widely used in
numerous disorder like nephritic syndrome,13 asthama,
jaundice, drosical swelling, worm infections, liver disorder,
heart disorder, urinary tract infections, cough, cold and
inflammation.14,15 Its also shown to have laxative, diuretic,
antiurethritis, anticonvulsant, antifibrinolytic, antinematodal
and antibacterial properties.16-20 Therefore the  object of
present study is to investigate the anticancer activity of
Hydroalcoholic extract of Boerhaavia diffusa against DMBA
induced breast cancer in experimental rats.
MATERIALS AND METHODS
Collection and authentification of Plant
Whole plant of Boerhaavia diffusa was collected from local
traders, Tamilnadu. The plant material was taxonomically
identified and authenticated by Dr.stephan, American college,
madurai and the voucher specimens (KMCP/GN/BD/0290)
were retained in the Institute for future reference. The whole
plant of Boerhaavia diffusa linn were dried in a shade, milled
into coarse powder by a mechanical grinder and stored in
closed vessel for further use.
Plant crude extract
About 500gm of air dried fine powder of Boerhaavia diffusa
were soaked in the extractor and macerated for 30 hrs with
petroleum ether. There it is reflexed successfully with
chloroform, after that it is extracted with alcohol and water by
continuous hot percolation method using soxhlet apparatus for
40hrs separately. Hydro alcoholic extracted was filtered and
concentrated in vacuum using rotary flask evaporator under
reduced pressure. Then the extract of Boerhaavia diffusa
concentrated to brownish residue stored in air tight container
Chemicals
DMBA were purchased from Sigma Chemicals Co. (St. Louis,
MO, USA). All the other Chemicals used in this study were of
analytical grade available commercially.
Technique for inducing tumour
Currently available mouse models for human breast cancer can
be categorized into three main groups: (a) xenograft models
(b) chemically induced, virally induced or ionizing
radiationinduced models; and (c) genetically engineered mice
(GEM) such as transgenics and knockouts 21 DMBA induced
Breast cancer model.
Animals
Female mice weighing (25g) were procured from animal
experimental laboratory, and used throughout the study. The
animals were housed in well ventilated large spacious
polypropylene cages and had 12±1 h light and dark cycle
throughout the experimental period. The animals received a
balanced diet of commercially available pellet rat feed and
water ad libitum. As per the standard practice the mice were
quarantined for 15 days before the commencement of the
experiment.22,23 The Guidelines for Breeding and Experiments
on Animals, 1998 defined by the Ministry of Social Justice and
Empowerment of India were followed and the protocol was
approved by the Institutional Animal Ethics Committee
(IAEC/KMCP/123/2014-2015).
Experimental design
30 female albino mice weighing 25 gms were segregated into 5
groups, each group comprising of 6 animals each .Group 1
served as the normal control. Group 2 served as the tumor
control, was treated with a single dose of 7.5 mg of DMBA
dissolved in sun flower oil (0.5 ml) given
subcutaneously.24,25Group 1 and 2 receives normal diet and
Water. Group 3 served as the positive control, was treated with
injection Vinblastine at0.5 mg/kg body weight, Intra
peritoneally.26Group 4 served as the treatment control, which
was treated with   Hydro alcoholic extract of
Boerhaaviadiffusa (200 mg/kg body weight) orally.Group 5
served as treatment control which was treated with Hydro
alcoholic extract of Boerhaaviadiffusa (400 mg/kg body
weight) orally.27
The experimental mice were regularly monitored for food and
water consumption, the apparent signs of toxicity, weight loss,
or mortality. Forty-five days after DMBA administration, all
the experimental animals were sacrificed. At the end of the
experimental period, all the mice were alive, starved overnight
anesthetized with diethyl ether and sacrificed by euthanasia
method. The breast tumor was surgically dissected out, tumor
volumes (mm in diameter) of both cancer controls, as well as
the experimental groups were measured, and total body weight
(g) also recorded.
Breast were dissected out, cut into small pieces with a heavy-
duty blade and washed with ice-cold 0.9% NaCl solution.
One hundred milligrams of the tissues were homogenized in
0.1M Tris–HCl buffer (pH 7.4). The homogenate was used for
estimation of biochemical parameters.28 such as SOD radical
scavenging activity, Inhibition of LPx formation, GPx activity,
Group 1- Normal control Received vehicle
Group 2 - Tumor control Received subcutaneous injection of DMBA at 7.5mg/kg b.w. once a week for four consecutive weeks 33,34
Group 3 - Standard Received subcutaneous injection of DMBA at 7.5mg/kg b.w. once a week for four consecutive weeks and  injection vinblastin at0.5 mg/kg body weight intra peritoneally once a week for 45 days35
Group 4 Treatment control Received subcutaneous injection of DMBA at 7.5mg/kg b.w. once a week for four consecutive weeks and 200mg/kg b.w.hydroalcoholic extract of Boerhaaviadiffusa orally daily for 45 days.
Group 5 Treatment control Received subcutaneous injection of DMBA at 7.5mg/kg b.w. once a week for four consecutive weeks and  400mg/kg b.w.hydroalcoholic extract of Boerhaaviadiffusa orally daily for 45 days.
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CAT activity. Derived parameters such as Body weight,
Tumour Volume, Percentage reduction of tumour volume29
were also determined. Tumour volume was measured weekly.
Tumor volume was calculated using the formula. (cc) = 4/3 πr3.
On 45th day, mice were sacrificed and tumors were removed
from the animals and weighed. The tumor incidence and its
percentage reduction were also recorded at the termination of
the experiment.30, 31
Evaluation of Biochemical Parameters
The following biochemical measurements were carried out in
the rat breast tissues. Effects of HABD on activities of
superoxidedismutase, catalase, glutathione peroxidase and
lipidperoxide were estimated in the breasts of treated, as well
as untreated, rats.
Assay of Super oxide dismutase radical scavenging activity
SOD activity was assessed by the Nitroblue tetrazolium(NBT)
reduction method. Approximately, a known concentration of
tissue supernatant was addedto a reaction mixture containing
0.1mMEDTA, 0.12mM riboflavin and 0.6M phosphate
buffer(pH 7.8) in a final volume of 3 ml. The optical
densitywas measured at 560 nm.32, 33
Assay of of lipid Peroxidase activity:
Induction by Fe3+/ascorbate system: the reaction
mixturecontaining rat Breast homogenate(0.1 ml, 50%, w/v) in
Tris–HCl (30 mM), ferrous ammoniumsulfate (0.16 mM),
ascorbic acid (0.06 mM)and thereaction mixture was incubated
for 1 h at 37 ◦C, and theresulting thiobarbituric reacting
substances (TBARS)were measured.34,35 Briefly, a 0.4 ml
aliquot of thereaction mixture was treated with sodium dodecyl
sulfate(0.2 ml, 8%), thiobarbituric acid (1.5 ml, 0.8%)
andacetic acid (1.5 ml, pH 3.5), made up to a total volume
of4ml by adding distilled water, and then kept in a waterbath at
95 ◦C for 1 h. After cooling, 1ml of distilledwater and 5ml of
n-butanol/pyridine (15:1, v/v) wereadded. The organic layer
was separated after shakingand centrifugation. LPx activity
was measured in termsof thiobarbituric acid formation and the
color intensitymeasured spectrophotometrically at 530 nm.36
Assay of Glutathione peroxidase activity
The activity of glutathione peroxidase (GPx) was assayed by
the method of Rotruck et al.37 The reaction mixture containing
0.2 ml of EDTA (0.8 mM, pH 7.0), 0.4 ml of phosphate buffer
(10 mM), and 0.2 ml of tissue homogenate was incubated with
0.1 M of H2O2 and 0.2 ml of glutathione for 10 min.
Oxidation of glutathione by the enzyme was measured
spectrophotometrically at 420 nm. The activity of GPx was
expressed as lmol glutathione oxidized/min/mg protein.
Assay of Catalase activity
Breast catalase activities were determined
spectrophotometrically. The reaction mixture(2 ml) contained
1.95 ml of 10mM H2O2 in 60Mmphosphate buffer (pH 7.0).
The reaction was initiated byadding 0.5 ml supernatant to it,
and the absorbance wastaken for 3 min at 240 nm. Phosphate
buffer (60 mM,pH 7.0) was used as a reference. The extinction
coefficientof 0.04mM−1 cm−1 was used to determine
thespecific activity of CAT. The data is expressed
asmolH2O2consumed/ (min (mg protein)).38
Histopathological Examination
Mammary tissues were fixed in 10% buffered formalin,
embedded in paraffin using a conventional automated
system.Tissue fragments were fixed in formalin and 5µm
section was obtained from the paraffin block and stained with
haematoxylin and eosin for histologic examination. Breast
tissue pathology and histologic type were evaluated by
application of the same pathologic criteria used for the
classification of human tumours. Serial paraffin sections of
each tissue image were captured by light microscopy.
Statistical analysis
Statistical comparisons between control and treatmentmean
values of two parameters were analyzed usingthe Students t-
test. Multiple comparisons were doneusing ANOVA. The
differences were statistically significantat P < 0.01; P < 0.05.
RESULTS
Anti-tumor activity
Table 1 illustrates the body weight, protection percentage&
tumour volume in DMBA induced Breast cancer in mice. The
body weight was significantly decreased in tumor-induced
animals versus control (P\0.01). Tumor promotional stage is a
reversible stage in themultistage carcinogenesis; therefore, it is
the most suitablestage for the anti-carcinogenic agent to
prevent, reverse, or slow down the process of carcinogenesis.
Animals in the breast cancer control Group 2 attaineda
promotional stage tumor after 45 days. At the end of the
experiment in non-treated mice, DMBA-inducedbreast tumors
increased to the maximum in terms of tumor incidence
(100%), tumor multiplicity, compared to the normal control
rats. A Significant reduction in Tumor volume was observed in
G3 achieved (37.85%) of tumor reduction after 45 days
treatment wheras G4HAEBD (200 mg/kg, orally) treated
animals achieved a significant decrease (24%) in the mammary
tumor size with change in the total body weight of the animals
G2. However, HAEBD at a dose of 400mg/kg treated
groupachieved 31.70% breast tumor reduction after 45 days as
shown in Table No 1.
Table 1 Effect of HAEBD on Anti-Tumour activity in
experimental Breast tissue cancer in Mice
Group
Body
Weight(mg) TumourVolume(mm)
Reduction of
Tumour
Percentage (%)
G1 30.5±1.40 - -
G2 48.0±1.65**a 46.78 ± 1.88**a -
G3 36.0±1.44**b 9.07 ±1.54**b 37.84**b
G4 40.5±1.50**b 35.54±0.86**b 24.02**b
G5 38.0±1.48**b 31.95±0.94**b 31.70**b
Note: G1 – Normal Control, G2 – Toxic Control, G3 – Positive control, G4 – Treatment
(HAEBD 200mg/kg), G5 – Treatment (HAEBD 400mg/kg)
Values are expressed as Mean ± SEM.Values are found out by
using one way ANOVA followed by NewmannKeuls multiple
range tests.
*a – values are significantly different from Normal control at
p< 0.001.
*b – values are significantly different from Toxic control (G2)
at p< 0.001.
Antioxidant activity
Free radical scavengers such as superoxide dismutase (SOD),
catalase (CAT), glutathione peroxidase (GPx) and lipid
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peroxide (LPx) levels were recorded (Tables 2). Results in
Table 2 showed a significant reduction in the activities of
antioxidant enzymes like SOD, CAT, GPX in DMBA induced
Breast cancer in mice whereas the values were significantly
elevated after treatment with HAEBD (200mg/kg &
400mg/kg). Mice treated with standard drug vinblastine G3
showed similar changes.The GPx level was equally increased
in vinblastin and both doses of Hydroalcoholic extract of
Boerhaavia diffusa therapy treated groups versus the cancer
control rats. The level of LPx rises in DMBA induced breast
cancer animals which is much influenced by the chemical
carcinogen in the control animals, whereas significant
reduction was observed in the mice treated withvinblastin and
both doses of Hydroalcoholic extract of Boerhaavia diffusa.
Table 2 Effect of HAEBD on enzymatic antioxidants in the
breast tissue of control and experimental animals
GROUP
SOD
(units/mg
protein)
CAT (μmol
H2O2
consumed/
[min(mg
protein)] )
GPx (μg GSH
utilized/[min(mg
protein)])
LPO(n mol MDA
found/[min/(mg
protein)])
G1 3.75±0.08 45.85±0.47 3.83±0.10 0.75±0.02
G2 1.53±0.07**a 14.51±1.08**a 2.09±0.03**a 2.16±0.07**a
G3 3.20±0.06**b 37.91±0.78**b 3.55±0.07**b 1.11±0.04**b
G4 2.80±0.07**b 27.71±0.65**b 3.06±0.04**b 1.46±0.04**b
G5 3.14±0.06**b 34.05±0.72**b 3.22±0.02**b 1.35±0.02**b
Note: G1 – Normal Control, G2 – Toxic Control, G3 – Positive control, G4 –
Treatment (HAEBD 200mg/kg), G5 – Treatment (HAEBD 400mg/kg)
Values are expressed as Mean ± SEM.Values are found out by
using one way ANOVA followed by NewmannKeuls multiple
range tests.
*a – values are significantly different from Normal control at
p< 0.001.
Histopathological examination
Histopathology revealed that in G2, the vast majority of the
lesions that developed in the mice mammary glands were
mostly carcinomas exhibited an identical nuclear pattern with
predominant epithelial cell & fibrous tissue surrounding the
mammary ducts.It also exhibit a mixed structural pattern with
invasion of neighbouring tissues and intense stromal
desmoplastic reaction. In vivo, the treated groups with
vinblastin and both doses of Hydroalcoholic extract of
Boerhaavia diffusa showed tubules formation & reduce intra-
tumor vascularization (Fig.No.) Treatment with hydroalcoholic
extract of Boerhaavia diffusa showed reduced proliferation
and replacement of normal ductular and alveolar structure of
mammary tissue.
DISCUSSION
Breast cancer is a complex and multifactorial disease. Since
the rat mammary gland shows a high susceptibility to
developing neoplasms which closely mimic human breast
cancer, they have been selected in comparison to other animal
models39 Treatment of female mice with DMBA induces the
development of hyperplastic lesions like alveolar/ductal
hyperplasia, benign tumors such as adenoma, malignant
neoplasms like adenocarcinomas similar to those seen in
humans.40-42 However, there was a severe body weight loss
observed in the toxic control group, versus the control rats.
Tumour volume was also increased in toxic group. In the
present investigation, vinblastin and both doses of
Hydroalcoholic extract of Boerhaavia diffusa treatment
reduced the breast tumor by an average of 37, 24 and 32 %. As
a result, the body weight had also slightly increased, the tumor
volume decreased, and the percentage of tumor inhibition was
statistically significant (P < 0.05).
Toxic manifestation of DMBA is associated with its oxidative
metabolism leading to the formation of reactive metabolites
(epoxides and quinines) capable of generating free radicals.
Metabolism of DMBA by the mixed function oxidases system
often results in the formation of oxy radicals O2 •-, H2O2,
and •OH, which bind covalently to nucleophilic sites on
cellular macromolecules there by eliciting cancerous
responses.43 The generation of ROS and the peroxidation of
membrane lipids are well associated with the initiation of
carcinogenesis affecting the normal biochemical process,
which further leads to the reduction of body weight.44 Taking
NORMAL CONTROL(G1)
TREATMENT HAEBD(200mg/kg (G4)
DMBA INDUCED  (G2) Toxic
TREATMENT HAEBD(G5)(400mg/kg)
STD CONTROL (G3)Vinblastine
.
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lead from this, ROS and intracellular Ca2+ levels were
analyzed, and an increase in both ROS and Ca2+ generation
was observed in DMBA treated animals in comparison to
control animals. This excessive ROS signal can cause Ca2+
overload, mitochondrial depolarization, and DNA damage
leading to apoptotic cell death45 which was also observed in
this investigation. Increasing evidence indicates that
intracellular Ca2+ modulates ROS homeostasis that might
influence redox balance and vice versa which, in turn, would
determine cancer progression.46,47
Oxidative damage in a cell or tissue occurs when the
concentration of reactive oxygen species (O2, H2O2 and OH)
generated exceeds the antioxidant capability of the cells.48 Free
radical scavenging enzymes like SOD and catalase protect the
biological system from oxidative stress. The present study
revealed that SOD activity was decreased in the cancer-bearing
animal, which may be due to altered antioxidant status caused
by carcinogenesis. SOD acts as an anti-carcinogen inhibitor
during initiation and promotion/transformation stages of
carcinogenesis. SOD is a major intracellular enzyme, which
protects against oxygen free radicals by catalyzing the
dismutation of superoxide free radical and anions to H2O2 and
oxygen. Decrease in CAT activity was measured in patients
with breast cancer and benign breast disease conditions.48
Catalase is an peroxisomalhaem protein which is present in
most cells and which catalyses the decomposition of H2O2 to
water and oxygen. SOD accelerates the conversion of
superoxide radical (O2-) to hydrogen peroxide while CAT
catalyses the removal of hydrogen peroxide formed during the
reaction catalysed by SOD. This is in accordance with our
results, which indicate that decreased CAT in cancer-bearing
animals may be due to the utilization of antioxidant enzymes
in the removal of H2O2 released Thus, SOD and CAT act as
mutually supportive antioxidative enzymes, which provide
protective defence against reactive oxygen species. 49
GPx is an important defense enzyme against oxidative damage
and this in turn requires glutathione as a cofactor. Decreased
GPx activity was also observed in cancerous conditions.50
Glutathione is one of the essential compounds for maintaining
cell integrity because of its reducing properties and
participation in the cell metabolism. GPx catalyses the
oxidation of GSH to GSSG at the expense of H2O2.51 GPx is
an equally important antioxidant, which reacts with H2O2,
thus preventing intracellular damage caused by the same. 52-54
The present findings include elevated ROS production with
use of the chemical mutagen (DMBA), and the decreased level
of antioxidants in breast cancer-bearing animals indicate
oxidative stress, which may be the cause of lipid peroxidation-
induced DNA damage, mutation and elevated level of LPO
also play an important role for higher pathology of breast
cancer in animals. It is regarded as one of the basic mechanism
of cellular damage caused by free radicals. Increased lipid
peroxidation alters membrane fluidity and membrane potential
and there by leading to loss of cellular function and cell
death.55 Malondialdehyde is the major end product of LPO and
readily reacts with DNA to form DNA-MDA adduct.
However, the potential reduction of lipid peroxides was
recorded in the vinblastin and both doses of Hydroalcoholic
extract of Boerhaavia diffusa treated group and it was near to
the normal in the control group. The biochemical alterations
observed in cancer bearing animals in the present study may be
due to the induction of LPO and reduction of antioxidant level
following carcinogen administration. However, administration
of vinblastin and Hydroalcoholic extract of Boerhaavia diffusa
significantly reversed the alteration to near normal level in
cancer-bearing animals. It did not promote tumor growth and
metastasis by the incidence of lesser production of ROS
formation due to the antioxidant enzymes such as SOD, CAT
and GPx that can directly counter the oxidant attack and may
protect cells against LPO and DNA damage.
From the results it can be inferred that Hydroalcoholic extract
of Boerhaavia diffusa positively modulated the antioxidant
activity by quenching and detoxifying the free radicals induced
by DMBA. Histopathopathological report also support the
studies The attenuation of DMBA induced oxidative stress by
the plant extract could be attributed to the antioxidants activity
of flavonoids, terpenoids, phenolic compounds, alkaloids such
as punarnovine, punarnoviside, boerhavin, boerhavic acid
ursolic acid  present in the B.diffusa plant, which is known to
quench the free radicals by maintaining antioxidants levels.56-59
References
1. Gonenc A, Ozkan Y, Torun M, Simsek B. Plasma
malondialdehyde (MDA) levels in breast and lung
cancer patients. J Clin Pharm Ther. 2001; 26:141-4
2. Aruoma OI (1994) Nutrition and health aspects of free
radicals and antioxidants. Food Chemistry and
Toxicology 32(7): 671-685.
3. Cerutti PA (1985) Prooxidant states and tumor
promotion. Science 227(4685): 375–381.
4. Gilbert DL, Colton CA (1999) Reactive Oxygen
Species in Biological Systems: An Interdisciplinary
Approach. New York, NY: Kluwer Academic/Plenum
Publishers.
5. Jagetia GC, Rao SK (2006) Evaluation of the
antineoplastic activity of guduchi (Tinospora cordifolia)
in Ehrlich ascites carcinoma bearing mice. Biol Pharm
Bull 29:460-466.
6. Manoharan S, Vasantha Selvan M. Chemopreventive
potential of geraniol in 7, 12-dimethylbenz (a)
anthracene (DMBA) induced skin carcinogenesis in
Swiss albino mice. J Environ Biol. 2012; 33:255-60.
7. Miyata M, Furukawa M, Takahashi K, Gonzales FJ,
Yamazoe Y (2001) Mechanism of 7,12-
dimethylbenz(a)anthracene-induced immunotoxicity:
role of metabolic activation at the target organ. Jpn J
Pharmacol 86:302-309
8. Wijnhoven SW, Kool HJ, Mullenders LHF, Slater R,
Van Zeeland AA, Vrieling H (2001) DMBA-induced
toxic and mutagenic response vary dramatically
between NER-deficient Xpa, Xpc and Csb mice.
Carcinogenesis 22:1099-1106
9. Conney AH (1982) Induction of microsomal enzymes
by foreign chemicals and carcinogenesis by polycyclic
aromatic hydrocarbons, Clowes GHA memorial lecture.
Cancer Res 4:4875-4917
10. Vijayavel K, Anbuselvam C, and Balasubramanian MP
(2006) Free radical scavenging activity of the marine
mangrove Rhizophora apiculata bark extract with
reference to naphthalene induced mitochondrial
dysfunction. Chemico-Biological Interactions 163(1-2):
170-175.
11. Dhar, M.L., Dhar, M.M., Dhawan, B.N., Mehrotra,
B.N., and Ray, C. 1968. Screening of Indian plants for
Protective Effect of Hydroalcoholic Extract of Boerhaavia Diffusa Against Dmba Induced Breast Cancer in Mice
2346
biological activity: Part I. Indian Journal of
Experimental Biology 6:232-247.
12. Surange S.R., Pendse G.S. J. Res. Indian Med. 1972; 7:
1.
13. Singh RH and Udupa KN Studies on the Indian
indigenous drug punarnava (Boerhaavia diffusa). Part
IV: Preliminarycontrolled clinical trial in nephritic
syndrome. Journal of Research in Indian Medicine 7:
(1972), 28-33
14. Lad, V... The complete Book of Ayurvedic Home
Remedies, Three Rivers Press: New York. 1999.
15. Guhabakshi, D.N, Sensarma, P., and Pal, D.C., A
lexicon of Medicinal Plants of India, Vol. I, Naya
Prakash, Calcutta, India. 1999.
16. Chopra RN and Nayar S. Glossary of Indian Medicinal
Plants. Publications New Delhi: C.S.I.R.1956.
17. Adesina SK. Anticonvulsant properties of the roots of
Boerhaavia diffusa. Quarterly Journal of Crude Drug
Research.1979; 17: 84-86.
18. Olukoya DK, Tdika N, and Odugbemi T. Antibacterial
activity of some medicinal plants from Nigeria. Journal
of Ethnopharmacology. 1993; 39: 69-72.
19. Vijayalakshmi K, Misra SD and Prasad SK.
Nematicidal properties of some indigenous plant
materials against second stage juveniles of Meloidogyne
incognita (Kofoid and White) Chitwood. Indian J. of
Entomology. 1979;41(4):326-331.
20. Jain GG and Khanna NM. Punarnavoside: A new
antifibrinolytic agent from Boerhaavia diffusa Linn.
Indian Journal of Chemistry. 1989; 28(B): 163-166.
21. Marklund, S., Marklund, G., Involvement of superoxide
anion radical in the autoxidation of pyrogallol and a
convenient assay for superoxide dismutase. Eur. J.
Biochem, 1974,47: 469-474.
22. Benakanakere, I., Besch-Williford, C., Carroll, C.,E.,
Hyder, S.,M., Synthetic progestins differentially
promote or prevent 7,12-DMBAinduced mammary
tumors in Sprague-Dawley rats. Cancer Prev Res, 2010,
3:1157-67.
23. Radhakrishnan Padmavathi, Palaniyandi Senthilnathan,
Dechen Chodon, Dhanapal Sakthisekaran, Therapeutic
effect of paclitaxel and propolis on lipid peroxidation
and antioxidant system in 7,12 dimethyl
benz(a)anthracene-induced breast cancer in female
Sprague Dawley rats, Life Sciences, 2006,78: 2820 -
2825.
24. Sinha, A., K., Colorimetric assay of catalase. Anal.
Biochem, 1972, 47:389-394.
25. Rotruck, J., T., Pope, A., L., Ganther, H.,E., Swanson,
A.,B., Hafeman, D.,G., Hoekstra, W.,G., Selenium:
biochemical role as a component of glutathione
peroxidase. Science, 1973, 179: 588-590
26. Ray.G., Batra,S., Shukla,N., K., Deo,S., Raina,V.,
Ashok,S., Husain, S.,A., Lipid        peroxidation,   free
radical production and antioxidant status in breast
cancer, Breast   Cancer Res. Treat,2000, 59 163-170.
27. G.Nalinia*, N.Chidambaranathana, R.Meerab,R.Thaila.a
Protective effect of hydro alcoholic extract of Clitoria
ternatea against dimethyl nitrosamine induced liver
cirrhosis in rats. The Journal of Physiology and Health.
Photon 110 (2014) 247-254.
28. Lowe, S., W., Lin, A.,W., Apoptosis in cancer.
Carcinogenesis, 2000; 21: 485-95.
29. Balasenthil, S., Nagini, S., Inhibition of 7,12-
dimethylbenz[a]anthracene- induced hamster buccal
pouch carcinogenesis by Sallylcysteine. Oral Oncology,
2000; 36:382–6.
30. 30) Fisher, B., Costantino, J., P., Wickerham, D., L.,
Tamoxifen for prevention of breast cancer: report of the
National Surgical Adjuvant Breast and Bowel Project P-
1 Study. J Natl Cancer Inst,1998, 90, 1371-1388.
31. Constantinou, A.,I., Rossi, H., Lantvit, D., Soy protein
isolate prevents chemically induced rat mammary
tumors. Pharm Biol, 2002, 40, 24-34.
32. Constantinou, A.,I., Husband,A., Phenoxodiol (2H-1-
benzopyran-7- 1,3-(4-hydroxyphenyl), a novel
isoflavone derivative, inhibits DNA topoisomerase II by
stabilizingthe cleavable complete. Anticancer Res,
2002, 22, 2581-2585.
33. Bayoumy, K., Evaluation of chemopreventative agents
against breast cancer and proposed strategies for future
clinical intervention trials. Carcinogenesis, 1994, 15:
2395- 2420.
34. Apurba Sarker Apu., Mahmuda Sultana Liza.,
Jamaluddin, A.T.M., Amran Howlader., Repon Kumar
Saha. Phytochemical screening and invitro bioactivities
of the extracts of aerial part of Boerhaavia diffusa Linn.
Asian Pacific Journal of Tropical Biomedicine. 2012,
2(9):673-678.
35. Mahesh, A.R., Harish Kumar., Ranganath, M.K., and
Raviraj Anand Devkar. Detail Study on Boerrhaavia
diffusaPlant for its Medicinal Important a Review.
Research Journal of Pharmaceutical science., 2012,
1(1): 28-36
36. Katoh, R., Zhou, H., Wang, P.,Y., Promoting effects of
milk on the development of 7, 12-dimethylbenz (a)
anthracene (DMBA)-induced mammary tumors in rats.
Acta Histochem Cytochem, 2007, 40 (2):61-7.
37. Ellman GL (1959) Tissue sulfhydryl groups. Arch
Biochem Biophys 82:70–77.
38. Hall, P.,A., Levison, D.,A., Woods, A.,L., Yu, C.,C.,
Kellock, D.,B., Watkins, J.,A., Proliferating cell nuclear
antigen (PCNA) immunolocalization in paraffin
sections: an index of cell  proliferation with evidence of
deregulated expression in some neoplasms. J Pathol,
1990; 162(4): 285-94.
39. Flohe,L., Otting,F., Superoxide dismutase assays. Meth.
Enzymol,1984,105: 93.
40. Fischer SM, Conti CJ, Locniskar M, Belury MA,
Maldve RE, Lee ML, Leyton J, Slaga TJ, Bechtel DH
(1992) The EVect of dietary fat on the rapid
development of mammary tumors induced by 7, 12-
dimethylbenz(a)anthracene in SENCAR mice. Cancer
Res 52:662-666
41. Qing WG, Conti CJ, LaBate M, Johnston D, Slaga TJ,
MacLeod MC (1997) Induction of mammary cancer and
lymphoma by multiple, low oral doses of 7, 12-
dimethylbenz[a]anthracene in sencar mice.
Carcinogenesis 18(3):553-559
42. Cardiv RD, Wellings SR (1999) The comparative
pathology of human and mouse mammary glands. J
Mammary Gland Biol Neoplasia 4:105-122
43. Giri U, Sharma SD, Abdulla M, Athar M (1995)
Evidence that in situ generated reactive oxygen species
act as a potent stage I tumor promoter in mouse skin.
Biochem Biophys Res Commun 209(2):698-705.
International Journal of Current Advanced Research Vol 6, Issue 03, pp 2339-2344, March 2017
2347
44. Davis L, Kuttan G (2001) Effect of Withania somnifera
on DMBA induced carcinogenesis. J Ethnopharmacol
75:165–168.
45. Yan Y, Wei CL, Zhang WR, Cheng HP, Liu J. Cross-
talk between calcium and reactive oxygen species
signaling. Acta Pharmacol Sin. 2006;27(7):821-6.
46. Joseph P, Muchnok TK, Klishis ML, Roberts JR,
Antonini JM, Whong WZ, et al. Cadmium-induced cell
transformation and tumorigenesis are associated with
transcriptional activation of c-fos, c-jun, and c-myc
proto-oncogenes: role of cellular calcium and reactive
oxygen species. Toxicol Sci. 2001;61:295-303.
47. Kesba HH, El-Belagi HS. Biochemical changes grape
rootstocksresulted from humic acid treatments in
relation to nematode infection. Asian Pac J Trop
Biomed 2012; 2(4):287-93.
48. 48) Gonenc A, Erten D, Aslan S, Akyncy M, Sximsxek
B, and Torun M (2006) Lipid peroxidation and
antioxidant status in blood and tissue of malignant
breast tumour and benign breast disease. Cell Biology
International 30(4): 376-380.
49. Weydert CJ, Waugh TA, Ritchie JM, Iyer KS, Smith
JL, Li L, Spitz DR, Oberley LW (2006) Overexpression
of manganese or copper-zinc superoxide dismutase
inhibits breast cancer growth. Free Radic Biol Med
41:226-237
50. Bewick M, CoutieW, Tudhope GR (1987) Superoxide
dismutase, glutathione peroxidase and catalase in the
red cells of patients with malignant lymphoma. Br J
Haematol 65:347-350. doi: 10.1111/j.1365-
2141.1987.tb06866.x
51. Cerutti P, Ghosh R, Oya Y, Amstad P (1994) The role
of cellular antioxidant defence in oxidant
carcinogenesis. Environ Health Perspect 102(10):123-
129. doi:10.2307/3432228
52. Gupta M, Mazumder UK, Kumar RS, Sivakumar T, and
Vamsi ML (2004) Antitumour activity and antioxidant
status of Caesalpina Bonducella against Ehrlich ascites
carcinoma in swiss albino mice. Journal of
Pharmacological Sciences 94(2): 177-184.
53. Weydert CJ, Waugh TA, Ritchie JM, Iyer KS, Smith
JL, Li L, et al. (2006) Over expression of manganese or
copper-zinc superoxide dismutase inhibits breast cancer
growth. Free Radical Biology and Medicine 41(2):226-
37.
54. Harbone,J.,B., Phytochemicalmethods, Champion and
Hall publications, London, 1984, 2nd edition:84-196.
55. Kolanjiappan K, Manoharan S, Kayalvizhi M,
Measurement of erythrocyte lipids, lipid peroxidation
antioxidants and osmotic fragility in cervical cancer
patients, Clinica Chimica ACTA, 326: 143-149, (2002).
56. Edeoga, H.,O., Okwu,D., E., Mbaebie, B., O .,
Phytochemical constituents of some Nigerian medicinal
plants. Afr.J. Biotechnol, 2005, 4:685-688.
57. Okwu,D.,E., Phytochemicals, minerals content of two
Nigeria plants. Int.J. Mol. Med. Adv.Science.,
2005,1:375-381.
58. Kokate,C.,K., Purohit,A.,P., Gokhale,S.,B.,
Pharmacognosy. NiraliPrakasan, Pune, India, 2005,
38:537-538.
59. Misra, A.,N.,Thiwari, H.,P., Constituents of roots of
Boerhaaviadiffusa. Phytochemistry, 1971, 10:3318-
3319.
 
ACUTE, SUB-CHRONIC AND CHRONIC TOXICITY STUDIES OF HYDRO ALCHOLIC
EXTRACT OF BOERRHAVIA DIFFUSA O
Nalini G1*., Ajithadasaruna1K.M. College of pharmacy, Uthangudi, M2Joint Directorate of Medical Education, Kilpauk, Chennai. 600010 
A R T I C L E  I N F O                              
Despite Boerhaavia diffusa has many ethnomedicinal benefits, very few studies have 
described the potential toxicity. The aim of the present study was to evaluate the 
toxicity studies of hydroalcoholic extract of Boerhaavia diffusa. The acute, subch
chronic toxicity of hydroalcoholic extract of Boerhaavia diffusa was evaluated in 
experimental animals. For the acute toxicity study, a single dose administration of 2000 
mg/kg was given by oral
mor
administered orally at doses of 50, 100, and 200 & 400 mg/kg per day for 20 days. In 
addition to toxicity signs & m
toxicity studies include administration of HAEBD 
600mg/kg for the three groups except the normal control. Change in body weight, 
heamatological parameters & blood chemical values were determined. There were n
subchronic, chronic toxicity observed and our results indicate that this extract could be 
devoid of any toxic risk.
 
 
 
 
INTRODUCTION 
 
 
 
 
 Natural plants have been used to prevent and to treat various 
diseases for thousands of years. In recent times, focus on plant 
research has increased all over the world and a large body of 
evidence has collected to show immense potential of medicinal 
plants used in various traditional systems. Herbal drugs or 
medicinal plants, their extracts and their isolated compounds 
have demonstrated spectrum of biological activities. 
plant, Boerhaavia diffusa linn, invites attention of the 
researchers worldwide for its pharmacological activities.
root, leaves, aerial parts or the whole plant of B. diffusa 
been employed for the treatment of various disorders in the 
Ayurvedic herbal medicine. The roots are reputed to be 
diuretic and laxative and are given for the treatment of 
anasarca, ascites and jaundice.1 Traditional use of any plant for 
medicinal purposes, guarantees the safety of plant & concern 
about the potential toxic effects resulting from the short
and long-term use of such plants. Therefore, evaluating the 
toxicological effects of any medicinal plant extract intended to 
be used in animals is a crucial part of its assessment for 
potential toxic effects. The present study aimed to assess the 
adverse effects related to different doses and to evaluate the 
safety profile of the Hydroalcoholic extract from the aerial 
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-gavage to swiss albino mice. The mice were observed
tality and toxicity signs for 14 days. In the subchronic toxicity study the rats were 
ortality, biochemical analysis 
for 90 days 
 
One such 
 The 
have 
-term 
 
parts or whole plants of Boerhaavia diffusa
determining acute, sub-chronic and chronic toxicity studies. 
 
Plant 
 
Boerhaavia diffusa is a perennial creeping weed, commonly 
known as 'Punarnava' in the Indian system of medicine, found 
throughout the waste land of India.  
 
Plant Extraction 
 200g of dried fine powder of Boerhaavia diffusa 
parts were successively extracted using Soxhlet apparatus by 
hot continuous percolation method. The powdered material 
were soaked in the extractor and macerated for 30h with 
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petroleum ether. There it was reflexed successfully with 
petroleum ether, chloroform, after that it was extracted with 
alcohol and water by continuous hot percolation method using 
Soxhlet apparatus for 40h separately. The hydro-alcoholic 
extract was filtered with Whatmann filter paper No. 40 and 
concentrated under vacuum using rotary flask evaporator 
under reduced pressure. 
 
Preparation of stock solution: 
 
Stock solutions of the hydroalcoholic extract of Boerhaavia 
diffusa (200 mg/mL) were prepared by weighing the powder 
and dissolving in 10% Carboxy Methyl cellulose (CMC). The 
solution was divided to aliquots and kept at −10°C, until used. 
 
Experimental Animals 
 
The experiments are carried out after getting the Institutional 
Animal Ethics Committee approval (App. No. G. Nalini / 
TNMGRMU /Ph.D / IAEC / KMCP /112 / 2014-15). The 
animals were housed at central animal house, K.M. College of 
Pharmacy, Madurai, Tamil Nadu, India under standard 
conditions of temperature (27±2◦C), relative humidity (44–
56%) and light and dark cycles of 10 and 14h respectively, for 
1 week before and during the experiments. Animals were 
provided with standard diet (Hindustan Ltd. Bangalore, India), 
and water ad libitum.  The food is withdrawn at 18–24h before 
the start of the experiment. All the experiments were 
performed in the morning according to the ethical guidelines 
for the care of the laboratory animals.2 
 
MATERIALS & METHODS 
 
Acute, sub-chronic & chronic toxicity studies of 
hydroalcoholic extract of Boerhaavia diffusa were evaluated 
on experimental animals. Body weight, organ weight 
determinations were carried out. Signs of behavior, mortality 
were observed. Heamatological parameter & biochemical 
examination were estimated. 
 
Acute toxicity study 
 
Healthy albino mice (25-30 g) were used in the acute toxicity 
study. The evaluation of acute toxicity study was carried out as 
per Organization of Economic Co-operation and Development 
(OECD) guidelines 423 (Acute toxic class method). The mice 
were fasted overnight and provided only water, after which the 
hydro-alcoholic extract of Boerhaavia diffusa Linn was 
administered by gastric intubation orally at a dose of 50mg/kg 
b.w. After this single administration, the animals were 
observed for signs of possible toxicity every 30 minutes after 
dosing for the first 24h and thereafter daily for a total of 14 
days.  All animals were weighed daily and monitored for any 
signs of toxicity and for mortality for up to 14 days. Additional 
signs of toxicity such as changes in body weight, skin and fur, 
eyes and mucus membranes, respiratory system, circulatory 
system, ANS and CNS, somatomotor activity and behaviour 
pattern were also recorded. If mortality observed in 2 to 3 
animals in 14 days, then the dose was said to be toxic dose. 
But if mortality in one animal was observed, then the same 
dose was repeated again for confirmation. However, if 
mortality was not observed, the procedure was repeated for 
further higher doses such as 300 and 2,000mg/kg b.w Toxic 
symptoms are observed for 72 hrs including behavioral 
changes, locomotion, convulsions and mortality.3, 4 
 
 
Subchronic toxicity study in rats 
A subchronic repeated dose (20days) study in rats was 
conducted according to the OECD testing guidelines. Rats of 
both sexes were randomly distributed to five groups of six 
animals each. HAEBD was orally administered daily for 20 
days in single doses of 50 mg/kg (group I), 100 mg/kg (group 
II), 200 mg/kg (group III), 400mg/kg.5-7 The control rats 
(group IV) received only vehicle 0.5 ml of Tween 80. The 
body weight was recorded every 5 days. Along with food and 
water consumption, signs of toxicity and mortality were also 
recorded daily throughout the study period. Other signs of 
toxicity such as changes in body weight, skin and fur, eyes and 
mucus membranes, respiratory system, circulatory system, 
ANS and CNS, somatomotor activity and behaviour pattern 
were observed systematically and recorded for each animal. At 
the end of the experiment, blood samples were collected by 
puncturing retro orbital plexus after mild anesthesia for 
biochemical analysis. The collected blood sample was 
centrifuged within 5min of collection at 4000g for 10min to 
obtain plasma, which was analyzed for total cholesterol, total 
triglyceride, HDL-cholesterol levels, LDL-cholesterol, plasma 
glucose, alanine aminotransferase (ALT), aspartate 
aminotransferase (AST), creatinine and urea.  
 
Chronic toxicity test 
 
The study on chronic toxicity of HAEBD was carried out 
based on the OECD signs of toxicity the male and female rats 
were randomly divided in to four groups of six each. The 
extract was prepared at the concentration of 200mg/kg, 
400mg/kg and 600mg/kg in distilled water. The extract was 
given orally to treated groups of rats at doses 200, 400, 
600mg/kg body weight daily for 90 days while the control 
group received water vehicle. Toxic manifestation such as 
Body weight, signs of toxicity and mortality were observed 
daily. At the end of the study, all rats were fasted overnight 
and anesthetized for blood collection. Heparinized blood 
samples were taken for determining complete blood count, red 
blood cell count, platelet count and red cell indices. The serum 
from non-heparinized blood was carefully collected for blood 
chemistry and enzyme analysis. All rats were sacrificed after 
the blood collection. The internal organs and some tissues 
were weighed to determine relative organs weights.  
 
Statistics 
 
The results were expressed as Mean ± SEM. The data was 
evaluated using one way Anova followed by Newman- keuls 
multiple range test & differences below p<0.05 are considered 
as significant. 
 
RESULTS 
 
Acute toxicity studies 
 
In acute toxicity studies, no mortality or morbidity were 
observed in animals throughout the 14 days period following 
the single oral administration of the extract (Table 1).The 
animals did not show any changes in general appearance 
during the observation period. Morphological characteristics 
such as fur, skin, eyes and nose appeared normal. No tremors, 
convulsion, salivation, diarrhea, lethargy or unusual behaviors 
such as self-mutilation, walking backward and so forth were 
observed. Gait and posture, reactivity to handling or sensory 
stimuli, grip strength was also normal. Thus it was reported no 
overt signs of acute toxicity or death were observed in mice 
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treated with a Hydroalcoholic extract of Boerhaavia diffusa up 
to the dose of 2000 mg/kg.  
 
Subchronic toxicity 
 
The results obtained for the effect of HAEBD on body weight, 
biochemical, liver parameters and haematological parameters 
in sub chronic toxicity study are presented in Table 2 to 4.  
HAEBD at doses of 50, 100, and 200, 400mg/kg administered 
orally daily for 20 days did not result in any mortality in the 
tested animals. No signs of observable toxicity were detected 
during the entire experimental period. Significant increase 
(p<0.05) in body weight in all the animals were observed. The 
effects of HAEBD on organ weight & macroscopical changes 
of the rats didn’t shows much difference in all the groups. The 
effect of HAEBD on various biochemical parameters of 
experimental rats was observed and there was significant 
decrease (p < 0.05) in plasma glucose level in treated rats 
especially at higher dose (400mg/kg) compared to control rats. 
A significant decrease (p<0.05) in plasma total cholesterol 
(TC), triglyceride (TG) and LDL cholesterol levels and 
significant increase (p< 0.05) in HDL cholesterol levels were 
observed in all the treated animals when compared to control 
animals (Table 4) and AST, ALT and ALP levels were normal 
in the HAEBD treated animals (Table 5). The effect of 
HAEBD on haematological parameters were studied and 
significant increase (p<0.01) in haemoglobin content and RBC 
count and significant decrease in (p<0.01) in the WBC count 
in group treated 200 and 400mg/kg b.w of HAEBD compared 
to normal control group was observed. There was no 
significant change in the calcium level in all the treated 
animals compared to the control. 
 
Chronic toxicity 
 
The results obtained for the effect of HAEBD on body weight, 
haematological parameters & biochemical values in chronic 
toxicity study are presented in Table 7-9 
 
In chronic toxicity study for 90 days, the rats treated with 
HAEBD at all three doses had no signs of behavior changes 
and toxic signs. The treated groups revealed that there was 
slight increase in body weight. However, the result from 
animal health monitoring in the entire period of 90 days 
showed no sign of morbidity and diseases. In regard to 
hematological values, most of values in treated groups were 
normal in comparison with the control group. Significantly, 
slight difference in values were observed for  RBC, MCV, 
MCHC and platelet  in treatment group from that of control 
group but such values are within the normal ranges. Therefore, 
these results suggest that the extract did not cause 
hematological or immunological defects in rats. Furthermore, 
blood chemical examination was performed in order to 
evaluate any toxic effects on liver and kidney. In this study, 
the levels of blood chemical value showed minor changes 
which remained within the normal range. This study clearly 
explain that HAEBD given orally to wistar rats did not 
produce chronic toxicities. 
 
Table 1 Acute toxicity studies of hydro-alcoholic extract  
of B. diffusa Linn on mice 
 
Group(n=3) Dose (mg/kg) 
Sign of Toxicity 
(ST/NB) 
Mortality 
(D/S) 
Group I 0 0/3 0/3 
Group II 300 0/3 0/3 
Group III 2000 0/3 0/3                           Note: ST- sign of toxicity; NB- normal behaviour; D- died; S- survived 
Sub chronic Toxicies ofhydroalcokolic extract of B.diffusa 
Linn on rats 
 
Table 2 Effects of HAEBD on body weight changes in rats 
 
Treatment n=6)
mg/kg b.w. Day 1 Day 5 Day 10 Day 20 
Control 185.10±6.5 188.45 ±6.20 191.08 ±6.40 196.3±6.58 
HAEBD50 190.22 ±6.8 192.32 ±6.34 195.25 ±6.72 198.28±6.75* 
HAEBD100 188.40 ±6.2 190.26 ±6.46 193.50±7.05 195.30±6.38* 
HAEBD200 192.34 ±7.2 195.10±6.55 198.20 ±7.22** 200.42±7.20** 
HAEBD400 186.65 ±6.1 189.4  ±6.44 191.64±6.32** 202.65±7.35** 
 
Note: Values are expressed as mean ± SEM. Statistical analysis was carried out using one  
way ANOVA method where ** p <0.01;*p <0.05. 
 
Table 3 Effect of HAEBD on kidney, heart, liver and brain of 
rats 
 
Treatment (n=6) 
mg/kg b.w. Heart (g) Kidney (g) Liver(g) Brain (g) 
Control 0.32 ± 0.02 0.63 ± 0.01 3.23 ± 0.02 0.64 ± 0.03
HAEBD 50 0.33 ± 0.01 0.78 ± 0.02 3.38 ± 0.01 0.65 ± 0.1 
HAEBD100 0.34 ± 0.02 0.76 ± 0.03 3.34 ±0.01 0.66 ± 0.2 
HAEBD200 0.33 ± 0.01 0.70 ± 0.03 3.28 ± 0.01 0.72 ± 0.06
HAEBD400 0.32 ± 0.01 0.72 ± 0.01 3.32 ± 0.02 0.74 ± 0.05
 
Note: Values are expressed as mean ± SEM. Statistical analysis was carried out using one 
way ANOVA method where ** p <0.01;*p <0.05. 
 Table 4 Effect of HAEBD on biochemical parameters 
 
Treatment 
mg/kg b.w. 
(n=6) 
Glucose 
(mg/dl) 
Cholesterol 
(mg/dl) 
Triglyceride 
(mg/dl) 
HDL 
(mg/dl) 
LDL 
(mg/dl) 
Control 90.62 ± 0.65 38.60 ± 0.55 25.25 ± 0.50 136.20 ± 0.55 80.10 ± 1.80 
HAEBD 50 88.50 ± 0.56 22.80 ± 0.20* 12.20 ± 0.22* 175.30 ± 0.70* 67.65 ± 1.10 
HAEBD 100 85.40 ± 0.48 23.75 ± 0.24* 12.40 ± 0.28* 165.20 ± 0.82* 65.80 ± 1.22 
HAEBD 200 86.20 ± 0.52** 30.20 ± 0.28 16.85 ± 0.35* 184.25 ± 0.88* 44.60 ± 1.05 
HAEBD 400 84.22 ± 0.42** 29.75 ± 0.26 16.30 ± 0.32* 182.3 ± 0.85* 42.50 ± 0.95 
 
Note: Values are expressed as mean ± SEM. Statistical analysis was carried out using one  
way ANOVA method where ** p <0.01;*p <0.05. 
 Table 5 Effect of HAEBD on AST, ALT, ALP, TP and 
albumin in rats 
 
Treatment 
mg/kg b.w. 
(n=6) 
AST 
(IU/l) 
ALT 
(IU/l) 
ALP 
(IU/l) 
TP 
(g/l) 
Albumin 
(g/l) 
Control 323.4 ± 10.47 68.4 ± 3.19 255.60 ± 8.78 68.86 ± 3.30 35.11 ± 2.33 
HAEBD 50 315.4 ± 9.81** 66.6 ± 2.16** 263.00 ± 2.74** 69.33 ± 2.30 36.25 ± 2.60 
HAEBD100 318.2 ± 7.47** 64.0 ± 3.02** 257.60 ± 6.98** 79.12 ± 2.80 34.25 ± 3.00 
HAEBD200 309.0 ± 7.70 59.5 ± 2.85 262.00 ± 5.50 69.20 ± 3.30 36.22 ± 2.80 
HAEBD 400 319.0 ±  8.99 61.4 ± 3.54 269.44 ± 4.40 70.00 ± 2.60 35.45 ± 2.70 
 
Note: Values are expressed as mean ± SEM. Statistical analysis was carried out using one  
way ANOVA method where ** p <0.01;*p <0.05. 
 
Table 6 Effect of HAEBD on Haematological parameters 
 
Treatment 
mg/kg b.w. 
(n=6) 
Haemoglobin 
(mg/dl) 
RBC 
(106 /mm3) 
WBC 
(106 /mm3) 
Calcium 
(mg/dl) 
Control 11.2± 0.20 9.06± 0.02 11.3± 0.03 9.05 ±0.02 
HAEBD50 12.6 ± 0.20* 9.57 ± 0.04* 8.4 ± 0.03* 9.05 ± 0.02 
HAEBD100 12.4 ± 0.12* 9.32 ± 0.02* 7.2 ± 0.30* 9.00 ± 0.30 
HAEBD200 10.8 ± 0.20* 8.16 ± 0.12* 10.2 ± 0.02* 9.68 ± 0.03 
HAEBD400 11.6 ± 0.30* 8.55 ± 0.45* 9.6 ± 0.12* 9.42 ± 0.22 
 
Note: Values are expressed as mean ± S.E.M.  Statistical analysis carried out using 
one way ANOVA method where *p < 0.05. 
 
Chronic Toxicity studies on hydroalcoholic extract on 
Boerhaavia diffusa 
 Table 7 Effect of HAEBD on the body weight 
 
Treatment (n=6) 
(Dose in mg.kg-1) Day 0 Day 90 
Control 215.65 ± 6.45 267.70 ± 7.90 
HAEBD @ 200 219.35 ± 6.40 272.20 ± 8.20 
HAEBD @ 400 222.80 ± 6.56 280.20 ± 8.30 
HAEBD @ 600 218.22 ± 6.80 275.35 ± 7.52               Note: Values are expresses as mean ± S.E.M. Not significant from normal control 
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Table 8 Effect of HAEBD on Hematological Parameters 
 
S. No Parameters Control Drug Concentration (mg/kg) 200 400 600 
1 White blood cells(X103/µl) 8.20 ± 0.30 8.15 ± 0.20 8.18 ± 0.13 8.26 ± 0.16 
2 Hemoglobin(g/dl) 10.10 ± 0.14 9.80 ± 0.26 9.40 ± 0.30 9.60 ± 0.20 
3 Mean corpuscular volume 60.35 ± 0.40 59.20 ± 0.5559.72 ± 0.36 58.58 ± 0.20 
4 Mean corpuscular hemoglobin conc.(g/dl) 34.60 ± 0.44 33.10 ± 0.3033.20 ± 0.12 32.82 ± 0.86 
5 Platelet(X105/µl) 5.70 ± 0.23 5.15 ± 0.15 5.46 ± 0.20 5.70 ± 0.14 
6 Red  blood cell(X106/µl) 3.70 ± 0.26 4.10 ± 0.25 4.65 ± 0.10 4.82± 0.42 
 
Note: Values are expressed as mean ± S.E.M.  No significant difference from normal 
control 
 
Table 9 Effect of HAEBD on Blood Chemical Values 
 
S. No  Parameters 
 
Control 
Drug Concentration (in mg/kg) 
200 400 600 
1 Glucose(mg/dl) 145.56 ± 8.52 143.30 ± 2.85 148.40 ± 0.40 153.80 ± 3.90 
2 BUN (mg/dl) 32.40 ± 1.40 18.16 ± 0.80 19.50 ± 0.36 20.45 ± 0.20 
3 Creatinine (mg/dl) 0.42 ± 0.06 0.46 ± 0.05 0.48 ± 0.07 0.39 ± 0.02 
4 Total protein (g/dl) 5.50 ± 0.20 5.45 ± 0.28 5.64 ± 0.32 5.86 ± 0.10 
5 Albumin (g/dl) 3.72 ± 0.16 3.70 ± 0.43 3.68 ± 0.24 3.85 ± 0.18 
6 Total bilirubin (mg/dl) 0.18 ± 0.10 0.16 ± 0.14 0.15 ± 0.15 0.14 ± 0.10 
7 AST(u/i) 142.30 ± 10.80 130.34 ±16.42 136.60 ±18.40 142.40 ± 17.30 
8 ALT(u/i) 83.40 ± 4.26 76.5 ± 3.50 74.40 ± 3.65 77.80 ± 3.66 
9 ALP(u/i) 71.40 ± 2.66 61.40 ± 2.40 61.70 ± 2.43 63.43 ± 2.46 
 Note: Values are expresses as mean ± S.E.M. Not significantly different from normal 
control 
 
DISCUSSION 
  
The evaluation of sub-chronic and chronic dosing in 
experimental animals may be more relevant in determining the 
overall toxicity of the plant preparation.  The highest overall 
concordance of toxicity in animals in comparison with humans 
is with hematological, gastrointestinal, and cardiovascular 
adverse effects whiles certain adverse effects in humans, 
especially hypersensitivity and idiosyncratic reactions, are 
poorly correlated with toxicity observed in animals.8 
 
In the present study, where the acute toxicity study of HAEBD 
was carried out as per OECD-423 guidelines, No mortality was 
observed in both the animals of control group as well as 
animals treated with a maximum dose of 2000 mg.kg-1.   
Hence, 1/10th of 2000 mg.kg-1 i.e. 200 mg.kg-1 of dose was 
selected as a minimum dose for sub-acutetoxicity study.9 The 
results of sub-acute toxicity study shows that there was no 
significant change in animal behaviour due to the absence of 
toxicity. The animals treated with HAEBD showed normal 
growth pattern and body weight compared with control rats 
treated with normal saline. So the changes in body weight can 
be used as an indicator of adverse effects of drugs and 
chemicals.10-12 The changes in enzymes like ALP, AST and 
ALT levels show liver impairment, due to toxicity.13   Serum 
cholesterol and proteins mainly regulated via synthesis in the 
liver and increase or decrease in serum concentrations of 
constituents suggest liver toxicity.   The results of the present 
study were assessed after 20 days of administration of 
HAEBD, and it was found that HAEBD at all concentrations 
do not produce liver damage. 
 
Analysis of blood parameters is likely to risk evaluation as the 
change in hematological system has a higher predictive value 
for human toxicity, when data are translated from animal 
studies.8 After 20 days of treatment, there were no significant 
changes in the haematological parameters between control and 
treated groups. No significant changes in the levels of WBC, 
RBC were observed between control and test groups following 
repeated administration of HAEBD. Interestingly, significant 
increase in the levels of hemoglobin was found in treatment 
with HAEBD with a higher dose of 400 mg.kg-1.   The possible 
reason could be that one of the constituents HAEBD may 
increase absorption of iron.  
 
The overall results suggest that HAEBD are non toxic to the 
haematopoietic and leucopoietic system.   The haematopoietic 
and leucopoietic systems are the most sensitive targets for 
toxic compounds and an important index of physiological and 
pathological status in man and animal.14  Therefore, it is 
possible to assume that the extract is non haematotoxic. 
 
In chronic toxicity study for 90 days, the doses of 200, 400 and 
600 mg/kg/day crude extract were chosen for the experiment, 
which are equivalent to 2.83-33.72 times of the normal human 
dose (crude plant material, 3–9 g/day for adults.15 In the aspect 
of general behaviors, the rats treated with HAEBD at all three 
doses had no signs of behavior changes and toxic signs. The 
increase of body weight may have resulted from physiological 
changes in rats such as metabolism, food and water intake. 
However, the result from animal health monitoring in the 
entire period of 90 days showed no sign of morbidity and 
diseases. The albino wistar rats were healthy as shown by the 
normal appearance of general behavior, respiratory pattern, 
cardiovascular signs, motor activities, reflexes, and normal 
change in skin and fur. 
 
RBC, MCV, MCHC, and platelet values are within the normal 
ranges. These variations may have resulted from normal 
variation among animal groups.16, 17 Therefore, these results 
suggest that the extract did not cause hematological or 
immunological defects in rats. 
 
In this study, the levels of these blood chemical values were 
remained within the normal range.18-20The above observations 
clearly establish the non-toxicity of HAEBD at a concentration 
of 1000mg.kg-1.  
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